Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,Cellular Response To Starvation R-HSA-9711097,-0.805428885398589,-3.014825986609575,0.0,0.0,0.0,79/135,4.84%,RPL6;ATP6V0C;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;ATP6V1D;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;ATP6V1A;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;ATP6V1G2;SESN1;RPL15;RPS14;RPS20;RPS16;RPL22L1;ATP6V0E2;RPL18;RPS12;RPL30;RPL36;UBA52;RPL26;RPL34;RPL39;RPS9;RPL31;LAMTOR2;ATP6V0B;RHEB;RPL32;RRAGA;RPL35A;ATP6V1F;LAMTOR3
gsea,Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,-0.7227627199923338,-2.960611939062987,0.0,0.0,0.0,74/170,6.10%,RPL6;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;RPL15;RPS14;RPS20;RPS16;RPL22L1;RPL18;RPS12;RPL30;RPL36;UBA52;RPL26;RPL34;RPL39;RPS9;RPL31;SNU13;RPL32;RPL35A;CSNK1E;PDCD11;RPL36AL;UTP3;RPL36A;C1D
gsea,Influenza Infection R-HSA-168255,-0.7619071810902636,-2.9397099678851313,0.0,0.0,0.0,74/140,4.81%,RPL6;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;HSP90AA1;RPL22;RAN;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;CALR;CLTA;RPS3;RPS17;RPL41;RPL23A;RPL4;RPL15;RPS14;RPS20;RPS16;RPL22L1;RPL18;RPS12;RPL30;RPL36;UBA52;RPL26;RPL34;RPL39;RPS9;RPL31;CANX;RPL32;RPL35A;POLR2G;POLR2F
gsea,Cap-dependent Translation Initiation R-HSA-72737,-0.8553025904323683,-2.9192326084203866,0.0,0.0,0.0,86/106,10.32%,RPL6;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;EIF4A1;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;EIF3C;RPL15;RPS14;RPS20;RPS16;RPL22L1;RPL18;RPS12;RPL30;RPL36;UBA52;EIF3F;RPL26;RPL34;RPL39;RPS9;EIF3H;EIF4A2;RPL31;EIF1AX;RPL32;RPL35A;EIF3A;EIF4H;RPL36AL;RPL36A;EIF3K;EIF3I;EIF5B;EIF2S2;RPLP0;PABPC1;EIF5;RPS13;RPS19
gsea,rRNA Processing In Nucleus And Cytosol R-HSA-8868773,-0.7095591777408605,-2.9143061561405097,0.0,0.0,0.0,76/180,6.10%,RPL6;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;RPL15;RPS14;RPS20;RPS16;RPL22L1;RPL18;RPS12;RPL30;RPL36;UBA52;RPL26;RPL34;RPL39;RPS9;RPL31;SNU13;THUMPD1;TRMT112;RPL32;RPL35A;CSNK1E;PDCD11;RPL36AL;UTP3;RPL36A;C1D
gsea,Translation R-HSA-72766,-0.6928500316071905,-2.913159583397091,0.0,0.0,0.0,131/253,13.76%,RPL6;EEF1A1;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;EIF4A1;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;SRP14;EIF3C;RPL15;RPS14;RPS20;RPS16;EEF1G;RPL22L1;EEF1B2;RPL18;SPCS2;EEF2;RPS12;MRPS26;RPL30;RPL36;UBA52;EIF3F;RPL26;RPL34;MRPL52;RPL39;RPS9;EIF3H;EEF1A2;EIF4A2;RPL31;AURKAIP1;MRPL36;EIF1AX;MRPS24;TRMT112;RPL32;RPL35A;MRPL9;MRPL41;EIF3A;MRPL54;EIF4H;MRPS16;MRPL18;RPL36AL;MRPS21;RPL36A;MRPL30;EIF3K;MRPL14;SSR3;MRPL23;MRPL57;EIF3I;EIF5B;SEC61G;EIF2S2;SSR2;MRPS14;RPLP0;PABPC1;EIF5;CHCHD1;RPS13;MRPL39;RPS19;MRPL19;MRPS33;MRPS2;DDOST;MRPL11;RPS27L;MRPL33;SPCS1;MRPL44;MRPL35;MRPL12;MTIF3;WARS2;SRP19;RPL35;MRPL20
gsea,Influenza Viral RNA Transcription And Replication R-HSA-168273,-0.7692514475151384,-2.907046878980239,0.0,0.0,0.0,72/126,6.08%,RPL6;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;HSP90AA1;RPL22;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;RPL15;RPS14;RPS20;RPS16;RPL22L1;RPL18;RPS12;RPL30;RPL36;UBA52;RPL26;RPL34;RPL39;RPS9;RPL31;RPL32;RPL35A;POLR2G;POLR2F;RPL36AL;RPL36A
gsea,rRNA Processing R-HSA-72312,-0.6987518922244698,-2.905013481116257,0.0,0.0,0.0,76/190,6.10%,RPL6;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;RPL15;RPS14;RPS20;RPS16;RPL22L1;RPL18;RPS12;RPL30;RPL36;UBA52;RPL26;RPL34;RPL39;RPS9;RPL31;SNU13;THUMPD1;TRMT112;RPL32;RPL35A;CSNK1E;PDCD11;RPL36AL;UTP3;RPL36A;C1D
gsea,GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,-0.8653215530509603,-2.8905158645909226,0.0,0.0,0.0,85/100,10.32%,RPL6;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;EIF4A1;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;EIF3C;RPL15;RPS14;RPS20;RPS16;RPL22L1;RPL18;RPS12;RPL30;RPL36;UBA52;EIF3F;RPL26;RPL34;RPL39;RPS9;EIF3H;EIF4A2;RPL31;EIF1AX;RPL32;RPL35A;EIF3A;EIF4H;RPL36AL;RPL36A;EIF3K;EIF3I;EIF5B;EIF2S2;RPLP0;EIF5;RPS13;RPS19
gsea,Selenoamino Acid Metabolism R-HSA-2408522,-0.8645255393401822,-2.886428178762045,0.0,0.0,0.0,69/92,6.08%,RPL6;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;RPL15;RPS14;RPS20;RPS16;RPL22L1;RPL18;RPS12;RPL30;RPL36;UBA52;RPL26;RPL34;RPL39;RPS9;RPL31;RPL32;RPL35A;RPL36AL;RPL36A
gsea,Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,-0.8204529146367227,-2.8845962260833833,0.0,0.0,0.0,71/105,6.26%,RPL6;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;RPL15;RPS14;RPS20;RPS16;RPL22L1;RPL18;RPS12;RPL30;RPL36;UBA52;RPL26;RPL34;RPL39;RPS9;RPL31;RPL32;PPP2R1A;RPL35A;RPL36AL;RPL36A;PPP2CA
gsea,L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,-0.8666593482345188,-2.8841657686705706,0.0,0.0,0.0,78/99,6.69%,RPL6;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;EIF4A1;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;EIF3C;RPL15;RPS14;RPS20;RPS16;RPL22L1;RPL18;RPS12;RPL30;RPL36;UBA52;EIF3F;RPL26;RPL34;RPL39;RPS9;EIF3H;EIF4A2;RPL31;EIF1AX;RPL32;RPL35A;EIF3A;EIF4H;RPL36AL;RPL36A;EIF3K
gsea,Viral mRNA Translation R-HSA-192823,-0.8929430404021236,-2.8826341664972865,0.0,0.0,0.0,69/83,6.08%,RPL6;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;RPL15;RPS14;RPS20;RPS16;RPL22L1;RPL18;RPS12;RPL30;RPL36;UBA52;RPL26;RPL34;RPL39;RPS9;RPL31;RPL32;RPL35A;RPL36AL;RPL36A
gsea,Formation Of A Pool Of Free 40S Subunits R-HSA-72689,-0.880288923378711,-2.8688481552808014,0.0,0.0,0.0,75/90,6.69%,RPL6;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;EIF3C;RPL15;RPS14;RPS20;RPS16;RPL22L1;RPL18;RPS12;RPL30;RPL36;UBA52;EIF3F;RPL26;RPL34;RPL39;RPS9;EIF3H;RPL31;EIF1AX;RPL32;RPL35A;EIF3A;RPL36AL;RPL36A;EIF3K
gsea,Selenocysteine Synthesis R-HSA-2408557,-0.8943563456012104,-2.856182948732328,0.0,0.0,0.0,69/82,6.08%,RPL6;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;RPL15;RPS14;RPS20;RPS16;RPL22L1;RPL18;RPS12;RPL30;RPL36;UBA52;RPL26;RPL34;RPL39;RPS9;RPL31;RPL32;RPL35A;RPL36AL;RPL36A
gsea,Eukaryotic Translation Elongation R-HSA-156842,-0.9039039536076148,-2.846924863652987,0.0,0.0,0.0,74/83,6.08%,RPL6;EEF1A1;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;RPL15;RPS14;RPS20;RPS16;EEF1G;RPL22L1;EEF1B2;RPL18;EEF2;RPS12;RPL30;RPL36;UBA52;RPL26;RPL34;RPL39;RPS9;EEF1A2;RPL31;RPL32;RPL35A;RPL36AL;RPL36A
gsea,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,-0.8380020976215585,-2.8462128989790867,0.0,0.0,0.0,69/99,4.64%,RPL6;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;SRP14;RPL15;RPS14;RPS20;RPS16;RPL22L1;RPL18;SPCS2;RPS12;RPL30;RPL36;UBA52;RPL26;RPL34;RPL39;RPS9;RPL31;RPL32;RPL35A
gsea,Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.6418188065567461,-2.842759973888692,0.0,0.0,0.0,112/263,14.24%,RPL6;RPS29;RPL37;RPL23;SERINC1;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;PSMA7;RPL15;RPS14;RPS20;RPS16;RPL22L1;PSMB5;RPL18;RPS12;RPL30;RPL36;UBA52;RPL26;RPL34;RPL39;RPS9;CKB;OAZ1;RPL31;PSMC3;SEM1;PSMC2;PSMA4;GLUL;RPL32;RPL35A;PSMA5;PHGDH;RPL36AL;DLAT;RPL36A;PSMD2;PSMD4;PSMC5;ACAD8;PSMB1;PSMA3;ALDH6A1;RPLP0;PSMD6;RPS13;PSMA1;PSMB3;RPS19;GOT2;RPS27L;PSMC1;CHGA;PSMD7;ETHE1;CHDH;PAOX;PSAT1;PSMC4;PSME3;PSMA2;RPL35;ADO;PHYKPL;ARG2;PSMC6
gsea,Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,-0.8759082369507173,-2.841566995125904,0.0,0.0,0.0,69/85,6.08%,RPL6;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;RPL15;RPS14;RPS20;RPS16;RPL22L1;RPL18;RPS12;RPL30;RPL36;UBA52;RPL26;RPL34;RPL39;RPS9;RPL31;RPL32;RPL35A;RPL36AL;RPL36A
gsea,Eukaryotic Translation Termination R-HSA-72764,-0.8901418535234593,-2.8372671350447787,0.0,0.0,0.0,70/83,6.08%,RPL6;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;RPL15;RPS14;RPS20;RPS16;RPL22L1;RPL18;RPS12;RPL30;RPL36;UBA52;RPL26;RPL34;RPL39;RPS9;RPL31;TRMT112;RPL32;RPL35A;RPL36AL;RPL36A
gsea,Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,-0.8747587869750546,-2.833937949828169,0.0,0.0,0.0,69/87,6.08%,RPL6;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;RPL15;RPS14;RPS20;RPS16;RPL22L1;RPL18;RPS12;RPL30;RPL36;UBA52;RPL26;RPL34;RPL39;RPS9;RPL31;RPL32;RPL35A;RPL36AL;RPL36A
gsea,Peptide Chain Elongation R-HSA-156902,-0.9040954475593388,-2.8037241356984253,0.0,0.0,0.0,71/79,6.08%,RPL6;EEF1A1;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;RPL15;RPS14;RPS20;RPS16;RPL22L1;RPL18;EEF2;RPS12;RPL30;RPL36;UBA52;RPL26;RPL34;RPL39;RPS9;RPL31;RPL32;RPL35A;RPL36AL;RPL36A
gsea,Signaling By ROBO Receptors R-HSA-376176,-0.6842573623485234,-2.7898204945175222,0.0,0.0,0.0,100/187,10.32%,RPL6;UBB;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;PFN2;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;PSMA7;RPL15;RPS14;ELOB;RPS20;RPS16;RPL22L1;PSMB5;RPL18;RPS12;RPL30;RPL36;UBA52;CDC42;RPL26;RPL34;RPL39;RPS9;RPL31;PSMC3;SEM1;PSMC2;PSMA4;RPL32;RPL35A;PSMA5;RPL36AL;PPP3CB;RBX1;RPL36A;NELL2;PSMD2;PSMD4;PSMC5;PFN1;NCK1;MAGOH;RBM8A;PSMB1;PSMA3;RPLP0;PABPC1;PSMD6;RPS13;FLRT3;PSMA1;PSMB3;RPS19
gsea,Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,-0.7368496902010159,-2.7884480744116957,0.0,0.0,0.0,93/151,10.32%,RPL6;UBB;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;RPL18A;RPS28;RPL28;RPL11;RPS15;RPS24;RPS25;RPS27A;RPS8;RPL7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;RPL22;RPS6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;RPS3;RPS17;RPL41;RPL23A;RPL4;PSMA7;RPL15;RPS14;ELOB;RPS20;RPS16;RPL22L1;PSMB5;RPL18;RPS12;RPL30;RPL36;UBA52;RPL26;RPL34;RPL39;RPS9;RPL31;PSMC3;SEM1;PSMC2;PSMA4;RPL32;RPL35A;PSMA5;RPL36AL;RBX1;RPL36A;PSMD2;PSMD4;PSMC5;MAGOH;RBM8A;PSMB1;PSMA3;RPLP0;PABPC1;PSMD6;RPS13;PSMA1;PSMB3;RPS19
gsea,Ribosomal Scanning And Start Codon Recognition R-HSA-72702,-0.8524086387976567,-2.774239084886314,0.0,0.0,0.0,42/52,11.40%,RPS29;RPS2;RPS7;RPSA;RPS23;RPS28;RPS15;RPS24;RPS25;RPS27A;RPS8;RPS21;RPS5;RPS11;FAU;EIF4A1;RPS6;RPS27;RPS15A;RPS4X;RPS10;RPS3;RPS17;EIF3C;RPS14;RPS20;RPS16;RPS12;EIF3F;RPS9;EIF3H;EIF4A2;EIF1AX;EIF3A;EIF4H;EIF3K;EIF3I;EIF2S2;EIF5;RPS13;RPS19;RPS27L
gsea,Translation Initiation Complex Formation R-HSA-72649,-0.8524132609377422,-2.737578611691728,0.0,0.0,0.0,42/52,11.40%,RPS29;RPS2;RPS7;RPSA;RPS23;RPS28;RPS15;RPS24;RPS25;RPS27A;RPS8;RPS21;RPS5;RPS11;FAU;EIF4A1;RPS6;RPS27;RPS15A;RPS4X;RPS10;RPS3;RPS17;EIF3C;RPS14;RPS20;RPS16;RPS12;EIF3F;RPS9;EIF3H;EIF4A2;EIF1AX;EIF3A;EIF4H;EIF3K;EIF3I;EIF2S2;PABPC1;RPS13;RPS19;RPS27L
gsea,"mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",-0.8524132609377422,-2.737578611691728,0.0,0.0,0.0,42/52,11.40%,RPS29;RPS2;RPS7;RPSA;RPS23;RPS28;RPS15;RPS24;RPS25;RPS27A;RPS8;RPS21;RPS5;RPS11;FAU;EIF4A1;RPS6;RPS27;RPS15A;RPS4X;RPS10;RPS3;RPS17;EIF3C;RPS14;RPS20;RPS16;RPS12;EIF3F;RPS9;EIF3H;EIF4A2;EIF1AX;EIF3A;EIF4H;EIF3K;EIF3I;EIF2S2;PABPC1;RPS13;RPS19;RPS27L
gsea,Respiratory Electron Transport R-HSA-611105,-0.7036416687714824,-2.735124892764136,0.0,0.0,0.0,66/89,22.08%,COX6C;COX8A;UQCRQ;NDUFA1;NDUFA3;NDUFS5;COX4I1;COX5B;COX6B1;UQCRB;COX5A;COX7C;COX7A2L;UQCR10;COX6A1;NDUFB1;NDUFB11;NDUFS2;NDUFB3;NDUFA2;UQCRH;UQCRC1;NDUFA13;NDUFB10;COX7B;NDUFS8;CYCS;NDUFS7;UQCR11;UQCRC2;NDUFA7;NDUFB8;COX20;NDUFV2;NDUFA8;SCO2;NDUFC1;NDUFV1;NDUFC2;COX14;NDUFA12;NDUFB6;NDUFA10;NDUFB4;NDUFA5;NDUFS6;NDUFB5;SDHA;SDHD;COX19;NDUFAB1;SURF1;UQCRFS1;NDUFAF3;SDHB;NDUFA9;NDUFAF2;NDUFA11;NDUFB7;CCNI;NDUFB9;NDUFB2;TMEM186;TIMMDC1;NDUFAF5;NDUFAF4
gsea,"Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",-0.6913593520372489,-2.7199816910284778,0.0,0.0,0.0,68/94,22.08%,COX6C;COX8A;UQCRQ;NDUFA1;NDUFA3;NDUFS5;COX4I1;COX5B;ATP5PB;COX6B1;UQCRB;COX5A;COX7C;COX7A2L;UQCR10;COX6A1;NDUFB1;NDUFB11;NDUFS2;NDUFB3;NDUFA2;UQCRH;UQCRC1;NDUFA13;NDUFB10;COX7B;NDUFS8;CYCS;NDUFS7;UQCR11;UQCRC2;NDUFA7;NDUFB8;COX20;NDUFV2;NDUFA8;SCO2;NDUFC1;NDUFV1;NDUFC2;COX14;NDUFA12;NDUFB6;NDUFA10;NDUFB4;NDUFA5;NDUFS6;NDUFB5;SDHA;SDHD;COX19;NDUFAB1;SURF1;UQCRFS1;NDUFAF3;SDHB;NDUFA9;NDUFAF2;NDUFA11;NDUFB7;CCNI;NDUFB9;NDUFB2;TMEM186;UCP2;TIMMDC1;NDUFAF5;NDUFAF4
gsea,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.6409657317704537,-2.7151132490859884,0.0,0.0,0.0,85/138,22.08%,COX6C;COX8A;UQCRQ;NDUFA1;NDUFA3;NDUFS5;COX4I1;MDH2;COX5B;IDH3B;ATP5PB;COX6B1;BSG;UQCRB;VDAC1;COX5A;COX7C;COX7A2L;UQCR10;COX6A1;NDUFB1;NDUFB11;NDUFS2;NDUFB3;NDUFA2;UQCRH;UQCRC1;NDUFA13;NDUFB10;COX7B;NDUFS8;CYCS;NDUFS7;UQCR11;UQCRC2;DLAT;LDHA;NDUFA7;GLO1;NDUFB8;COX20;HAGH;NDUFV2;NDUFA8;SCO2;NDUFC1;NDUFV1;NDUFC2;COX14;SUCLG1;LDHB;NDUFA12;NDUFB6;NDUFA10;NDUFB4;NDUFA5;SLC16A1;NDUFS6;NDUFB5;SDHA;SDHD;COX19;LDHD;NDUFAB1;FAHD1;SURF1;IDH2;UQCRFS1;NDUFAF3;IDH3A;SDHB;NDUFA9;IDH3G;NDUFAF2;NDUFA11;NDUFB7;CCNI;NDUFB9;NDUFB2;TMEM186;UCP2;TIMMDC1;MPC2;NDUFAF5;NDUFAF4
gsea,"Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",-0.8558885162448246,-2.684061414665007,0.0,0.0,0.0,38/45,11.40%,RPS29;RPS2;RPS7;RPSA;RPS23;RPS28;RPS15;RPS24;RPS25;RPS27A;RPS8;RPS21;RPS5;RPS11;FAU;RPS6;RPS27;RPS15A;RPS4X;RPS10;RPS3;RPS17;EIF3C;RPS14;RPS20;RPS16;RPS12;EIF3F;RPS9;EIF3H;EIF1AX;EIF3A;EIF3K;EIF3I;EIF2S2;RPS13;RPS19;RPS27L
gsea,Complex I Biogenesis R-HSA-6799198,-0.7264437582872177,-2.6223161905820316,0.0,0.0,0.0,39/50,23.33%,NDUFA1;NDUFA3;NDUFS5;NDUFB1;NDUFB11;NDUFS2;NDUFB3;NDUFA2;NDUFA13;NDUFB10;NDUFS8;NDUFS7;NDUFA7;NDUFB8;NDUFV2;NDUFA8;NDUFC1;NDUFV1;NDUFC2;NDUFA12;NDUFB6;NDUFA10;NDUFB4;NDUFA5;NDUFS6;NDUFB5;NDUFAB1;NDUFAF3;NDUFA9;NDUFAF2;NDUFA11;NDUFB7;NDUFB9;NDUFB2;TMEM186;TIMMDC1;NDUFAF5;NDUFAF4;NDUFAF7
gsea,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,-0.8299251525257854,-2.6109715814607517,0.0,0.0,0.0,30/43,5.36%,RPS29;RPS2;RPS7;RPSA;RPS23;RPS28;RPS15;RPS24;RPS25;RPS27A;RPS8;RPS21;RPS5;RPS11;FAU;RPS6;RPS27;RPS15A;RPS4X;RPS10;RPS3;RPS17;RPS14;RPS20;RPS16;RPS12;SNRPD2;RPS9;SNRPG;SNRPF
gsea,SARS-CoV-2-host Interactions R-HSA-9705683,-0.5734662513993053,-2.545855282274393,0.0,0.0,0.0,53/141,13.19%,HSP90AB1;RPS29;RPS2;RPS7;RPSA;RPS23;RPS28;RPS15;RPS24;RPS25;RPS27A;RPS8;YWHAG;RPS21;RPS5;YWHAH;RPS11;FAU;HSP90AA1;RPS6;RPS27;RPS15A;RPS4X;RPS10;RPS3;RPS17;YWHAB;RPS14;RPS20;RPS16;CNBP;RPS12;YWHAE;SNRPD2;RPS9;SNRPG;SNRPF;MAP1LC3B;YWHAZ;UBE2N;YWHAQ;NUP50;RPS13;DDX20;RPS19;G3BP2;MASP2;UBE2V1;RPS27L;SEC13;NUP62;NUP37;SNRPE
gsea,Cellular Response To Chemical Stress R-HSA-9711123,-0.540769479238253,-2.3795128274927255,0.0,0.0,0.0,57/144,14.86%,UBB;COX6C;RPS27A;COX8A;COX4I1;COX5B;PSMA7;SESN1;COX6B1;PSMB5;PRDX5;UBA52;SQSTM1;COX5A;COX7C;COX7A2L;COX6A1;PSMC3;SEM1;PSMC2;PSMA4;COX7B;SOD1;PSMA5;PHGDH;CYCS;RBX1;MAP1LC3B;PSMD2;PSMD4;PSMC5;GSTP1;SIN3B;COX20;CSNK2B;PRDX1;PSMB1;PSMA3;GCLM;PSMD6;SCO2;TBL1XR1;COX14;PSMA1;PSMB3;HMOX2;SRXN1;PSMC1;PSMD7;P4HB;PSMC4;PSME3;PSMA2;VCP;GSK3B;PSMC6;COX19
gsea,Synaptic Adhesion-Like Molecules R-HSA-8849932,0.7718669203303906,2.378374721743426,0.0,0.00046046670528645487,0.001,10/20,7.87%,GRIA3;PTPRS;GRIN2A;GRIA1;GRIA4;PTPRD;PTPRF;LRFN2;LRFN1;MPP3
gsea,Nuclear Events Mediated By NFE2L2 R-HSA-9759194,-0.6069722139020342,-2.3481198141598028,0.0,0.0,0.0,40/69,23.53%,UBB;RPS27A;PSMA7;PSMB5;UBA52;SQSTM1;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PHGDH;RBX1;PSMD2;PSMD4;PSMC5;PRDX1;PSMB1;PSMA3;GCLM;PSMD6;PSMA1;PSMB3;SRXN1;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;GSK3B;PSMC6;PSMB7;UBC;TXNRD1;SKP1;PSMB6;GSR;TALDO1;PSMD10;PSMB10
gsea,Cellular Response To Hypoxia R-HSA-1234174,-0.620548209302564,-2.346907318111567,0.0,0.0,0.0,33/62,18.89%,UBB;RPS27A;PSMA7;ELOB;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;CITED2;PSMA5;RBX1;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;HIGD1A;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6;LIMD1;ELOC;PSMB7;MIA3;UBC
gsea,Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,-0.6033619278621613,-2.340132976489267,0.0,0.0,0.0,33/71,14.24%,CALM1;UBB;PPIA;PPP3CA;RPS27A;FKBP1A;PSMA7;RASGRP1;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PPP3R1;PPP3CB;PSMD2;PSMD4;PSMC5;HRAS;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;NFKBIB;PSMC6
gsea,Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,-0.6585382677321049,-2.3336051382901872,0.0,0.0,0.0,26/49,14.24%,HSP90AB1;UBB;RPS27A;HSP90AA1;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,Mitochondrial Translation Elongation R-HSA-5389840,-0.5486056195336547,-2.326773372424791,0.0,0.0,0.0,48/82,27.92%,MRPS26;MRPL52;AURKAIP1;MRPL36;MRPS24;MRPL9;MRPL41;MRPL54;MRPS16;MRPL18;MRPS21;MRPL30;MRPL14;MRPL23;MRPL57;MRPS14;CHCHD1;MRPL39;MRPL19;MRPS33;MRPS2;MRPL11;MRPL33;MRPL44;MRPL35;MRPL12;MRPL20;MRPL48;OXA1L;MRPS36;MRPS31;MRPL16;MRPS5;MRPL17;ERAL1;MRPS34;MRPL50;TUFM;MRPL43;MRPL24;MRPL38;MRPS22;MRPL53;GADD45GIP1;MRPL34;MRPL21;MRPL46;TSFM
gsea,SARS-CoV-2 Infection R-HSA-9694516,-0.4931482438208233,-2.3252908532782004,0.0,0.0,0.0,63/212,13.19%,HSP90AB1;UBB;RPS29;DDX5;RPS2;RPS7;RPSA;RPS23;RPS28;RPS15;RPS24;RPS25;RPS27A;RPS8;YWHAG;RPS21;RPS5;YWHAH;RPS11;FAU;HSP90AA1;RPS6;RPS27;RPS15A;RPS4X;RPS10;RPS3;RPS17;YWHAB;RPS14;RPS20;RPS16;CNBP;RPS12;UBA52;YWHAE;SNRPD2;RPS9;SNRPG;CANX;CHMP4B;SNRPF;ZCRB1;MAP1LC3B;DAD1;YWHAZ;UBE2N;YWHAQ;NUP50;CHMP2A;RPS13;DDX20;RPS19;G3BP2;MASP2;UBE2V1;DDOST;RPS27L;SEC13;CHMP6;NUP62;NUP37;SNRPE
gsea,Axon Guidance R-HSA-422475,-0.46558306201643535,-2.3107845208135043,0.0,0.0,0.0,128/426,10.32%,HSP90AB1;RPL6;UBB;EPHA5;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;HSPA8;RPL18A;PFN2;RPS28;RPL28;RPL11;RPS15;PRNP;RPS24;RPS25;RPS27A;RPS8;RPL7;EPHA7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;HSP90AA1;RPL22;ACTG1;RPS6;MYL6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;CLTA;RPS3;RPS17;RPL41;RPL23A;RPL4;PSMA7;RPL15;RPS14;ELOB;RPS20;RPS16;RPL22L1;SEMA5A;PSMB5;RPL18;RPS12;RPL30;RPL36;UBA52;MYL12B;CDC42;AP2M1;RPL26;RPL34;RPL39;RPS9;RPL31;PSMC3;SEM1;ARPC5;PSMC2;PSMA4;WASL;PSENEN;RPL32;RPL35A;ARPC2;PSMA5;RPL36AL;CLSTN1;PPP3CB;RBX1;RPL36A;NELL2;IRS2;PSMD2;PSMD4;PSMC5;ARPC1A;PFN1;NCK1;MAGOH;ANK1;DPYSL2;HRAS;RBM8A;APH1A;ARPC3;CSNK2B;PSMB1;PSMA3;ACTR2;RPLP0;PABPC1;PSMD6;CDK5R1;RPS13;FLRT3;PSMA1;PSMB3;SCN1B;RPS19
gsea,Orc1 Removal From Chromatin R-HSA-68949,-0.6105810051033796,-2.3023052716385983,0.0,0.0,0.0,25/57,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;RBX1;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,Mitochondrial Translation Initiation R-HSA-5368286,-0.5448936264302605,-2.291586307528893,0.0,0.0,0.0,47/82,27.63%,MRPS26;MRPL52;AURKAIP1;MRPL36;MRPS24;MRPL9;MRPL41;MRPL54;MRPS16;MRPL18;MRPS21;MRPL30;MRPL14;MRPL23;MRPL57;MRPS14;CHCHD1;MRPL39;MRPL19;MRPS33;MRPS2;MRPL11;MRPL33;MRPL44;MRPL35;MRPL12;MTIF3;MRPL20;MRPL48;OXA1L;MRPS36;MRPS31;MRPL16;MRPS5;MRPL17;ERAL1;MRPS34;MRPL50;MRPL43;MRPL24;MRPL38;MRPS22;MRPL53;GADD45GIP1;MRPL34;MRPL21;MRPL46
gsea,Nervous System Development R-HSA-9675108,-0.4581252133880326,-2.2905751925317523,0.0,0.0,0.0,128/441,10.32%,HSP90AB1;RPL6;UBB;EPHA5;RPS29;RPL37;RPL23;RPS2;RPLP2;RPS7;RPL3;RPL5;RPL19;RPSA;RPL21;RPS23;RPLP1;HSPA8;RPL18A;PFN2;RPS28;RPL28;RPL11;RPS15;PRNP;RPS24;RPS25;RPS27A;RPS8;RPL7;EPHA7;RPL27;RPL14;RPS21;RPL38;RPS5;RPS11;FAU;HSP90AA1;RPL22;ACTG1;RPS6;MYL6;RPL37A;RPS27;RPL29;RPL9;RPS15A;RPS4X;RPL27A;RPL13A;RPL8;RPS10;RPL7A;RPL12;CLTA;RPS3;RPS17;RPL41;RPL23A;RPL4;PSMA7;RPL15;RPS14;ELOB;RPS20;RPS16;RPL22L1;SEMA5A;PSMB5;RPL18;RPS12;RPL30;RPL36;UBA52;MYL12B;CDC42;AP2M1;RPL26;RPL34;RPL39;RPS9;RPL31;PSMC3;SEM1;ARPC5;PSMC2;PSMA4;WASL;PSENEN;RPL32;RPL35A;ARPC2;PSMA5;RPL36AL;CLSTN1;PPP3CB;RBX1;RPL36A;NELL2;IRS2;PSMD2;PSMD4;PSMC5;ARPC1A;PFN1;NCK1;MAGOH;ANK1;DPYSL2;HRAS;RBM8A;APH1A;ARPC3;CSNK2B;PSMB1;PSMA3;ACTR2;RPLP0;PABPC1;PSMD6;CDK5R1;RPS13;FLRT3;PSMA1;PSMB3;SCN1B;RPS19
gsea,Signaling By B Cell Receptor (BCR) R-HSA-983705,-0.5600305489330131,-2.289830851903109,0.0,0.0,0.0,37/88,14.24%,CALM1;UBB;PPIA;PPP3CA;RPS27A;FKBP1A;PSMA7;RASGRP1;PSMB5;UBA52;ORAI2;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PPP3R1;CLSTN1;PPP3CB;PSMD2;PSMD4;PSMC5;NCK1;HRAS;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;LYN;PSMA2;NFKBIB;PSMC6
gsea,SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,-0.6351799900500311,-2.289523685413684,0.0,0.0,0.0,32/51,23.53%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;CDK4;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6;CDKN1B;PSMB7;UBC;SKP1;PSMB6;PSMD10;PSMB10
gsea,Iron Uptake And Transport R-HSA-917937,-0.657429335211406,-2.28945511854747,0.0,0.0,0.0,18/43,12.98%,FTH1;UBB;ATP6V0C;ATP6V1D;RPS27A;ATP6V1A;ATP6V1G2;SLC22A17;ATP6V0E2;UBA52;ATP6V0B;ATP6V1F;NEDD8;HMOX2;ALAD;ATP6V1C1;ATP6V1E1;ATP6V1B2
gsea,Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,-0.6444098462154115,-2.283529658774814,0.0,0.0,0.0,26/47,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;CDK4;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;GSK3B;PSMC6
gsea,GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,-0.640991576773393,-2.2803332584503897,0.0,0.0,0.0,26/49,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;RBX1;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;GSK3B;PSMC6
gsea,Amino Acids Regulate mTORC1 R-HSA-9639288,-0.6023853881270032,-2.2743889329039324,0.0,0.0,0.0,26/48,23.71%,ATP6V0C;ATP6V1D;ATP6V1A;ATP6V1G2;SESN1;ATP6V0E2;LAMTOR2;ATP6V0B;RHEB;RRAGA;ATP6V1F;LAMTOR3;RRAGD;ITFG2;ATP6V1C1;SEC13;ATP6V1E1;ATP6V1B2;KICS2;ATP6V1G1;RRAGC;WDR24;SEH1L;LAMTOR1;FLCN;LAMTOR5
gsea,Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,-0.6179774998235644,-2.2731733148542457,0.0,0.0,0.0,26/51,15.64%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;VCP;PSMC6;OS9
gsea,SARS-CoV Infections R-HSA-9679506,-0.4689612902040006,-2.26939838696258,0.0,0.0,0.0,83/279,14.71%,ATP1B1;HSP90AB1;UBB;RPS29;DDX5;RPS2;RPS7;RPSA;RPS23;RPS28;RPS15;RPS24;RPS25;RPS27A;RPS8;YWHAG;RPS21;RPS5;FKBP1A;YWHAH;RPS11;FAU;HSP90AA1;RPS6;RPS27;RPS15A;RPS4X;RPS10;RPS3;RPS17;YWHAB;RPS14;RPS20;RPS16;CNBP;RPS12;UBA52;YWHAE;AP2M1;SNRPD2;RPS9;ATP1A3;SNRPG;CANX;CHMP4B;PTGES3;SNRPF;ZCRB1;SAP18;RBX1;ATP1B2;MAP1LC3B;IFNGR2;DAD1;CHD3;NCK1;YWHAZ;COMT;UBE2N;YWHAQ;NUP50;RBBP7;CHMP2A;RPS13;DDX20;RPS19;G3BP2;MASP2;UBE2V1;DDOST;RPS27L;SEC13;FXYD1;FKBP4;CHMP6;NUP62;NUP37;SNRPE;IMPDH2;VCP;GSK3B;ATP1A2;AP2S1
gsea,FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,-0.631339525307542,-2.2688893269687918,0.0,0.0,0.0,25/49,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;RBX1;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,Attenuation Phase R-HSA-3371568,-0.7786228058829081,-2.266893646602773,0.0,0.0,0.0,9/19,5.55%,HSP90AB1;UBB;HSBP1;HSPA8;HSP90AA1;DNAJB6;HSPA2;PTGES3;MRPL18
gsea,KEAP1-NFE2L2 Pathway R-HSA-9755511,-0.551249646424402,-2.264764952590374,0.0,0.0,0.0,46/87,23.53%,UBB;RPS27A;PSMA7;SESN1;PSMB5;UBA52;SQSTM1;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PHGDH;RBX1;MAP1LC3B;PSMD2;PSMD4;PSMC5;CSNK2B;PRDX1;PSMB1;PSMA3;GCLM;PSMD6;PSMA1;PSMB3;SRXN1;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;VCP;GSK3B;PSMC6;PSMB7;UBC;MUL1;TXNRD1;SKP1;PSMB6;GSR;TALDO1;KEAP1;PSMD10;PSMB10
gsea,Regulation Of Apoptosis R-HSA-169911,-0.6289826504888009,-2.2642581736030474,0.0,0.0,0.0,24/48,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,-0.6388228108573758,-2.2639865961126207,0.0,0.0,0.0,26/49,14.24%,UBB;HSPA8;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PABPC1;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,-0.6207640073107418,-2.2634984469853734,0.0,0.0,0.0,30/55,18.89%,UBB;RPS27A;PSMA7;ELOB;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;RBX1;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6;LIMD1;ELOC;PSMB7;UBC
gsea,Activation Of BH3-only Proteins R-HSA-114452,-0.7100025773313902,-2.262584439179696,0.0,0.0,0.0,10/23,10.60%,DYNLL1;DYNLL2;YWHAG;YWHAH;YWHAB;YWHAE;PPP3R1;YWHAZ;YWHAQ;BAD
gsea,Hh Mutants Are Degraded By ERAD R-HSA-5362768,-0.6190687926001153,-2.2612360193118866,0.0,0.0,0.0,26/50,15.64%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;VCP;PSMC6;OS9
gsea,Autophagy R-HSA-9612973,-0.5151805550859814,-2.260273540157374,0.0,0.0,0.0,36/117,12.59%,HSP90AB1;UBB;EEF1A1;DYNLL1;GABARAPL1;HSPA8;RPS27A;DYNLL2;HSP90AA1;PARK7;UBA52;SQSTM1;VDAC1;GABARAPL2;TOMM5;LAMTOR2;RHEB;RRAGA;TOMM7;LAMTOR3;CHMP4B;PINK1;VPS28;MAP1LC3B;MAP1LC3A;UBE2N;GABARAP;CSNK2B;ATG12;TSG101;CHMP2A;TOMM20;RRAGD;UBE2V1;CHMP6;ATG3
gsea,Regulation Of RUNX3 Expression And Activity R-HSA-8941858,-0.6256404918152441,-2.256830212872166,0.0,0.0,0.0,27/49,18.89%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6;CBFB;PSMB7;UBC
gsea,CLEC7A (Dectin-1) Signaling R-HSA-5607764,-0.5492468209421841,-2.25367228303919,0.0,0.0,0.0,32/82,14.24%,CALM1;UBB;PPP3CA;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PPP3R1;PPP3CB;NFKB2;PSMD2;PSMD4;PSMC5;UBE2N;UBA3;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;UBE2V1;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,Mitochondrial Translation Termination R-HSA-5419276,-0.5353720742528464,-2.252965861517049,0.0,0.0,0.0,46/82,27.63%,MRPS26;MRPL52;AURKAIP1;MRPL36;MRPS24;MRPL9;MRPL41;MRPL54;MRPS16;MRPL18;MRPS21;MRPL30;MRPL14;MRPL23;MRPL57;MRPS14;CHCHD1;MRPL39;MRPL19;MRPS33;MRPS2;MRPL11;MRPL33;MRPL44;MRPL35;MRPL12;MRPL20;MRPL48;OXA1L;MRPS36;MRPS31;MRPL16;MRPS5;MRPL17;ERAL1;MRPS34;MRPL50;MRPL43;MRPL24;MRPL38;MRPS22;MRPL53;GADD45GIP1;MRPL34;MRPL21;MRPL46
gsea,Vif-mediated Degradation Of APOBEC3G R-HSA-180585,-0.6323421362253401,-2.2521427107583842,0.0,0.0,0.0,26/48,14.24%,UBB;RPS27A;PSMA7;ELOB;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;RBX1;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,-0.6344069516917874,-2.2513813876332276,0.0,2.2429125659855285e-05,0.001,33/50,23.53%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;RBX1;PSMD2;PSMD4;PSMC5;YWHAZ;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6;PSMB7;UBC;FBXW7;SKP1;PSMB6;PSMD10;PSMB10
gsea,Mitochondrial Translation R-HSA-5368287,-0.5259842330118644,-2.245758560695896,0.0,4.419857115324424e-05,0.001,49/88,27.92%,MRPS26;MRPL52;AURKAIP1;MRPL36;MRPS24;MRPL9;MRPL41;MRPL54;MRPS16;MRPL18;MRPS21;MRPL30;MRPL14;MRPL23;MRPL57;MRPS14;CHCHD1;MRPL39;MRPL19;MRPS33;MRPS2;MRPL11;MRPL33;MRPL44;MRPL35;MRPL12;MTIF3;MRPL20;MRPL48;OXA1L;MRPS36;MRPS31;MRPL16;MRPS5;MRPL17;ERAL1;MRPS34;MRPL50;TUFM;MRPL43;MRPL24;MRPL38;MRPS22;MRPL53;GADD45GIP1;MRPL34;MRPL21;MRPL46;TSFM
gsea,Stabilization Of P53 R-HSA-69541,-0.6247552113270152,-2.2438493528515653,0.0,4.35580121510233e-05,0.001,25/49,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PHF20;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,0.7668162063672613,2.2364522146007704,0.0,0.0011511667632161371,0.005,8/16,6.61%,PRKG1;PDE2A;GUCY1A2;PDE1A;PDE9A;PDE10A;KCNMA1;KCNMB4
gsea,G1/S DNA Damage Checkpoints R-HSA-69615,-0.6042098522905314,-2.233249296330386,0.0,6.440363225187018e-05,0.002,28/54,18.89%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PHF20;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6;CDKN1B;PSMB7;UBC
gsea,Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,-0.6368357975054998,-2.2308776536992894,0.0,6.3496538839872e-05,0.002,24/45,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,-0.6050063634811956,-2.2290825845696394,0.0,0.00010435773744516001,0.002,28/54,15.64%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;RNF5;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;VCP;PSMC6;RNF185;OS9
gsea,NRAGE Signals Death Thru JNK R-HSA-193648,0.5894469761488748,2.225107872792518,0.0,0.0010744223123350613,0.007,21/43,17.08%,PLEKHG5;KALRN;TRIO;FGD4;ABR;ITSN1;TIAM1;RASGRF2;ARHGEF33;PRPF38B;FGD1;ARHGEF18;ARHGEF17;SOS1;ARHGEF7;PREX1;ARHGEF2;ARHGEF4;ARHGEF3;OBSCN;ARHGEF10L
gsea,Degradation Of GLI2 By Proteasome R-HSA-5610783,-0.6012696210550337,-2.2248798851501803,0.0,0.00010153725805475028,0.002,27/53,15.12%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;RBX1;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;GSK3B;PSMC6;PRKACB
gsea,GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,-0.6012696210550337,-2.2248798851501803,0.0,0.00010153725805475028,0.002,27/53,15.12%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;RBX1;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;GSK3B;PSMC6;PRKACB
gsea,ER-Phagosome Pathway R-HSA-1236974,-0.5846174112741874,-2.22432799094942,0.0,0.0001001834279473536,0.002,34/64,18.89%,UBB;HMGB1;RPS27A;CALR;PSMA7;PSMB5;UBA52;PSMC3;SEM1;NDUFA2;PSMC2;PSMA4;PDIA3;PSMA5;PSMD2;PSMD4;PSMC5;SEC61G;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6;VAMP3;SEC61B;PSMB7;S100A1;UBC
gsea,G2/M Checkpoints R-HSA-69481,-0.5160108576802598,-2.223166701665991,0.0,9.886522494804632e-05,0.002,35/104,14.24%,UBB;RPS27A;YWHAG;YWHAH;YWHAB;PSMA7;PSMB5;UBA52;YWHAE;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;H2BC4;PSMD2;PSMD4;PSMC5;YWHAZ;UBE2N;YWHAQ;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;RFC3;PSMC1;PSMD7;RNF168;RPA3;PSMC4;PSME3;PSMA2;PSMC6
gsea,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,-0.753437960857174,-2.220888297089895,0.0,9.75812609876821e-05,0.002,19/22,20.63%,TUBA4A;TUBA1A;TUBB2A;CCT2;CCT6A;TUBB4A;TUBB4B;PFDN6;TUBB2B;PFDN2;PFDN5;CCT5;CCT7;PFDN4;TUBA1B;CCT8;CCT3;VBP1;PFDN1
gsea,Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,-0.6337547661993383,-2.2206699450511294,0.0,9.63302191801477e-05,0.002,24/45,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,-0.6467893813365224,-2.2190445131769354,0.0,9.511084931710786e-05,0.002,14/35,11.90%,HSP90AB1;DYNLL1;HSPA8;DYNLL2;HSP90AA1;DNAJA1;CAPZA2;DNAJA2;HSPA2;DCTN6;PTGES3;DCTN3;ACTR10;FKBP4
gsea,p53-Dependent G1 DNA Damage Response R-HSA-69563,-0.6054983164409391,-2.217356707350186,0.0,9.392196370064402e-05,0.002,28/53,18.89%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PHF20;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6;CDKN1B;PSMB7;UBC
gsea,Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,-0.6309680491619774,-2.217132506896129,0.0,9.276243328458668e-05,0.002,24/46,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,Antigen processing-Cross Presentation R-HSA-1236975,-0.5665158958061812,-2.2138218376585184,0.0,9.163118409818928e-05,0.002,35/71,18.89%,UBB;HMGB1;RPS27A;CALR;PSMA7;PSMB5;UBA52;PSMC3;SEM1;NDUFA2;PSMC2;PSMA4;PDIA3;PSMA5;PSMD2;PSMD4;PSMC5;SEC61G;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;ITGAV;PSMC4;PSME3;PSMA2;PSMC6;VAMP3;SEC61B;PSMB7;S100A1;UBC
gsea,Regulation Of RUNX2 Expression And Activity R-HSA-8939902,-0.5802037916906039,-2.213124298995359,0.0,9.052719392833157e-05,0.002,36/61,23.53%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;RBX1;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;STUB1;PSMA2;GSK3B;PSMC6;ESRRA;CBFB;PSMB7;UBC;FBXW7;SKP1;PSMB6;PSMD10;PSMB10
gsea,RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.5814807639445976,-2.2105821998131336,0.0,8.944948923870859e-05,0.002,32/63,18.89%,UBB;RPS27A;PSMA7;H2AZ1;LMO1;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;H2BC4;PSMD2;PSMD4;PSMC5;H2AJ;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6;H2AX;CBFB;PSMB7;UBC
gsea,Protein Localization R-HSA-9609507,-0.49846485444984046,-2.2099677394684876,0.0,8.839714230648848e-05,0.002,54/137,23.21%,UBB;SLC25A4;PRNP;RPS27A;VAMP2;CHCHD2;DNAJC19;COX17;TIMM8B;UBA52;VDAC1;CHCHD10;TOMM5;ATAD1;VAPA;TOMM7;TIMM13;SEC61G;NDUFB8;EMD;BCS1L;MPV17;PAM16;PEX12;TOMM20;GRPEL1;TIMM23;PAOX;TIMM22;TIMM10;SAMM50;TIMM50;COX19;LDHD;PEX19;CYB5A;ZFAND6;FXN;FIS1;NUDT19;TOMM6;IDH3G;TIMM44;SEC61B;UBC;CCNI;HSPD1;MTX2;HSPA9;HSCB;CROT;CHCHD4;TOMM22;ACOX1
gsea,Chaperone Mediated Autophagy R-HSA-9613829,-0.8327926674551542,-2.208684290299182,0.0,8.736926855873861e-05,0.002,8/15,2.81%,HSP90AB1;UBB;EEF1A1;HSPA8;RPS27A;HSP90AA1;PARK7;UBA52
gsea,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,-0.7520155711659223,-2.206993252777485,0.0,8.636502409254623e-05,0.002,18/21,20.63%,TUBA4A;TUBA1A;TUBB2A;CCT2;CCT6A;TUBB4A;TUBB4B;PFDN6;TUBB2B;PFDN2;PFDN5;CCT5;CCT7;PFDN4;CCT8;CCT3;VBP1;PFDN1
gsea,Transcriptional Regulation By RUNX3 R-HSA-8878159,-0.5381363508050514,-2.203870319760432,0.0,8.538360336422183e-05,0.002,33/75,19.36%,UBB;RPS27A;PSMA7;PSMB5;UBA52;SNW1;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6;CXXC1;JAG1;CBFB;BRD2;PSMB7;UBC;MAMLD1;NRAS
gsea,Degradation Of GLI1 By Proteasome R-HSA-5610780,-0.5951688092991703,-2.2035411415814052,0.0,8.442423703428675e-05,0.002,26/53,15.12%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;RBX1;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6;PRKACB
gsea,Programmed Cell Death R-HSA-5357801,-0.4910495540312539,-2.2001798341732868,0.0,8.348618995612801e-05,0.002,48/156,13.41%,UBB;HMGB1;DYNLL1;RPS27A;DYNLL2;YWHAG;YWHAH;HSP90AA1;YWHAB;PSMA7;PSMB5;UBA52;YWHAE;MAGED1;PSMC3;SEM1;NDUFA2;PSMC2;PSMA4;BAX;PSMA5;CHMP4B;PPP3R1;IL18;CYCS;PSMD2;PSMD4;PSMC5;CDC37;YWHAZ;C1QBP;YWHAQ;PSMB1;PSMA3;PSMD6;CHMP2A;PSMA1;PSMB3;BAD;PSMC1;PSMD7;CHMP6;MAPK3;PSMC4;GSDME;PSME3;STUB1;PSMA2
gsea,Signaling By NOTCH4 R-HSA-9013694,-0.542798514758104,-2.2001100980574115,0.0,8.256875929726947e-05,0.002,37/75,21.35%,UBB;RPS27A;PSMA7;PSMB5;UBA52;SNW1;PSMC3;SEM1;PSMC2;PSMA4;PSENEN;PSMA5;RBX1;PSMD2;PSMD4;PSMC5;YWHAZ;APH1A;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6;JAG1;HEY1;PSMB7;UBC;MAMLD1;FBXW7;SKP1;PSMB6
gsea,C-type Lectin Receptors (CLRs) R-HSA-5621481,-0.5195390301744671,-2.1989448719294695,0.0,8.16712727831687e-05,0.002,35/96,15.12%,CALM1;UBB;PPP3CA;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PPP3R1;PPP3CB;NFKB2;PSMD2;PSMD4;PSMC5;UBE2N;HRAS;UBA3;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;UBE2V1;PSMC1;PSMD7;PSMC4;PSME3;LYN;PSMA2;PSMC6;PRKACB
gsea,Metabolism Of Polyamines R-HSA-351202,-0.5967963527016353,-2.197732052619029,0.0,8.079308705431742e-05,0.002,23/49,14.24%,PSMA7;PSMB5;OAZ1;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PAOX;PSMC4;PSME3;PSMA2;PSMC6
gsea,Hedgehog Ligand Biogenesis R-HSA-5358346,-0.5888545412695362,-2.195582068338877,0.0,7.993358612820768e-05,0.002,27/55,15.64%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;P4HB;PSMC4;PSME3;PSMA2;VCP;PSMC6;OS9
gsea,Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,-0.5910171138462538,-2.192425346441815,0.0,7.909217995843706e-05,0.002,26/54,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;NFKB2;PSMD2;PSMD4;PSMC5;UBA3;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,Mitochondrial Protein Import R-HSA-1268020,-0.5740317611572705,-2.1912420066123333,0.0,7.826830308387e-05,0.002,35/57,24.62%,SLC25A4;CHCHD2;DNAJC19;COX17;TIMM8B;VDAC1;CHCHD10;TOMM5;TOMM7;TIMM13;NDUFB8;BCS1L;PAM16;TOMM20;GRPEL1;TIMM23;TIMM22;TIMM10;SAMM50;TIMM50;COX19;LDHD;FXN;TOMM6;IDH3G;TIMM44;CCNI;HSPD1;MTX2;HSPA9;HSCB;CHCHD4;TOMM22;PMPCA;TIMM21
gsea,HSF1 Activation R-HSA-3371511,-0.7356182102384373,-2.190737436222874,0.0,7.746141336135588e-05,0.002,13/22,16.16%,HSP90AB1;UBB;EEF1A1;HSBP1;HSP90AA1;DNAJB6;YWHAE;PTGES3;MRPL18;FKBP4;RPA3;VCP;HSPH1
gsea,Asymmetric Localization Of PCP Proteins R-HSA-4608870,-0.5838329444490539,-2.189114854744799,0.0,7.667099077603592e-05,0.002,24/54,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,-0.6168786708101537,-2.1885134812857423,0.0,7.589653632375275e-05,0.002,24/48,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,-0.5531643211685549,-2.1867736144558365,0.0,7.513757096051522e-05,0.002,31/74,14.24%,UBB;RPS27A;TLE5;PSMA7;PSMB5;UBA52;PSMC3;SEM1;TLE4;PSMC2;PSMA4;PPP2R1A;PSMA5;RBX1;PPP2CA;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PPP2R5D;GSK3B;PSMC6
gsea,NIK To Noncanonical NF-kB Signaling R-HSA-5676590,-0.5927950860667596,-2.183466779154906,0.0,7.43936346143715e-05,0.002,26/53,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;NFKB2;PSMD2;PSMD4;PSMC5;UBA3;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,-0.5727925886041836,-2.1827720637209187,0.0,7.366428525540707e-05,0.002,26/60,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;UBE2S;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;ANAPC11;PSMC6
gsea,Plasma Lipoprotein Clearance R-HSA-8964043,-0.695492011031317,-2.1819920541552182,0.0,7.294909801991767e-05,0.002,7/22,3.06%,UBB;APOE;RPS27A;CLTA;NCEH1;UBA52;AP2M1
gsea,Vpu Mediated Degradation Of CD4 R-HSA-180534,-0.6208586320963028,-2.181600197062,0.0,7.224766438511077e-05,0.002,24/46,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,Degradation Of DVL R-HSA-4641258,-0.5916138703010352,-2.180133595264595,0.0,7.155959139096686e-05,0.002,25/51,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;RBX1;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,Degradation Of AXIN R-HSA-4641257,-0.5996656828245428,-2.1780804383504093,0.0,7.088450090614643e-05,0.002,24/50,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,Assembly Of Pre-Replicative Complex R-HSA-68867,-0.5402081691555085,-2.175114825748946,0.0,7.022202893506095e-05,0.002,29/79,14.24%,UBB;RPS27A;PSMA7;H2AZ1;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;H2BC4;PSMD2;PSMD4;PSMC5;H2AJ;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;UBE2S;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;ANAPC11;PSMC6
gsea,Switching Of Origins To A Post-Replicative State R-HSA-69052,-0.5353353887713415,-2.175026602884013,0.0,6.957182496344001e-05,0.002,27/76,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;RBX1;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;UBE2S;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;ANAPC11;PSMC6
gsea,Synthesis Of DNA R-HSA-69239,-0.5066131815541746,-2.1694253686774774,0.0,6.893355133992222e-05,0.002,32/100,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;RBX1;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;GINS2;PSMD6;PSMA1;PSMB3;PCNA;RFC3;UBE2S;PSMC1;PSMD7;RPA3;PSMC4;PSME3;PSMA2;ANAPC11;POLD4;PSMC6
gsea,Platelet Degranulation R-HSA-114608,-0.5328097646054296,-2.1683499216372986,0.0,6.830688269137746e-05,0.002,24/75,13.57%,CALM1;PPIA;TMSB4X;TTR;TUBA4A;APLP2;FAM3C;VEGFC;TIMP3;SOD1;MANF;PDGFA;PFN1;VTI1B;MAGED2;VEGFB;OLA1;SCCPDH;CLU;CD63;TAGLN2;TLN1;ENDOD1;CHID1
gsea,APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,-0.5549416944379687,-2.1603854466397263,0.0,8.122980644380021e-05,0.003,26/64,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;UBE2S;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;ANAPC11;PSMC6
gsea,Macroautophagy R-HSA-1632852,-0.4960355018478175,-2.1592325595646997,0.0,9.392196370064402e-05,0.004,32/104,12.59%,UBB;DYNLL1;GABARAPL1;HSPA8;RPS27A;DYNLL2;HSP90AA1;PARK7;UBA52;SQSTM1;VDAC1;GABARAPL2;TOMM5;LAMTOR2;RHEB;RRAGA;TOMM7;LAMTOR3;CHMP4B;PINK1;MAP1LC3B;MAP1LC3A;UBE2N;GABARAP;CSNK2B;ATG12;CHMP2A;TOMM20;RRAGD;UBE2V1;CHMP6;ATG3
gsea,Protein Methylation R-HSA-8876725,-0.7589410960203237,-2.157823601068331,0.0,9.309079588028433e-05,0.004,5/17,2.57%,CALM1;EEF1A1;RPS2;HSPA8;EEF2
gsea,Interaction Between L1 And Ankyrins R-HSA-445095,0.6897214593381786,2.1569331791556747,0.0,0.002072100173789047,0.015,10/21,10.16%,ANK3;SPTBN4;SCN1A;SCN8A;SPTB;NFASC;KCNQ2;KCNQ3;SPTAN1;L1CAM
gsea,APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,-0.5614402291945112,-2.156827236732032,0.0,9.22742099515099e-05,0.004,26/61,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;UBE2S;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;ANAPC11;PSMC6
gsea,CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,-0.5573130336288062,-2.1566455798624595,0.0,9.147182551714895e-05,0.004,26/63,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;UBE2S;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;ANAPC11;PSMC6
gsea,Apoptosis R-HSA-109581,-0.4913391538541772,-2.154154697143085,0.0,0.00010363802891105545,0.005,41/136,13.41%,UBB;HMGB1;DYNLL1;RPS27A;DYNLL2;YWHAG;YWHAH;YWHAB;PSMA7;PSMB5;UBA52;YWHAE;MAGED1;PSMC3;SEM1;NDUFA2;PSMC2;PSMA4;BAX;PSMA5;PPP3R1;CYCS;PSMD2;PSMD4;PSMC5;YWHAZ;C1QBP;YWHAQ;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;BAD;PSMC1;PSMD7;MAPK3;PSMC4;GSDME;PSME3;PSMA2
gsea,Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,-0.5996789700291264,-2.151262440586446,0.0,0.00011559626301617725,0.005,22/44,14.24%,PSMA7;PSMB5;OAZ1;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,Neutrophil Degranulation R-HSA-6798695,-0.4415944615672789,-2.1511627325538125,0.0,0.00011461663366858252,0.005,88/274,16.68%,FTH1;HSP90AB1;ATP6V0C;EEF1A1;HMGB1;PPIA;TTR;RAB3A;DYNLL1;HSPA8;ATP6V1D;HSP90AA1;CST3;PDAP1;SRP14;ARL8A;PGRMC1;NME2;PKM;RAP2B;EEF2;PRDX5;ALDOC;PSMC3;LAMTOR2;NDUFA2;ARPC5;PSMC2;VAPA;CCT2;LAMTOR3;CTSB;PSMA5;COMMD3;TUBB4B;YPEL5;CD47;RAB6A;PSMD2;ACTR1B;PDXK;GSTP1;ARSA;LAMP1;RAB14;APRT;CSNK2B;CSTB;SNAP25;RAB24;PSMB1;NIT2;ACTR2;ATP6AP2;PSMD6;NDUFC2;CPPED1;FUCA1;HMOX2;COTL1;CD63;ACTR10;RAB18;VAT1;ALAD;TRAPPC1;DDOST;ACLY;PSMD7;ITGAV;CYB5R3;SNAP29;RAB31;CAB39;GUSB;PSMA2;IMPDH2;CYSTM1;VCP;PAFAH1B2;FAF2;PFKL;RCAN1;EGFL7;MAPK1;CCT8;TMEM179B;SVIP
gsea,Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,-0.5450506702813535,-2.1508670670267196,0.0,0.00011365346867977091,0.005,32/78,14.24%,UBB;HSPA8;RPS27A;ANP32A;SET;YWHAB;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;YWHAZ;PSMB1;PSMA3;PABPC1;PSMD6;EXOSC4;PSMA1;PSMB3;PSMC1;PSMD7;EXOSC3;PSMC4;PSME3;PSMA2;PSMC6
gsea,Regulated Necrosis R-HSA-5218859,-0.6141233831194022,-2.1445068121899387,0.0,0.00011270635644077283,0.005,17/37,18.89%,UBB;HMGB1;RPS27A;HSP90AA1;UBA52;BAX;CHMP4B;IL18;CYCS;CDC37;CHMP2A;CHMP6;GSDME;STUB1;CHMP7;CHMP4C;UBC
gsea,Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,-0.5541520918876358,-2.1441432299508514,0.0,0.00011085871125321916,0.005,26/61,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;UBE2S;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;ANAPC11;PSMC6
gsea,APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,-0.5541520918876358,-2.1441432299508514,0.0,0.00011085871125321916,0.005,26/61,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;UBE2S;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;ANAPC11;PSMC6
gsea,DNA Replication Pre-Initiation R-HSA-69002,-0.5179252401711351,-2.1436642273240185,0.0,0.00010995742091782714,0.005,30/90,14.24%,UBB;RPS27A;PSMA7;H2AZ1;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;H2BC4;PSMD2;PSMD4;PSMC5;H2AJ;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;UBE2S;PSMC1;PSMD7;RPA3;PSMC4;PSME3;PSMA2;ANAPC11;PSMC6
gsea,DNA Replication R-HSA-69306,-0.4974032145101473,-2.141026058903784,0.0,0.00010907066752332853,0.005,35/112,14.24%,UBB;RPS27A;PSMA7;H2AZ1;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;H2BC4;RBX1;PSMD2;PSMD4;PSMC5;H2AJ;PSMB1;PSMA3;GINS2;PSMD6;PSMA1;PSMB3;PCNA;RFC3;UBE2S;PSMC1;PSMD7;RPA3;PSMC4;PSME3;PSMA2;ANAPC11;POLD4;PSMC6
gsea,Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,-0.5535194452126088,-2.1385012769946967,0.0,0.00011926598565161145,0.005,26/62,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;UBE2S;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;ANAPC11;PSMC6
gsea,APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,-0.5535194452126088,-2.1385012769946967,0.0,0.00011926598565161145,0.005,26/62,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;UBE2S;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;ANAPC11;PSMC6
gsea,Selective Autophagy R-HSA-9663891,-0.565650647970631,-2.1367189192437284,0.0,0.00013015957174262476,0.005,20/54,11.29%,UBB;DYNLL1;HSPA8;RPS27A;DYNLL2;HSP90AA1;PARK7;UBA52;SQSTM1;VDAC1;TOMM5;TOMM7;PINK1;MAP1LC3B;MAP1LC3A;UBE2N;CSNK2B;ATG12;TOMM20;UBE2V1
gsea,Amyloid Fiber Formation R-HSA-977225,-0.6067569903461855,-2.1336378570182064,0.0,0.00012914270008838552,0.005,13/38,9.14%,UBB;TTR;ITM2B;APOE;RPS27A;CST3;H2AZ1;UBA52;CALB1;PSENEN;H2BC4;APH1A;SNCA
gsea,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.5134340175061477,-2.1313400838920753,0.0,0.00016308930130964542,0.007,24/79,13.57%,CALM1;PPIA;TMSB4X;TTR;TUBA4A;APLP2;FAM3C;VEGFC;TIMP3;SOD1;MANF;PDGFA;PFN1;VTI1B;MAGED2;VEGFB;OLA1;SCCPDH;CLU;CD63;TAGLN2;TLN1;ENDOD1;CHID1
gsea,Intrinsic Pathway For Apoptosis R-HSA-109606,-0.5983378714253771,-2.1307431762130804,0.0,0.00016183476822264814,0.007,15/41,13.23%,DYNLL1;DYNLL2;YWHAG;YWHAH;YWHAB;YWHAE;BAX;PPP3R1;CYCS;YWHAZ;C1QBP;YWHAQ;BAD;MAPK3;GSDME
gsea,ABC Transporter Disorders R-HSA-5619084,-0.5531660900814515,-2.125763806076497,0.0,0.00020648492783042346,0.01,28/63,15.64%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;RNF5;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;VCP;PSMC6;RNF185;OS9
gsea,CDC42 GTPase Cycle R-HSA-9013148,0.46987698996193605,2.124807961669832,0.0,0.002670706890661438,0.02,41/116,16.12%,DOCK9;IQGAP2;TRIO;SHKBP1;FMNL2;DOCK11;DOCK10;MYO9B;DLC1;FGD4;ABR;SRGAP2;SH3PXD2A;DOCK7;FNBP1;ITSN1;FMNL1;PREX2;TIAM1;RASGRF2;CDC42BPA;GMIP;LBR;CPNE8;ARAP2;FGD1;FARP1;STEAP3;DAAM1;ARHGEF7;SPATA13;VANGL1;PREX1;WDR81;WIPF2;ARHGEF4;SRGAP1;ARFGAP3;ARHGAP32;GIT2;ARHGAP42
gsea,Transcriptional Regulation By RUNX2 R-HSA-8878166,-0.5163565318001689,-2.1247794463143546,0.0,0.00020492064807413237,0.01,40/86,21.35%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;BAX;PSMA5;RBX1;PSMD2;PSMD4;PPM1D;PSMC5;PSMB1;PSMA3;CDK4;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;MAPK3;PSMC4;PSME3;STUB1;PSMA2;GSK3B;PSMC6;MAPK1;ESRRA;CBFB;HEY1;PSMB7;UBC;FBXW7;SKP1;PSMB6
gsea,TP53 Regulates Metabolic Genes R-HSA-5628897,-0.5173424819513058,-2.1174624658181616,0.0,0.00022597765702410592,0.011,28/77,10.68%,COX6C;YWHAG;YWHAH;COX8A;COX4I1;COX5B;YWHAB;SESN1;COX6B1;PRDX5;YWHAE;COX5A;COX7C;COX7A2L;COX6A1;LAMTOR2;RHEB;COX7B;RRAGA;LAMTOR3;CYCS;YWHAZ;YWHAQ;COX20;PRDX1;SCO2;COX14;RRAGD
gsea,Interleukin-1 Signaling R-HSA-9020702,-0.49969014823691865,-2.1154442054197573,0.0,0.00022429125659855287,0.011,33/93,14.91%,UBB;HMGB1;RPS27A;PSMA7;PSMB5;UBA52;SQSTM1;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;USP14;RBX1;NFKB2;PSMD2;PSMD4;PSMC5;UBE2N;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;UBE2V1;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;NFKBIB;PSMC6;IL1R2
gsea,ROS And RNS Production In Phagocytes R-HSA-1222556,-0.6986483481384627,-2.113360937986276,0.0,0.0002337613318771584,0.012,11/20,16.03%,ATP6V0C;ATP6V1D;ATP6V1A;ATP6V1G2;ATP6V0E2;ATP6V0B;ATP6V1F;ATP6V1C1;ATP6V1E1;ATP6V1B2;ATP6V1G1
gsea,UCH Proteinases R-HSA-5689603,-0.5112151935534307,-2.112616664537656,0.0,0.00023204249855453225,0.012,43/78,25.21%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;NEDD8;H2AC25;PSMD2;SENP8;PSMD4;PSMC5;KDM1B;PSMB1;PSMA3;PSMD6;RUVBL1;PSMA1;PSMB3;UCHL1;ADRM1;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6;ACTR8;FOXK1;UCHL3;PSMB7;UBC;YY1;PSMB6;PSMD10;PSMB10;SMAD7;HCFC1;PSMD5
gsea,Cytoprotection By HMOX1 R-HSA-9707564,-0.5723244162310812,-2.1079050138140762,0.0,0.0002632557230733379,0.015,17/44,10.70%,COX6C;COX8A;COX4I1;COX5B;COX6B1;COX5A;COX7C;COX7A2L;COX6A1;COX7B;CYCS;SIN3B;COX20;SCO2;TBL1XR1;COX14;HMOX2
gsea,Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,-0.517971361018004,-2.09732437822172,0.0,0.00031579558809491896,0.015,33/74,23.53%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;CDK4;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6;CDKN1B;PSMB7;UBC;SKP1;PSMB6;E2F4;PSMD10;PSMB10
gsea,G1/S Transition R-HSA-69206,-0.48493246097068227,-2.0962364221272787,0.0,0.00031352367738920014,0.015,30/102,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PPP2R1A;PSMA5;PPP2CA;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;CDK4;PSMD6;DHFR;PSMA1;PSMB3;PCNA;PSMC1;PSMD7;RPA3;PSMC4;PSME3;PSMA2;PSMC6
gsea,Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,-0.6014298718691211,-2.0958106304599498,0.002012072434607646,0.0003220181612593509,0.015,21/41,14.24%,PSMA7;PSMB5;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,Regulation Of PTEN Stability And Activity R-HSA-8948751,-0.5441715122700581,-2.094311654336961,0.0,0.00034104996748035273,0.016,27/62,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;CSNK2B;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;MKRN1;PSMC4;PSME3;STUB1;PSMA2;PSMC6
gsea,Cyclin E Associated Events During G1/S Transition R-HSA-69202,-0.5236529031783861,-2.091520272229117,0.0,0.00035981372009260805,0.017,33/72,23.53%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;CDK4;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6;CDKN1B;PSMB7;UBC;SKP1;PSMB6;E2F4;PSMD10;PSMB10
gsea,FCERI Mediated NF-kB Activation R-HSA-2871837,-0.5327782980580953,-2.088808750031863,0.0,0.0003783150425983983,0.018,28/68,14.24%,UBB;RPS27A;PSMA7;RASGRP1;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;UBE2N;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;UBE2V1;PSMC1;PSMD7;PSMC4;PSME3;LYN;PSMA2;PSMC6
gsea,Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,-0.5347548729454955,-2.085277350338761,0.0,0.000386123628547092,0.018,26/65,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;UBE2S;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;ANAPC11;PSMC6
gsea,Late Endosomal Microautophagy R-HSA-9615710,-0.6450660595492551,-2.0850320628499284,0.0,0.0003938245098620107,0.019,13/25,18.89%,UBB;HSPA8;RPS27A;PARK7;UBA52;CHMP4B;VPS28;TSG101;CHMP2A;CHMP6;CHMP7;CHMP4C;UBC
gsea,APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.5298006405000647,-2.0817154863595304,0.0,0.0004117127175918642,0.021,26/68,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;UBE2S;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;ANAPC11;PSMC6
gsea,TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,-0.5462105950291155,-2.07677841839085,0.0019801980198019802,0.00048047154219649186,0.026,26/58,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;NFKB2;PSMD2;PSMD4;PSMC5;UBA3;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,0.6127370855083729,2.071801030409869,0.0,0.005602344914318534,0.047,8/27,11.67%,TJP2;ROCK1;SATB1;TJP1;MAPT;PTK2;SPTAN1;STK26
gsea,G2/M Transition R-HSA-69275,-0.4618045513622663,-2.0710013346706457,0.0,0.0005787623709120766,0.033,40/151,13.41%,HSP90AB1;UBB;TUBA4A;DYNLL1;TUBA1A;RPS27A;YWHAG;HSP90AA1;NME7;PSMA7;PSMB5;UBA52;YWHAE;CETN2;PSMC3;SEM1;PSMC2;PSMA4;PPP2R1A;CSNK1E;PSMA5;TUBB4A;TUBB4B;PAFAH1B1;RBX1;PPP2CA;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;DCTN3;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2
gsea,ABC-family Proteins Mediated Transport R-HSA-382556,-0.5042564048680468,-2.0677956192166906,0.0,0.0006152203796767017,0.035,31/80,15.79%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;EIF2S2;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;RNF5;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;VCP;PSMC6;ABCB10;RNF185;OS9;PEX19
gsea,Mitotic G2-G2/M Phases R-HSA-453274,-0.4613397624567592,-2.065206530477479,0.0,0.000641173938863063,0.038,40/152,13.41%,HSP90AB1;UBB;TUBA4A;DYNLL1;TUBA1A;RPS27A;YWHAG;HSP90AA1;NME7;PSMA7;PSMB5;UBA52;YWHAE;CETN2;PSMC3;SEM1;PSMC2;PSMA4;PPP2R1A;CSNK1E;PSMA5;TUBB4A;TUBB4B;PAFAH1B1;RBX1;PPP2CA;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;DCTN3;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2
gsea,Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,-0.4764731712100899,-2.0590742282336487,0.0,0.0007065917269134542,0.041,35/105,14.24%,CALM1;UBB;PPP3CA;RPS27A;JUN;PSMA7;RASGRP1;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PPP3R1;PPP3CB;PSMD2;PSMD4;PSMC5;UBE2N;HRAS;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;UBE2V1;PSMC1;PSMD7;MAPK3;PSMC4;PSME3;LYN;PSMA2;PSMC6
gsea,Hedgehog On State R-HSA-5632684,-0.5201235701247464,-2.0563635320522504,0.0,0.0007414891871103474,0.042,27/71,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;RBX1;PSMD2;PSMD4;PSMC5;HHIP;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;GAS8;PSMC6
gsea,Uptake And Actions Of Bacterial Toxins R-HSA-5339562,-0.6262502894844342,-2.0561675534673927,0.0,0.0007366428525540708,0.042,5/26,2.57%,CALM1;HSP90AB1;VAMP2;HSP90AA1;EEF2
gsea,Host Interactions Of HIV Factors R-HSA-162909,-0.4805087631857216,-2.0558391617699754,0.0,0.0007318594574076158,0.042,48/113,18.89%,UBB;SLC25A4;PPIA;RPS27A;RAN;PSMA7;ELOB;PSIP1;PSMB5;SLC25A5;BANF1;UBA52;AP2M1;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;RBX1;PSMD2;PSMD4;PSMC5;RANBP1;NUP50;NPM1;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;SEC13;PSMD7;NUP62;NUP37;PSMC4;PSME3;PSMA2;PSMC6;AP2S1;HCK;NUP205;NUP35;ELOC;AP2B1;PSMB7;NUP107;UBC
gsea,Activation Of NF-kappaB In B Cells R-HSA-1169091,-0.5331404577003951,-2.0480745654213166,0.0,0.0007853088061679654,0.046,33/60,23.53%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;NFKBIB;PSMC6;BCL10;PSMB7;UBC;SKP1;PSMB6;NFKBIA;PSMD10;PSMB10
gsea,PCP/CE Pathway R-HSA-4086400,-0.5114010206030922,-2.0427906143573695,0.0,0.0008573389507033145,0.052,39/75,25.93%,UBB;RPS27A;CLTA;PSMA7;PSMB5;UBA52;AP2M1;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PFN1;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6;AP2S1;AP2B1;PSMB7;UBC;PSMB6;VANGL2;PSMD10;PSMB10;CLTB;AP2A2;PSMD5;WNT5B
gsea,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,-0.7502685855006398,-2.040187340130779,0.0,0.0008710215232365456,0.053,12/16,16.39%,TUBA4A;TUBA1A;TUBB2A;CCT2;CCT6A;TUBB4A;TUBB4B;TUBB2B;CCT5;CCT7;TUBA1B;CCT8
gsea,Chaperonin-mediated Protein Folding R-HSA-390466,-0.49889716345360635,-2.0398304032112957,0.0,0.0008655087287856814,0.053,34/68,22.07%,TUBA4A;TUBA1A;TUBB2A;GNB2;GNG2;CCT2;CCT6A;TUBB4A;TUBB4B;PFDN6;TUBB2B;PFDN2;CSNK2B;GNG13;FBXW2;PFDN5;GNA11;CCT5;CCT7;GNG10;PFDN4;PDCL;FBXO6;TUBA1B;GNG3;GNG7;CCT8;AP3M1;CCT3;VBP1;FBXW7;PFDN1;DCAF7;FBXL3
gsea,Insulin Receptor Recycling R-HSA-77387,-0.6909418979767767,-2.0317127055277426,0.0019230769230769232,0.0009829317458985637,0.06,11/19,16.03%,ATP6V0C;ATP6V1D;ATP6V1A;ATP6V1G2;ATP6V0E2;ATP6V0B;ATP6V1F;ATP6V1C1;ATP6V1E1;ATP6V1B2;ATP6V1G1
gsea,Protein-protein Interactions At Synapses R-HSA-6794362,0.49112016904876665,2.0310211597247076,0.0,0.009669800811015553,0.081,23/81,9.93%,DLGAP2;GRIA3;PTPRS;DLGAP1;GRIN2A;NLGN1;SHANK2;GRIA1;IL1RAPL2;GRIA4;PTPRD;NTRK3;DLGAP3;PTPRF;LRFN2;CASK;EPB41L1;SHANK3;LRFN1;SHANK1;MPP3;BEGAIN;STX1A
gsea,O-linked Glycosylation R-HSA-5173105,0.5095641060786339,2.0275419197474847,0.0,0.008691309062281835,0.083,34/59,26.50%,ST6GALNAC3;ADAMTS17;GALNT18;SEMA5B;GALNT14;ADAMTS20;SPON1;ADAMTS18;ADAMTS3;GALNTL6;LARGE1;ST3GAL3;GALNT10;CFP;GALNT9;THSD1;B3GALNT2;POMGNT1;ADAMTS1;POMT2;ST3GAL4;GALNT12;B3GNTL1;ST3GAL2;GALNT11;POFUT2;B3GNT2;GALNT3;THSD7B;ADAMTS13;SBSPON;ADAMTS15;MUC15;ADAMTS9
gsea,PINK1-PRKN Mediated Mitophagy R-HSA-5205685,-0.6891712619262316,-2.023971339478041,0.0,0.001080102582557406,0.063,12/21,9.99%,UBB;RPS27A;UBA52;SQSTM1;VDAC1;TOMM5;TOMM7;PINK1;MAP1LC3B;MAP1LC3A;ATG12;TOMM20
gsea,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,-0.5101235539191807,-2.0239215867782985,0.0,0.0010733938708645029,0.063,19/59,16.15%,RPS2;RPS7;RPS6;RPS14;RPS9;SNU13;THUMPD1;TRMT112;PDCD11;UTP3;EMG1;NOC4L;NOP10;MPHOSPH10;GAR1;NOL11;UTP11;FCF1;DKC1
gsea,Regulation Of RAS By GAPs R-HSA-5658442,-0.5323857515260538,-2.022470406875476,0.0,0.0010945967127581227,0.065,27/59,14.24%,UBB;RPS27A;PSMA7;RASAL2;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;RBX1;PSMD2;PSMD4;PSMC5;HRAS;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6
gsea,Interleukin-1 Family Signaling R-HSA-446652,-0.4573168933356878,-2.0201620807135012,0.0,0.0011247587309426816,0.066,35/111,14.91%,UBB;HMGB1;RPS27A;PSMA7;PSMB5;UBA52;SQSTM1;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;IL18;USP14;RBX1;NFKB2;PSMD2;PSMD4;PSMC5;UBE2N;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;UBE2V1;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;NFKBIB;IL1RAPL1;PSMC6;IL1R2
gsea,HSF1-dependent Transactivation R-HSA-3371571,-0.6134970503713166,-2.0173063854702997,0.0,0.0011545529196371849,0.067,13/28,13.06%,HSP90AB1;UBB;HSBP1;HSPA8;HSP90AA1;DNAJB6;HSPA2;PTGES3;MRPL18;CAMK2B;FKBP4;CRYAB;AKT1S1
gsea,Mitophagy R-HSA-5205647,-0.6387434671696383,-2.012748578639716,0.0,0.0012113087197270936,0.069,13/27,9.99%,UBB;RPS27A;UBA52;SQSTM1;VDAC1;TOMM5;TOMM7;PINK1;MAP1LC3B;MAP1LC3A;CSNK2B;ATG12;TOMM20
gsea,Protein Folding R-HSA-391251,-0.48564541423084695,-2.010063763287134,0.0,0.0012764334343894751,0.073,37/74,22.07%,TUBA4A;TUBA1A;TUBB2A;GNB2;GNG2;CCT2;CCT6A;TUBB4A;TUBB4B;PFDN6;TUBB2B;PFDN2;TBCC;CSNK2B;GNG13;FBXW2;PFDN5;GNA11;TBCA;CCT5;CCT7;GNG10;PFDN4;PDCL;FBXO6;TUBA1B;GNG3;GNG7;CCT8;AP3M1;TBCB;CCT3;VBP1;FBXW7;PFDN1;DCAF7;FBXL3
gsea,DARPP-32 Events R-HSA-180024,-0.6583912700932429,-2.0047805628351054,0.0,0.001331779700857036,0.076,12/22,20.39%,CALM1;PPP3CA;PPP2R1A;PPP3R1;PPP3CB;PPP2CA;PPP1CA;PRKAR1B;PPP2R5D;PRKACB;PPP1R1B;PRKAR1A
gsea,RHOBTB2 GTPase Cycle R-HSA-9013418,-0.6200566216935097,-2.0045946321440598,0.0,0.001323852440732887,0.076,10/23,15.86%,HSP90AB1;HSP90AA1;ACTG1;CCT2;CCT6A;CDC37;TXNL1;CCT7;TWF1;DDX39B
gsea,Negative Regulation Of MAPK Pathway R-HSA-5675221,-0.5941114567411541,-2.0043484937550398,0.001996007984031936,0.001333803034802045,0.077,15/34,20.81%,UBB;PEBP1;RPS27A;YWHAB;UBA52;DUSP7;PPP2R1A;PPP2CA;HRAS;MAPK3;PPP2R5D;MAPK1;UBC;NRAS;DUSP8
gsea,Downstream TCR Signaling R-HSA-202424,-0.4946101745841275,-1.998640981987915,0.0,0.001396674848442518,0.08,40/74,25.67%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;UBE2N;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;UBE2V1;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6;BCL10;PSMB7;UBC;PIK3R2;SKP1;PSMB6;NFKBIA;PIK3CB;PSMD10;PSMB10;CD247;PSMD5;TRAT1;CDC34
gsea,Cellular Response To Heat Stress R-HSA-3371556,-0.47621473869034475,-1.9929984629492858,0.0,0.001590631619164123,0.091,32/84,16.37%,HSP90AB1;UBB;EEF1A1;HSBP1;HSPA8;HSP90AA1;DNAJB6;YWHAE;HSPA2;PTGES3;MRPL18;ST13;BAG5;NUP50;BAG1;HIKESHI;CAMK2B;SEC13;FKBP4;CRYAB;MAPK3;NUP62;RPA3;NUP37;AKT1S1;BAG4;VCP;GSK3B;NUP205;NUP35;HSPH1;MAPK1
gsea,Translesion Synthesis By REV1 R-HSA-110312,-0.6880460420151974,-1.9882209996237614,0.0017482517482517483,0.0016774899563277812,0.096,6/16,12.74%,UBB;RPS27A;UBA52;PCNA;RFC3;RPA3
gsea,Mitotic Metaphase And Anaphase R-HSA-2555396,-0.4221994069361291,-1.9843623024241086,0.0,0.0017013909746231605,0.098,64/177,19.75%,UBB;TUBA4A;DYNLL1;TUBA1A;RPS27A;TUBB2A;DYNLL2;RAN;RPS27;PSMA7;PSMB5;BANF1;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PPP2R1A;PSMA5;TUBB4A;CHMP4B;TUBB4B;TUBB2B;SMC1A;PAFAH1B1;PPP2CA;PSMD2;PSMD4;PSMC5;EMD;PSMB1;PSMA3;RAD21;PSMD6;CHMP2A;PSMA1;PSMB3;UBE2S;PSMC1;SEC13;PSMD7;CHMP6;NUP62;NUP37;PSMC4;PSME3;PSMA2;ZWINT;PPP2R5D;ANAPC11;PSMC6;TUBA1B;PPP1CC;NUP205;NUP35;VPS4A;CHMP7;PSMB7;NUP107;CHMP4C;UBC;B9D2;CENPP;ITGB3BP
gsea,Mitotic Anaphase R-HSA-68882,-0.4221994069361291,-1.9843623024241086,0.0,0.0017013909746231605,0.098,64/177,19.75%,UBB;TUBA4A;DYNLL1;TUBA1A;RPS27A;TUBB2A;DYNLL2;RAN;RPS27;PSMA7;PSMB5;BANF1;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PPP2R1A;PSMA5;TUBB4A;CHMP4B;TUBB4B;TUBB2B;SMC1A;PAFAH1B1;PPP2CA;PSMD2;PSMD4;PSMC5;EMD;PSMB1;PSMA3;RAD21;PSMD6;CHMP2A;PSMA1;PSMB3;UBE2S;PSMC1;SEC13;PSMD7;CHMP6;NUP62;NUP37;PSMC4;PSME3;PSMA2;ZWINT;PPP2R5D;ANAPC11;PSMC6;TUBA1B;PPP1CC;NUP205;NUP35;VPS4A;CHMP7;PSMB7;NUP107;CHMP4C;UBC;B9D2;CENPP;ITGB3BP
gsea,Transferrin Endocytosis And Recycling R-HSA-917977,-0.6434711815271621,-1.982654733531941,0.0018796992481203006,0.001751778797250869,0.103,11/22,16.03%,ATP6V0C;ATP6V1D;ATP6V1A;ATP6V1G2;ATP6V0E2;ATP6V0B;ATP6V1F;ATP6V1C1;ATP6V1E1;ATP6V1B2;ATP6V1G1
gsea,HIV Infection R-HSA-162906,-0.41829667835191164,-1.976422499478867,0.0,0.0019125927153585689,0.112,93/202,27.04%,UBB;SLC25A4;PPIA;RPS27A;RAN;PSMA7;ELOB;PSIP1;PSMB5;SLC25A5;BANF1;UBA52;AP2M1;PSMC3;SEM1;PSMC2;PSMA4;POLR2G;POLR2F;PSMA5;CHMP4B;RBX1;VPS28;PSMD2;PSMD4;PSMC5;POLR2I;RANBP1;GTF2B;NUP50;NPM1;TSG101;PSMB1;PSMA3;TCEA1;PSMD6;CHMP2A;POLR2E;POLR2C;PSMA1;TAF11;PSMB3;TAF10;PSMC1;SEC13;PSMD7;CHMP6;NUP62;NUP37;PSMC4;PSME3;PSMA2;PSMC6;AP2S1;HCK;NUP205;NUP35;VPS4A;NCBP2;POLR2L;ELOC;AP2B1;GTF2H5;CHMP7;PSMB7;NUP107;CHMP4C;UBC;TAF5;SSRP1;ERCC3;POLR2J;SKP1;PSMB6;GTF2H4;NMT1;SEH1L;UBAP1;TAF7L;PSMD10;PSMB10;HMGA1;TAF12;CD247;AP2A2;NUP85;PSMD5;TAF7;POLR2B;XRCC6;B2M;AP1S1;TPR
gsea,Activation Of BAD And Translocation To Mitochondria R-HSA-111447,-0.7143056376368928,-1.9755561746449475,0.0,0.0019442377118596588,0.112,8/15,10.60%,YWHAG;YWHAH;YWHAB;YWHAE;PPP3R1;YWHAZ;YWHAQ;BAD
gsea,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,-0.4786836039412357,-1.9711417166156213,0.0,0.0020515089599331677,0.119,15/76,5.88%,UBB;TUBA4A;DYNLL1;TUBA1A;RPS27A;YWHAG;HSP90AA1;UBA52;YWHAE;CETN2;PPP2R1A;CSNK1E;TUBB4A;TUBB4B;PAFAH1B1
gsea,RAC1 GTPase Cycle R-HSA-9013149,0.42770638581919646,1.9612768923413328,0.0,0.016576801390312375,0.155,42/132,16.12%,DOCK9;KALRN;IQGAP2;TRIO;CYFIP1;DOCK3;DOCK11;DOCK10;ARHGAP15;MYO9B;DLC1;ABR;SRGAP2;DOCK7;DOCK4;FMNL1;PIK3R3;PREX2;ABL2;TIAM1;RASGRF2;CDC42BPA;GMIP;LBR;ARAP2;SH3BP1;ARHGEF18;DHDDS;FARP2;SOS1;FARP1;ARHGEF7;SPATA13;VANGL1;PREX1;WIPF2;ARHGEF4;SRGAP1;LEMD3;ARHGAP32;GIT2;ARHGAP42
gsea,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.5154443625862888,-1.9604731330990022,0.0,0.0022415342398276602,0.132,19/47,17.95%,MDH2;IDH3B;BSG;VDAC1;DLAT;LDHA;GLO1;HAGH;SUCLG1;LDHB;SLC16A1;SDHA;SDHD;LDHD;FAHD1;IDH2;IDH3A;SDHB;IDH3G
gsea,Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.5875325311190555,-1.9588190230568523,0.0,0.002270824366806682,0.135,13/28,19.01%,UBB;RPS27A;UBA52;CHMP4B;VPS28;TSG101;CHMP2A;CHMP6;VPS4A;CHMP7;CHMP4C;UBC;STAM2
gsea,Pyroptosis R-HSA-5620971,-0.7060676061357136,-1.9496553612034204,0.0,0.002557168160866153,0.152,10/15,18.89%,HMGB1;BAX;CHMP4B;IL18;CYCS;CHMP2A;CHMP6;GSDME;CHMP7;CHMP4C
gsea,S Phase R-HSA-69242,-0.4281156343141892,-1.948771201234536,0.0,0.0025761452900748072,0.153,36/135,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;SMC1A;RBX1;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;CDK4;GINS2;RAD21;PSMD6;PSMA1;PSMB3;PCNA;RFC3;UBE2S;PSMC1;PSMD7;RPA3;PSMC4;PSME3;PSMA2;ANAPC11;POLD4;GSK3B;PSMC6
gsea,ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,-0.6593461437939354,-1.9463999680839892,0.0019455252918287938,0.0026195502881316227,0.155,9/16,15.66%,GNB2;GNG2;P2RY12;GNAI1;GNG13;GNAI2;GNG10;GNG3;GNG7
gsea,Budding And Maturation Of HIV Virion R-HSA-162588,-0.591283267925066,-1.9453672304513003,0.0,0.002629814983618032,0.156,13/27,18.89%,UBB;PPIA;RPS27A;UBA52;CHMP4B;VPS28;TSG101;CHMP2A;CHMP6;VPS4A;CHMP7;CHMP4C;UBC
gsea,Translesion Synthesis By POLI R-HSA-5656121,-0.665041518163637,-1.9433953140584042,0.0017574692442882249,0.002656214670712267,0.158,6/17,12.74%,UBB;RPS27A;UBA52;PCNA;RFC3;RPA3
gsea,Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,-0.6698798019060291,-1.9418982982457103,0.003838771593090211,0.002650013255381612,0.158,13/19,18.89%,TUBA4A;TUBA1A;TUBB2A;TUBB4A;CHMP4B;TUBB4B;TUBB2B;CHMP2A;CHMP6;TUBA1B;VPS4A;CHMP7;CHMP4C
gsea,Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,-0.6003986815349325,-1.9382224334581057,0.0,0.002836744657653676,0.164,8/24,11.35%,PPIA;CDC42;AURKAIP1;HNRNPA2B1;SOD1;RPLP0;RALA;HNRNPF
gsea,Mitotic G1 Phase And G1/S Transition R-HSA-453279,-0.44042898400189495,-1.9370750774609333,0.0,0.002845635666164193,0.166,31/114,14.24%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PPP2R1A;PSMA5;PPP2CA;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;CDK4;PSMD6;DHFR;PSMA1;PSMB3;PCNA;PSMC1;PSMD7;RPA3;PSMC4;PSME3;LYN;PSMA2;PSMC6
gsea,COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,-0.558167579757878,-1.9340927269840833,0.0,0.002886236852768997,0.171,14/31,19.34%,DYNLL1;DYNLL2;CAPZA2;DCTN6;RAB6B;PAFAH1B1;RAB6A;DCTN3;ACTR10;RAB18;PAFAH1B2;DCTN5;DCTN1;BICD2
gsea,TCR Signaling R-HSA-202403,-0.4588045624689786,-1.9333581098365793,0.0,0.002910592222470484,0.174,43/88,25.67%,UBB;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;NCK1;UBE2N;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;UBE2V1;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6;VASP;BCL10;PSMB7;UBC;PIK3R2;SKP1;PSMB6;NFKBIA;PIK3CB;PSMD10;PSMB10;CD247;PSMD5;EVL;TRAT1;CDC34
gsea,Negative Regulation Of FGFR4 Signaling R-HSA-5654733,-0.63186692277966,-1.9306940281991936,0.001949317738791423,0.002966163796032904,0.178,7/19,6.26%,UBB;RPS27A;UBA52;SPRY2;PPP2R1A;FGF13;PPP2CA
gsea,Response Of Mtb To Phagocytosis R-HSA-9637690,-0.6439665236868805,-1.9301375348473833,0.005628517823639775,0.0029741955171870603,0.178,9/19,20.68%,UBB;RPS27A;UBA52;PGK1;MAPK3;MAPK1;ENO1;UBC;RAB5A
gsea,MAPK6/MAPK4 Signaling R-HSA-5687128,-0.481068293552332,-1.9210612168559333,0.0,0.0033325264633264776,0.201,32/71,19.51%,UBB;RPS27A;JUN;PSMA7;PSMB5;UBA52;CDC42;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;SEPTIN7;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6;PRKACB;MAPKAPK5;PSMB7;UBC;CCND3
gsea,Nuclear Envelope (NE) Reassembly R-HSA-2995410,-0.47965882246045205,-1.9187587149593976,0.0,0.00342379447057193,0.206,24/60,18.89%,TUBA4A;TUBA1A;TUBB2A;RAN;BANF1;PPP2R1A;TUBB4A;CHMP4B;TUBB4B;TUBB2B;PPP2CA;EMD;CHMP2A;SEC13;CHMP6;NUP62;NUP37;TUBA1B;NUP205;NUP35;VPS4A;CHMP7;NUP107;CHMP4C
gsea,Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,-0.5975270144254557,-1.915641573827905,0.0,0.003583484153501494,0.215,8/26,14.02%,UBB;RPS27A;UBA52;RBX1;PCNA;RFC3;RPA3;POLD4
gsea,Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,-0.5081144753273945,-1.915219223324637,0.0020325203252032522,0.003618870764628895,0.22,11/45,10.61%,CALM1;YWHAG;YWHAH;VAMP2;YWHAB;YWHAE;YWHAZ;YWHAQ;RAB14;RALA;RAB11A
gsea,Translesion Synthesis By POLK R-HSA-5655862,-0.6493021732748298,-1.9071071989931623,0.0017857142857142857,0.003913256233781148,0.232,6/17,12.74%,UBB;RPS27A;UBA52;PCNA;RFC3;RPA3
gsea,NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,-0.6039456907372398,-1.9052944926208801,0.0018552875695732839,0.003946619888835143,0.234,6/23,7.96%,UBB;RPS27A;UBA52;PSENEN;YBX1;APH1A
gsea,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,-0.6418724031867369,-1.904851686692543,0.0038684719535783366,0.00396454520143422,0.235,10/18,21.10%,UBB;RPS27A;ELOB;UBA52;RNF7;LYN;HCK;ELOC;UBC;JAK1
gsea,Translesion Synthesis By POLH R-HSA-110320,-0.6400344826646943,-1.904725147154868,0.0,0.003944722475427049,0.235,7/19,14.15%,UBB;RPS27A;UBA52;PCNA;RFC3;RPA3;VCP
gsea,Assembly Of HIV Virion R-HSA-175474,-0.6555394002650213,-1.9032052998554798,0.0,0.004037242618773951,0.24,6/17,8.74%,UBB;PPIA;RPS27A;UBA52;VPS28;TSG101
gsea,O-linked Glycosylation Of Mucins R-HSA-913709,0.5621570634475981,1.897228182902707,0.0,0.029792195832033627,0.276,14/26,21.79%,ST6GALNAC3;GALNT18;GALNT14;GALNTL6;ST3GAL3;GALNT10;GALNT9;ST3GAL4;GALNT12;B3GNTL1;ST3GAL2;GALNT11;B3GNT2;GALNT3
gsea,Beta-catenin Independent WNT Signaling R-HSA-3858494,-0.43700906734644535,-1.896880264722464,0.0,0.0043073914441721095,0.256,38/112,15.66%,CALM1;UBB;PPP3CA;RPS27A;CLTA;PSMA7;GNB2;PSMB5;UBA52;AP2M1;GNG2;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PPP3R1;PPP3CB;PSMD2;PSMD4;PSMC5;PFN1;GNG13;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;GNG10;PSMD7;PSMC4;PSME3;PSMA2;PSMC6;AP2S1;GNG3;GNG7
gsea,Negative Regulation Of FGFR3 Signaling R-HSA-5654732,-0.6119980706009149,-1.8955443536647412,0.001953125,0.004345394497913539,0.261,11/20,20.74%,UBB;RPS27A;UBA52;SPRY2;PPP2R1A;FGF13;PPP2CA;MAPK3;MAPK1;UBC;FGF5
gsea,RAS Processing R-HSA-9648002,-0.6359245580090795,-1.89088271454839,0.0,0.0045303535432075345,0.27,6/16,19.36%,CALM1;HRAS;ABHD17A;LYPLA1;ABHD17C;NRAS
gsea,Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,-0.6205717195629366,-1.8872142987120146,0.0,0.004720838604738711,0.277,6/18,7.58%,UBB;RPS27A;HSP90AA1;UBA52;CDC37;HRAS
gsea,M Phase R-HSA-68886,-0.38165155806647477,-1.886430103773557,0.0,0.00474898628109664,0.278,92/288,20.36%,UBB;TUBA4A;DYNLL1;TUBA1A;RPS27A;TUBB2A;DYNLL2;YWHAG;HSP90AA1;RAN;RPS27;SET;NME7;PSMA7;RAB2A;H2AZ1;PSMB5;BANF1;UBA52;YWHAE;CETN2;PSMC3;SEM1;PSMC2;PSMA4;PPP2R1A;CSNK1E;PSMA5;TUBB4A;CHMP4B;RAB1B;H2BC4;TUBB4B;TUBB2B;SMC1A;PAFAH1B1;PPP2CA;PSMD2;PSMD4;PSMC5;ENSA;H2AJ;CSNK2B;EMD;NUP50;PSMB1;PSMA3;RAD21;PSMD6;CHMP2A;DCTN3;NCAPH2;PSMA1;PSMB3;UBE2S;PSMC1;SEC13;PSMD7;CHMP6;MAPK3;NUP62;NUP37;PSMC4;PSME3;PSMA2;ZWINT;PPP2R5D;ANAPC11;PSMC6;TUBA1B;PPP1CC;NUP205;SSNA1;NUP35;VPS4A;MAPK1;CTDNEP1;NEK6;H2AX;HAUS2;CEP78;CHMP7;PSMB7;DCTN1;NUP107;CHMP4C;UBC;B9D2;CENPP;ITGB3BP;KMT5A;RCC2
gsea,Spry Regulation Of FGF Signaling R-HSA-1295596,-0.6488844228592586,-1.886318323586241,0.003968253968253968,0.004733303987077866,0.279,9/16,18.89%,UBB;RPS27A;UBA52;SPRY2;PPP2R1A;PPP2CA;MAPK3;MAPK1;UBC
gsea,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,-0.5121629914034762,-1.8856345860652999,0.002012072434607646,0.0047611210829788,0.282,13/45,8.88%,HSP90AB1;HSP90AA1;ACTG1;CDC42;BRK1;ARPC5;WASL;ARPC2;ARPC1A;ABI1;NCK1;ARPC3;ACTR2
gsea,DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,-0.5131489487101689,-1.8837223938341967,0.0,0.0048174327792866204,0.287,8/43,8.42%,HSP90AB1;UBB;HMGB1;RPS27A;HSP90AA1;UBA52;NFKB2;ATG12
gsea,Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,-0.46152156527027527,-1.882267726031029,0.0,0.0048517402963075525,0.288,21/67,21.41%,SCG2;SPARCL1;PPP3CA;APOE;CST3;APLP2;CHGB;IGFBP7;TMEM132A;PDIA6;P4HB;VGF;CXXC1;IGFBP5;PAPPA2;SCG3;MIA3;HSP90B1;PRSS23;GOLM1;CALU
gsea,Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,0.5174639079880752,1.8812622813720474,0.0,0.031814063274336876,0.316,21/36,26.50%,ADAMTS17;SEMA5B;NOTCH2;ADAMTS20;SPON1;ADAMTS18;ADAMTS3;LARGE1;CFP;THSD1;POMGNT1;ADAMTS1;POMT2;GALNT12;GALNT3;THSD7B;ADAMTS13;SBSPON;ADAMTS15;MUC15;ADAMTS9
gsea,Interleukin-12 Family Signaling R-HSA-447115,-0.5268697037655959,-1.8789420370343988,0.0018726591760299626,0.004964065114642569,0.297,15/36,23.59%,PPIA;CDC42;AURKAIP1;HNRNPA2B1;CANX;SOD1;RPLP0;RALA;HNRNPF;P4HB;IL27;JAK1;HSPA9;TALDO1;MTAP
gsea,Post-translational Protein Phosphorylation R-HSA-8957275,-0.46384450581229864,-1.8747868667943213,0.0,0.005181657016239303,0.307,20/63,21.41%,SCG2;SPARCL1;PPP3CA;APOE;CST3;APLP2;CHGB;IGFBP7;TMEM132A;PDIA6;P4HB;VGF;CXXC1;IGFBP5;SCG3;MIA3;HSP90B1;PRSS23;GOLM1;CALU
gsea,Class B/2 (Secretin Family Receptors) R-HSA-373080,-0.5334394870891156,-1.870163700915579,0.0,0.005354874775495872,0.317,12/34,19.65%,GNAS;GLP2R;GNB2;GNG2;RAMP2;GNG13;GNG10;GNG3;GNG7;PTRH2;RAMP1;WNT16
gsea,Regulation Of Necroptotic Cell Death R-HSA-5675482,-0.6051743387187276,-1.8700142761522924,0.003816793893129771,0.005329851996171126,0.317,5/20,6.82%,UBB;RPS27A;HSP90AA1;UBA52;CDC37
gsea,RHO GTPases Activate PKNs R-HSA-5625740,-0.5687474300864689,-1.8676064815688447,0.0,0.005458831899549988,0.325,16/32,20.26%,YWHAG;YWHAH;MYL6;YWHAB;H2AZ1;YWHAE;MYL12B;H2BC4;YWHAZ;YWHAQ;H2AJ;MYL9;MYH14;H2AX;RHOB;MYH10
gsea,Cell Cycle Checkpoints R-HSA-69620,-0.3926995217263124,-1.8661398224751569,0.0,0.005530960084593481,0.33,61/187,20.78%,UBB;DYNLL1;RPS27A;DYNLL2;YWHAG;YWHAH;RPS27;YWHAB;PSMA7;PSMB5;UBA52;YWHAE;PSMC3;SEM1;PSMC2;PSMA4;PPP2R1A;PSMA5;H2BC4;PAFAH1B1;PPP2CA;PSMD2;PSMD4;PSMC5;YWHAZ;UBE2N;YWHAQ;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;RFC3;PHF20;UBE2S;PSMC1;SEC13;PSMD7;RNF168;RPA3;NUP37;PSMC4;PSME3;PSMA2;ZWINT;PPP2R5D;ANAPC11;PSMC6;PPP1CC;RAD50;CDKN1B;H2AX;PSMB7;NUP107;UBC;B9D2;CENPP;ITGB3BP;BABAM2;RCC2;UIMC1
gsea,Signaling By FGFR4 R-HSA-5654743,-0.5503810557457972,-1.864623126382988,0.0,0.005574723006747902,0.333,12/28,19.36%,UBB;RPS27A;UBA52;SPRY2;PPP2R1A;FGF13;PPP2CA;HRAS;MAPK3;MAPK1;UBC;NRAS
gsea,Signaling By EGFR In Cancer R-HSA-1643713,-0.5973958551655885,-1.8606433462178698,0.0018832391713747645,0.005790418312553465,0.338,6/20,7.58%,UBB;RPS27A;HSP90AA1;UBA52;CDC37;HRAS
gsea,Infection With Mycobacterium Tuberculosis R-HSA-9635486,-0.6164653431600077,-1.8600984536024856,0.005671077504725898,0.005798287439418753,0.34,9/20,20.68%,UBB;RPS27A;UBA52;PGK1;MAPK3;MAPK1;ENO1;UBC;RAB5A
gsea,Interleukin-12 Signaling R-HSA-9020591,-0.5503062655491797,-1.8586556289472789,0.0019157088122605363,0.005867561223189324,0.344,13/29,23.59%,PPIA;CDC42;AURKAIP1;HNRNPA2B1;SOD1;RPLP0;RALA;HNRNPF;P4HB;JAK1;HSPA9;TALDO1;MTAP
gsea,MET Promotes Cell Motility R-HSA-8875878,0.5980963363498233,1.8584573038760221,0.003875968992248062,0.03649198639395154,0.382,8/20,15.10%,TNS3;DOCK7;LAMB1;LAMB3;LAMC1;PTK2;SOS1;ITGA3
gsea,mRNA Splicing R-HSA-72172,-0.39492851787527905,-1.8576701529784765,0.0,0.0059226085345347275,0.35,82/187,26.39%,DDX5;HSPA8;SNRPD2;WBP11;SNW1;SNRPG;CPSF2;SNU13;HNRNPA2B1;POLR2G;SF3B4;POLR2F;SF3B2;SNRNP27;SNRPF;TFIP11;ZCRB1;WBP4;PCBP1;MAGOH;POLR2I;RBM22;YBX1;RBM8A;HNRNPA1;LSM2;RBM42;U2AF1;BUD31;SART1;LSM7;POLR2E;POLR2C;ZRSR2;LSM4;PUF60;HNRNPF;SRSF3;CDC40;HNRNPK;SNRPE;SNRNP200;LSM8;RBM17;PRPF38A;U2AF1L4;U2AF2;SNRPN;NCBP2;SNRPB;PQBP1;TXNL4A;USP39;MAGOHB;POLR2L;PRPF19;CTNNBL1;LSM3;SLU7;PPIE;PHF5A;PDCD7;CWC15;POLR2J;SNRPC;ZMAT5;HNRNPUL1;SF3B6;DHX16;ELAVL2;GPKOW;HNRNPC;XAB2;SYF2;LSM5;DNAJC8;SRRT;POLR2B;SNRPB2;HNRNPA0;EIF4A3;CSTF1
gsea,Aggrephagy R-HSA-9646399,-0.6167261652133635,-1.8568775734828178,0.0019455252918287938,0.005923006719860433,0.351,7/22,2.81%,UBB;DYNLL1;RPS27A;DYNLL2;HSP90AA1;PARK7;UBA52
gsea,SARS-CoV-1 Infection R-HSA-9678108,-0.5171290174831685,-1.8562128597830572,0.0,0.0059234013340172965,0.352,16/41,18.89%,UBB;DDX5;RPS27A;UBA52;CANX;CHMP4B;ZCRB1;MAP1LC3B;CHMP2A;CHMP6;VCP;GSK3B;CHMP7;PARP16;CHMP4C;UBC
gsea,Neurexins And Neuroligins R-HSA-6794361,0.4780945915923489,1.851303713395322,0.0,0.03549135682284829,0.397,20/52,16.93%,DLGAP2;DLGAP1;GRIN2A;NLGN1;SHANK2;DLGAP3;CASK;EPB41L1;SHANK3;SHANK1;MPP3;BEGAIN;STX1A;EPB41L3;GRIN2B;SYT1;APBA1;DLGAP4;APBA3;SIPA1L1
gsea,Negative Regulation Of FGFR2 Signaling R-HSA-5654727,-0.5806715557877169,-1.8485548568293189,0.0,0.006319606414714762,0.371,8/22,6.26%,UBB;RPS27A;UBA52;SPRY2;PPP2R1A;FGFR2;FGF13;PPP2CA
gsea,Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,-0.5460781956445553,-1.8485493184620265,0.001937984496124031,0.006291519275093807,0.371,14/28,16.39%,GNB2;GNG2;CCT2;CCT6A;CSNK2B;GNG13;GNA11;CCT5;CCT7;GNG10;PDCL;GNG3;GNG7;CCT8
gsea,Ub-specific Processing Proteases R-HSA-5689880,-0.4087086129205819,-1.8470391620390305,0.0,0.006336823462422212,0.375,49/141,19.07%,UBB;RPS27A;PSMA7;PSMB5;UBA52;VDAC1;USP2;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;H2BC4;MAT2B;H2AC25;USP14;PSMD2;PSMD4;PSMC5;SNX3;OTUB1;USP22;PSMB1;PSMA3;PSMD6;RUVBL1;TOMM20;PSMA1;PSMB3;TAF10;TADA3;ADRM1;PSMC1;PSMD7;VDAC2;TADA2B;PSMC4;DDB2;PSME3;PSMA2;PSMC6;USP20;FOXO4;PTRH2;USP30;PSMB7;UBC;STAM2;MUL1
gsea,Glucagon-type Ligand Receptors R-HSA-420092,-0.628805273477576,-1.8459880396686315,0.001941747572815534,0.006361868343000451,0.376,8/16,15.66%,GNAS;GLP2R;GNB2;GNG2;GNG13;GNG10;GNG3;GNG7
gsea,mRNA Splicing - Major Pathway R-HSA-72163,-0.39266690212248273,-1.8434540466344245,0.002070393374741201,0.006465785711602229,0.381,78/179,26.39%,DDX5;HSPA8;SNRPD2;WBP11;SNW1;SNRPG;CPSF2;SNU13;HNRNPA2B1;POLR2G;SF3B4;POLR2F;SF3B2;SNRNP27;SNRPF;TFIP11;WBP4;PCBP1;MAGOH;POLR2I;RBM22;YBX1;RBM8A;HNRNPA1;LSM2;RBM42;U2AF1;BUD31;SART1;LSM7;POLR2E;POLR2C;LSM4;PUF60;HNRNPF;SRSF3;CDC40;HNRNPK;SNRPE;SNRNP200;LSM8;RBM17;PRPF38A;U2AF1L4;U2AF2;SNRPN;NCBP2;SNRPB;PQBP1;TXNL4A;USP39;MAGOHB;POLR2L;PRPF19;CTNNBL1;LSM3;SLU7;PPIE;PHF5A;CWC15;POLR2J;SNRPC;HNRNPUL1;SF3B6;DHX16;ELAVL2;GPKOW;HNRNPC;XAB2;SYF2;LSM5;DNAJC8;SRRT;POLR2B;SNRPB2;HNRNPA0;EIF4A3;CSTF1
gsea,RIPK1-mediated Regulated Necrosis R-HSA-5213460,-0.5754974788526771,-1.8432955404619384,0.0037735849056603774,0.006457237539314145,0.381,5/22,6.82%,UBB;RPS27A;HSP90AA1;UBA52;CDC37
gsea,Signaling By FGFR R-HSA-190236,-0.4472079074068037,-1.838700519034634,0.0,0.006703578070042487,0.39,27/64,21.26%,UBB;RPS27A;UBA52;SPRY2;FLRT2;PPP2R1A;FGFR2;POLR2G;POLR2F;FGF13;PPP2CA;POLR2I;HRAS;HNRNPA1;POLR2E;POLR2C;FLRT3;HNRNPF;FGFR1;MAPK3;NCBP2;MAPK1;POLR2L;UBC;NRAS;FGF5;POLR2J
gsea,Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,-0.44960236214549065,-1.8373604265145278,0.0,0.0067721395125451365,0.394,26/67,18.71%,UBB;HSBP1;HSPA8;DNAJB6;YWHAE;HSPA2;MRPL18;ST13;BAG5;NUP50;BAG1;HIKESHI;SEC13;FKBP4;MAPK3;NUP62;RPA3;NUP37;BAG4;GSK3B;NUP205;NUP35;HSPH1;MAPK1;RPS19BP1;NUP107
gsea,G-protein Activation R-HSA-202040,-0.6228932942321372,-1.836632235828704,0.003883495145631068,0.006788290893674132,0.395,11/17,27.51%,GNB2;GNG2;GNG13;GNA11;GNG10;GNG3;GNG7;OPRM1;PDYN;GNG11;GNB4
gsea,G Alpha (12/13) Signaling Events R-HSA-416482,0.45377992534593536,1.8346697559676741,0.0,0.03815295558087769,0.44,22/58,15.38%,PLEKHG5;KALRN;TRIO;FGD4;ABR;ROCK1;ITSN1;GNA12;TIAM1;RASGRF2;ARHGEF33;PRPF38B;FGD1;ARHGEF18;ARHGEF17;SOS1;ARHGEF7;PREX1;ARHGEF2;ARHGEF4;ARHGEF3;OBSCN
gsea,Signaling By FGFR3 R-HSA-5654741,-0.5313786623301137,-1.8256944986255854,0.0,0.0076491982110876424,0.432,13/30,20.74%,UBB;RPS27A;UBA52;SPRY2;PPP2R1A;FGF13;PPP2CA;HRAS;MAPK3;MAPK1;UBC;NRAS;FGF5
gsea,Centrosome Maturation R-HSA-380287,-0.44360521508901735,-1.824575435335139,0.002012072434607646,0.007693573505187796,0.433,13/71,5.88%,TUBA4A;DYNLL1;TUBA1A;YWHAG;HSP90AA1;NME7;YWHAE;CETN2;PPP2R1A;CSNK1E;TUBB4A;TUBB4B;PAFAH1B1
gsea,Hedgehog Off State R-HSA-5610787,-0.43262236863759124,-1.8235392860758852,0.0,0.007743965824100758,0.437,30/87,15.12%,UBB;GNAS;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;RBX1;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PRKAR1B;PSMC4;PSME3;PSMA2;GSK3B;PSMC6;FUZ;PRKACB
gsea,Pyruvate Metabolism R-HSA-70268,-0.5713150746126663,-1.8212383472080875,0.0019120458891013384,0.007889444950854096,0.441,9/24,14.88%,BSG;VDAC1;DLAT;LDHA;GLO1;HAGH;LDHB;SLC16A1;LDHD
gsea,Gluconeogenesis R-HSA-70263,-0.5856412051874539,-1.8164688652604106,0.002012072434607646,0.008179533041271276,0.449,10/22,17.57%,MDH2;MDH1;ALDOC;TPI1;ENO2;PGK1;GOT2;PGAM2;G6PC3;ENO1
gsea,Detoxification Of Reactive Oxygen Species R-HSA-3299685,-0.5886605862154248,-1.8150937205262356,0.001841620626151013,0.008201991989723467,0.453,9/19,21.63%,PRDX5;SOD1;CYCS;GSTP1;PRDX1;P4HB;TXNRD1;CCS;GSR
gsea,G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,-0.6367722637473135,-1.8148807232198503,0.003968253968253968,0.008180249357291237,0.455,7/15,15.66%,GNB2;CDC42;GNG2;GNG13;GNG10;GNG3;GNG7
gsea,Signaling By FGFR2 R-HSA-5654738,-0.4486081722582582,-1.8136979813952814,0.0,0.008246348412916545,0.46,24/56,21.26%,UBB;RPS27A;UBA52;SPRY2;PPP2R1A;FGFR2;POLR2G;POLR2F;FGF13;PPP2CA;POLR2I;HRAS;HNRNPA1;POLR2E;POLR2C;HNRNPF;MAPK3;NCBP2;MAPK1;POLR2L;UBC;NRAS;FGF5;POLR2J
gsea,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,-0.4402338908407831,-1.8120634252943812,0.0019880715705765406,0.008336840860930195,0.463,13/71,5.88%,TUBA4A;DYNLL1;TUBA1A;YWHAG;HSP90AA1;NME7;YWHAE;CETN2;PPP2R1A;CSNK1E;TUBB4A;TUBB4B;PAFAH1B1
gsea,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,-0.4651284605899332,-1.8110241728322585,0.0018083182640144665,0.00839553685443112,0.466,24/59,22.02%,UBB;RPS27A;UBA52;HMGN1;POLR2G;POLR2F;RBX1;POLR2I;TCEA1;POLR2E;POLR2C;PCNA;RFC3;RPA3;POLD4;POLR2L;GTF2H5;PRPF19;UBC;PPIE;ERCC3;POLR2J;GTF2H4;POLD2
gsea,AURKA Activation By TPX2 R-HSA-8854518,-0.45095311022560347,-1.8104456780861595,0.00199203187250996,0.0083636738823262,0.467,12/62,5.88%,TUBA4A;DYNLL1;TUBA1A;YWHAG;HSP90AA1;YWHAE;CETN2;PPP2R1A;CSNK1E;TUBB4A;TUBB4B;PAFAH1B1
gsea,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,-0.45095311022560347,-1.8104456780861595,0.00199203187250996,0.0083636738823262,0.467,12/62,5.88%,TUBA4A;DYNLL1;TUBA1A;YWHAG;HSP90AA1;YWHAE;CETN2;PPP2R1A;CSNK1E;TUBB4A;TUBB4B;PAFAH1B1
gsea,N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,-0.5231131833463908,-1.8100693670194572,0.0019646365422396855,0.00836633851348104,0.468,16/35,22.38%,UBB;RPS27A;CALR;UBA52;CANX;PDIA3;UBXN1;RNF5;PSMC1;VCP;RNF185;OS9;RNF103;UBC;RNF139;DERL1
gsea,Disorders Of Transmembrane Transporters R-HSA-5619115,-0.3975943987513991,-1.8078036922689509,0.0,0.00857057008598397,0.475,39/122,15.91%,UBB;RPS27A;PSMA7;PSMB5;BSG;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;PSMD2;PSMD4;PSMC5;NUP50;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;SLC3A1;RNF5;SLC35A1;PSMC1;SEC13;PSMD7;NUP62;NUP37;PSMC4;PSME3;PSMA2;SLC24A5;SLC16A1;VCP;PSMC6;NUP205;RNF185;OS9;NUP35
gsea,IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,-0.6115353077154808,-1.8067878598964724,0.0,0.008718391836956947,0.482,6/17,11.29%,UBB;RPS27A;UBA52;NDUFA2;UBE2N;UBE2V1
gsea,mTORC1-mediated Signaling R-HSA-166208,-0.5678734049665335,-1.8046307903277956,0.003875968992248062,0.008901378366209422,0.492,9/23,13.06%,FKBP1A;RPS6;YWHAB;LAMTOR2;RHEB;RRAGA;LAMTOR3;RRAGD;AKT1S1
gsea,Signaling By Interleukins R-HSA-449147,-0.36726100506161996,-1.803556584920164,0.0,0.009016508515261824,0.495,91/264,23.88%,UBB;HMGB1;PPIA;HSPA8;RPS27A;VAMP2;HSP90AA1;JUN;PSMA7;CEBPD;PSMB5;UBA52;MEF2C;SQSTM1;NDN;CDC42;DUSP3;PSMC3;AURKAIP1;DUSP7;SEM1;HNRNPA2B1;PSMC2;PSMA4;CANX;PPP2R1A;SOD1;PSMA5;IL18;FGF13;CLSTN1;USP14;RBX1;IRS2;PPP2CA;NFKB2;PSMD2;PSMD4;PSMC5;YWHAZ;UBE2N;IL17RB;SNAP25;PSMB1;PSMA3;RPLP0;PSMD6;PSMA1;PSMB3;RALA;UBE2V1;HNRNPF;PSMC1;PSMD7;MAPK3;P4HB;PSMC4;PSME3;LYN;PSMA2;NFKBIB;PPP2R5D;IL1RAPL1;PSMC6;IL1R2;HCK;NKIRAS1;MAPK1;CRLF2;VRK3;PSMB7;OPRM1;UBC;HSP90B1;TBK1;PIK3R2;IL27;CSF1R;JAK1;HSPA9;SKP1;PSMB6;VIM;NFKBIA;TALDO1;IL10RB;PIK3CB;PSMD10;PSMB10;MTAP;MAP2K1
gsea,"Cell Cycle, Mitotic R-HSA-69278",-0.3506411466072369,-1.8030993164015043,0.0,0.009022519520938665,0.499,107/388,20.07%,HSP90AB1;UBB;TUBA4A;DYNLL1;TUBA1A;RPS27A;TUBB2A;DYNLL2;YWHAG;HSP90AA1;RAN;RPS27;SET;NME7;PSMA7;RAB2A;H2AZ1;PSMB5;BANF1;UBA52;YWHAE;CETN2;PSMC3;SEM1;PSMC2;PSMA4;PPP2R1A;CSNK1E;PSMA5;TUBB4A;CHMP4B;RAB1B;H2BC4;TUBB4B;TUBB2B;SMC1A;PAFAH1B1;RBX1;PPP2CA;PSMD2;PSMD4;PSMC5;ENSA;H2AJ;CSNK2B;EMD;NUP50;PSMB1;PSMA3;CDK4;GINS2;RAD21;PSMD6;CHMP2A;DCTN3;NCAPH2;DHFR;PSMA1;PSMB3;PCNA;RFC3;UBE2S;PSMC1;SEC13;PSMD7;CHMP6;MAPK3;NUP62;RPA3;NUP37;PSMC4;PSME3;LYN;PSMA2;ZWINT;PPP2R5D;ANAPC11;POLD4;GSK3B;PSMC6;TUBA1B;PPP1CC;NUP205;LCMT1;SSNA1;NUP35;VPS4A;MAPK1;CDKN1B;CTDNEP1;NEK6;H2AX;HAUS2;CEP78;CHMP7;PSMB7;DCTN1;NUP107;CHMP4C;UBC;B9D2;CCND3;CENPP;ITGB3BP;CDKN2D;GINS4;KMT5A
gsea,Separation Of Sister Chromatids R-HSA-2467813,-0.3974709658337779,-1.8027514793400852,0.0,0.009004534400367718,0.501,39/130,14.96%,UBB;DYNLL1;RPS27A;DYNLL2;RPS27;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PPP2R1A;PSMA5;SMC1A;PAFAH1B1;PPP2CA;PSMD2;PSMD4;PSMC5;PSMB1;PSMA3;RAD21;PSMD6;PSMA1;PSMB3;UBE2S;PSMC1;SEC13;PSMD7;NUP37;PSMC4;PSME3;PSMA2;ZWINT;PPP2R5D;ANAPC11;PSMC6;PPP1CC
gsea,TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,-0.5088513413690435,-1.8000546976873701,0.0,0.00925504048656505,0.51,10/34,16.20%,UBB;HMGB1;RPS27A;UBA52;USP14;NFKB2;UBE2N;UBE2V1;NFKBIB;NKIRAS1
gsea,Cell Cycle R-HSA-1640170,-0.34270582321729054,-1.7965587734219086,0.0,0.009539204661074104,0.519,137/488,20.36%,HSP90AB1;UBB;TUBA4A;DYNLL1;TUBA1A;RPS27A;TUBB2A;DYNLL2;YWHAG;YWHAH;HSP90AA1;RAN;RPS27;SET;NME7;YWHAB;PSMA7;RAB2A;H2AZ1;PSMB5;BANF1;UBA52;YWHAE;CETN2;PSMC3;HSPA2;SEM1;PSMC2;PSMA4;PPP2R1A;POLR2G;CSNK1E;POLR2F;PSMA5;TUBB4A;CHMP4B;RAB1B;H2BC4;TUBB4B;TUBB2B;SMC1A;PAFAH1B1;RBX1;PPP2CA;PSMD2;PSMD4;PSMC5;CENPX;YWHAZ;UBE2N;POLR2I;ENSA;YWHAQ;H2AJ;NOP10;CSNK2B;EMD;NUP50;NPM1;HJURP;PSMB1;PSMA3;CDK4;GINS2;RBBP7;RAD21;TERF1;PSMD6;CHMP2A;DCTN3;POLR2E;POLR2C;NCAPH2;RUVBL1;DHFR;PSMA1;PSMB3;PCNA;RFC3;PHF20;UBE2S;PSMC1;SEC13;PSMD7;GAR1;ANKRD28;RNF168;CHMP6;MAPK3;NUP62;RPA3;NUP37;PSMC4;PSME3;LYN;PSMA2;ZWINT;PPP2R5D;ANAPC11;POLD4;GSK3B;PSMC6;CENPW;TUBA1B;PPP1CC;NUP205;LCMT1;SSNA1;NUP35;DKC1;VPS4A;RAD50;MAPK1;CDKN1B;CTDNEP1;NEK6;H2AX;POLR2L;RAD51;HAUS2;CEP78;CHMP7;PSMB7;DCTN1;NUP107;CHMP4C;UBC;B9D2;SYCP3;CCND3;CENPP;ITGB3BP;CDKN2D;GINS4;KMT5A;BABAM2;RCC2
gsea,Signaling By FGFR1 R-HSA-5654736,-0.4945621093838587,-1.7952261161491503,0.0,0.009679139062315188,0.527,16/37,20.74%,UBB;RPS27A;UBA52;SPRY2;FLRT2;PPP2R1A;FGF13;PPP2CA;HRAS;FLRT3;FGFR1;MAPK3;MAPK1;UBC;NRAS;FGF5
gsea,RHOA GTPase Cycle R-HSA-8980692,0.39677367628345234,1.7940727673120853,0.0,0.05209413325807426,0.563,41/114,18.92%,PLEKHG5;KALRN;TRIO;ARHGEF28;MYO9B;DLC1;ABR;TJP2;MYO9A;ROCK1;STK10;PREX2;TIAM1;RASGRF2;GMIP;LBR;ARAP2;PRPF38B;ARHGAP18;ARHGEF18;DHDDS;ARHGEF17;FARP1;DAAM1;ARHGEF7;VANGL1;PREX1;ARHGEF2;SCFD1;ARHGEF4;ARHGEF3;SRGAP1;ARHGAP32;OBSCN;ARHGAP42;AAAS;ARHGEF10L;PCDH7;ABCD3;FLOT2;IQGAP1
gsea,Leishmania Infection R-HSA-9658195,-0.40258596641854677,-1.7936398200468116,0.0,0.009794403367558924,0.534,38/133,17.33%,CALM1;HSP90AB1;GNAS;ACTG1;GLP2R;JUN;GNB2;CDC42;BRK1;GNG2;PLK2;ARPC5;WASL;ARPC2;IL18;RAMP2;NFKB2;ARPC1A;ABI1;NCK1;GNAI1;ARPC3;GNG13;ACTR2;GNAI2;CHGA;GNG10;PRKAR1B;MAPK3;LYN;ADRB1;GNG3;PRKACB;HCK;GNG7;MAPK1;PTRH2;RAMP1
gsea,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,-0.5417759111219023,-1.7924849639061229,0.004008016032064128,0.009926377538611813,0.541,12/30,12.46%,ACTG1;CDC42;BRK1;ARPC5;WASL;ARPC2;ARPC1A;ABI1;NCK1;ARPC3;ACTR2;MAPK3
gsea,Neuronal System R-HSA-112316,0.3524816935588122,1.7919889040174342,0.0,0.049759183340017527,0.565,74/299,10.48%,GRIK4;DLGAP2;GRIA3;PTPRS;DLGAP1;GRIN2A;NBEA;CACNA1E;NLGN1;SHANK2;CACNB2;GRIA1;LRRC7;CACNA2D3;GABRA2;CACNA1A;GABRG3;IL1RAPL2;GABBR2;GRIA4;ADCY8;RPS6KA2;KCNN3;KCNAB1;PRKAG2;KCNK9;KCNK13;CHRNA4;UNC13B;SLC6A1;KCNJ6;CACNA1B;KCND3;PTPRD;ADCY2;ACTN2;NTRK3;NRG1;KCNH1;ERBB4;PPM1E;CAMK2A;DLGAP3;KCNQ2;MAPT;PTPRF;PRKCG;LRFN2;CASK;EPB41L1;KCNMA1;SHANK3;CAMK2G;ADCY9;RIMS1;KCNQ3;SYN2;GRIK5;RASGRF2;KCNMB4;LRFN1;KCNQ5;TSPOAP1;SHANK1;MPP3;CACNG3;KCNG3;BEGAIN;GABRB1;SLC1A1;STX1A;GRIK1;KCNG1;RPS6KA6
gsea,Cyclin D Associated Events In G1 R-HSA-69231,-0.4930420870525716,-1.7903740171625009,0.0,0.010016393700806425,0.547,13/36,23.19%,UBB;RPS27A;UBA52;PPP2R1A;PPP2CA;CDK4;LYN;CDKN1B;UBC;CCND3;CDKN2D;SKP1;E2F4
gsea,Signal Amplification R-HSA-392518,-0.5609231739387431,-1.7879744554691293,0.004,0.010216379803468501,0.555,10/22,15.66%,GNB2;GNG2;P2RY12;GNAI1;GNG13;GNA11;GNAI2;GNG10;GNG3;GNG7
gsea,FCERI Mediated Ca+2 Mobilization R-HSA-2871809,-0.5984584320950861,-1.7873580896903452,0.004158004158004158,0.01026396625707733,0.558,4/17,5.85%,CALM1;PPP3CA;PPP3R1;PPP3CB
gsea,Signaling By CSF3 (G-CSF) R-HSA-9674555,-0.5615147826150688,-1.7872540309802882,0.005703422053231939,0.010241828903233304,0.558,11/23,21.10%,UBB;RPS27A;ELOB;UBA52;RNF7;LYN;HCK;ELOC;UBC;NRAS;JAK1
gsea,Golgi-to-ER Retrograde Transport R-HSA-8856688,-0.41232941439415605,-1.7861047221066595,0.0038095238095238095,0.010300468540104345,0.561,31/93,20.65%,DYNLL1;DYNLL2;TMED9;CAPZA2;ARF4;DCTN6;RAB6B;NAPG;RAB1B;PAFAH1B1;RAB6A;ARF3;TMED2;DCTN3;ACTR10;RAB18;ARF5;COPG2;TMED7;UBE2Z;PAFAH1B2;KIF15;DCTN5;NSF;COPB2;COPG1;ARFGAP2;DCTN1;BICD2;SURF4;COPE
gsea,Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,-0.4674399503166071,-1.7832431889008056,0.0,0.010519259934472128,0.574,22/50,21.65%,UBB;RPS27A;UBA52;HMGN1;POLR2G;POLR2F;RBX1;COPS6;POLR2I;TCEA1;POLR2E;POLR2C;GPS1;COPS8;POLR2L;GTF2H5;PRPF19;UBC;PPIE;ERCC3;POLR2J;GTF2H4
gsea,Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,-0.5817095318103821,-1.7818345391154766,0.0035149384885764497,0.010644965376383255,0.578,7/22,14.02%,UBB;RPS27A;UBA52;PCNA;RFC3;RPA3;POLD4
gsea,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",-0.48522833893142897,-1.7800182370131765,0.0019120458891013384,0.010781102984789074,0.586,15/40,19.73%,UBB;APOE;RPS27A;CLTA;NCEH1;UBA52;AP2M1;P4HB;AP2S1;PRKACB;AP2B1;ANGPTL3;UBC;NR1H2;PLTP
gsea,Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,-0.36222873336806066,-1.7760742472436388,0.002044989775051125,0.011233775703606086,0.6,96/234,26.39%,DDX5;HSPA8;SNRPD2;WBP11;SNW1;SNRPG;CPSF2;SNU13;HNRNPA2B1;POLR2G;SF3B4;POLR2F;SF3B2;SNRNP27;SNRPF;TFIP11;ZCRB1;WBP4;PCBP1;MAGOH;POLR2I;RBM22;YBX1;RBM8A;HNRNPA1;NUP50;SLBP;LSM2;RBM42;U2AF1;BUD31;SART1;LSM7;POLR2E;POLR2C;ZRSR2;LSM4;PUF60;HNRNPF;SRSF3;SEC13;CDC40;CHTOP;NUP62;HNRNPK;NUP37;SNRPE;SNRNP200;LSM8;RBM17;PRPF38A;U2AF1L4;U2AF2;NUP205;SNRPN;DDX39B;NUP35;NCBP2;SNRPB;PQBP1;TXNL4A;USP39;MAGOHB;POLR2L;PRPF19;POLDIP3;NUP107;CTNNBL1;LSM3;SLU7;PPIE;PHF5A;PDCD7;THOC7;CWC15;POLR2J;SNRPC;ZMAT5;SEH1L;HNRNPUL1;SF3B6;DHX16;ELAVL2;GPKOW;HNRNPC;XAB2;SYF2;LSM5;NUP85;DNAJC8;SRRT;POLR2B;SNRPB2;HNRNPA0;EIF4A3;CSTF1
gsea,Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,0.5339942810929726,1.7729128852755194,0.0021008403361344537,0.05674574985736017,0.622,14/28,17.87%,ATP2B4;RIPOR2;CASK;EPB41L1;KCNMA1;PLS1;SPTAN1;MYH9;PCDH15;ESPN;EPS8;EPB41L3;KCNN2;SPTBN1
gsea,Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,-0.5662679235697033,-1.7723839824816237,0.0019455252918287938,0.011575705481059824,0.609,12/22,19.75%,H2AZ1;H2BC4;CENPX;H2AJ;NPM1;HJURP;RBBP7;RUVBL1;CENPW;H2AX;CENPP;ITGB3BP
gsea,Netrin-1 Signaling R-HSA-373752,0.49527718530066805,1.7715860819357416,0.0019193857965451055,0.05441181567468275,0.63,12/37,7.15%,DSCAML1;SLIT3;TRIO;ABLIM2;MAPK14;ABLIM3;DSCAM;TRPC5;DCC;PTK2;TRPC1;TRPC6
gsea,TCF Dependent Signaling In Response To WNT R-HSA-201681,-0.38607355302020363,-1.7709917295783766,0.0,0.011718084100359,0.615,38/137,14.80%,UBB;RPS27A;PSMA7;H2AZ1;PSMB5;UBA52;PSMC3;SEM1;TLE4;PSMC2;PSMA4;PPP2R1A;CSNK1E;PSMA5;H2BC4;RBX1;PPP2CA;PSMD2;PSMD4;PSMC5;YWHAZ;H2AJ;CSNK2B;PSMB1;PSMA3;PSMD6;RUVBL1;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PPP2R5D;GSK3B;PSMC6;SOX4
gsea,Neddylation R-HSA-8951664,-0.3696010630097258,-1.7663218682461,0.0,0.012190229796131349,0.632,70/200,23.85%,UBB;RPS27A;PSMA7;ELOB;PSMB5;UBA52;SQSTM1;KLHL9;PSMC3;SEM1;PSMC2;PSMA4;FBXL16;PSMA5;COMMD3;NEDD8;RBX1;PSMD2;SENP8;PSMD4;PSMC5;COPS6;UBA3;FBXW2;PSMB1;PSMA3;FBXO32;RBBP7;PSMD6;COMMD4;PSMA1;PSMB3;ASB13;GPS1;FBXO9;RNF7;PSMC1;COMMD5;PSMD7;FBXO6;COPS8;WSB2;ASB5;PSMC4;DDB2;PSME3;PSMA2;COMMD6;COMMD1;VCP;PSMC6;DDA1;ELOC;BTBD6;UCHL3;PSMB7;COMMD8;UBC;MUL1;KBTBD7;FBXW7;SKP1;PSMB6;DCAF7;FBXL3;KEAP1;NUB1;PSMD10;PSMB10;COMMD2
gsea,Dual Incision In TC-NER R-HSA-6782135,-0.45047828154886865,-1.7648575882477324,0.003683241252302026,0.012306919615317102,0.634,24/60,22.02%,UBB;RPS27A;UBA52;HMGN1;POLR2G;POLR2F;RBX1;POLR2I;TCEA1;POLR2E;POLR2C;PCNA;RFC3;RPA3;POLD4;POLR2L;GTF2H5;PRPF19;UBC;PPIE;ERCC3;POLR2J;GTF2H4;POLD2
gsea,Calnexin/calreticulin Cycle R-HSA-901042,-0.5405102938504277,-1.7638908015200394,0.00749063670411985,0.012411613573477696,0.637,11/26,18.89%,UBB;RPS27A;CALR;UBA52;CANX;PDIA3;RNF5;RNF185;OS9;RNF103;UBC
gsea,DNA Damage Recognition In GG-NER R-HSA-5696394,-0.5012904104191156,-1.7636431188694464,0.002012072434607646,0.012382449885965346,0.638,14/36,19.79%,UBB;RPS27A;UBA52;CETN2;RBX1;COPS6;RUVBL1;PARP1;GPS1;COPS8;DDB2;ACTR8;UBC;YY1
gsea,RHOB GTPase Cycle R-HSA-9013026,0.43536242730630703,1.7619035747238314,0.0,0.05639505385271476,0.659,20/56,18.71%,ARHGEF28;MYO9B;DLC1;ABR;TJP2;MYO9A;ROCK1;STK10;PRPF38B;DHDDS;ARHGEF17;DAAM1;VANGL1;PREX1;ARHGEF2;ARHGEF3;ARHGAP32;ARHGEF10L;PCDH7;FLOT2
gsea,Basigin Interactions R-HSA-210991,-0.578865207016808,-1.7598244028413714,0.00539568345323741,0.012795486348864208,0.652,4/19,6.16%,ATP1B1;PPIA;BSG;ATP1B2
gsea,Signaling By Insulin Receptor R-HSA-74752,-0.45501032975954775,-1.7579226242892356,0.0038022813688212928,0.012963295209671304,0.656,21/51,20.74%,ATP6V0C;ATP6V1D;ATP6V1A;ATP6V1G2;ATP6V0E2;ATP6V0B;FGFR2;ATP6V1F;FGF13;IRS2;HRAS;FGFR1;ATP6V1C1;MAPK3;ATP6V1E1;ATP6V1B2;ATP6V1G1;MAPK1;NRAS;PIK3R2;FGF5
gsea,PTEN Regulation R-HSA-6807070,-0.3914499418557116,-1.7572419483359336,0.002036659877800407,0.013014704809438145,0.659,42/125,16.37%,UBB;RPS27A;JUN;PSMA7;PSMB5;UBA52;PSMC3;LAMTOR2;SEM1;RHEB;PSMC2;PSMA4;VAPA;RRAGA;LAMTOR3;PSMA5;EGR1;PML;PSMD2;PSMD4;PSMC5;CHD3;CSNK2B;PSMB1;PSMA3;RBBP7;PSMD6;PSMA1;PSMB3;RRAGD;PSMC1;PSMD7;MAPK3;MKRN1;PSMC4;PSME3;STUB1;PSMA2;PSMC6;CBX6;RING1;MAPK1
gsea,mRNA Splicing - Minor Pathway R-HSA-72165,-0.45558122258330286,-1.7560073620821066,0.0,0.013158637881666954,0.666,23/49,23.00%,SNRPD2;SNRPG;POLR2G;SF3B4;POLR2F;SF3B2;SNRPF;ZCRB1;POLR2I;YBX1;POLR2E;POLR2C;ZRSR2;SNRPE;SNRNP200;NCBP2;SNRPB;TXNL4A;POLR2L;PDCD7;POLR2J;ZMAT5;SF3B6
gsea,Glycogen Metabolism R-HSA-8982491,-0.5872980630862114,-1.755476141513744,0.016574585635359115,0.013154519669609037,0.666,4/19,2.81%,CALM1;UBB;RPS27A;UBA52
gsea,Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,-0.6350369608423159,-1.7526698325137953,0.007858546168958742,0.013497637296011685,0.677,5/15,6.10%,FTH1;APOE;HSP90AA1;CALR;C1D
gsea,Transcriptional Regulation By TP53 R-HSA-3700989,-0.3539141674638119,-1.7469873510172353,0.0,0.014243704998630041,0.69,88/287,21.65%,UBB;COX6C;RPS27A;YWHAG;YWHAH;COX8A;JUN;COX4I1;COX5B;YWHAB;SESN1;COX6B1;ELOB;PRDX5;UBA52;YWHAE;COX5A;COX7C;COX7A2L;BNIP3L;COX6A1;USP2;PLK2;LAMTOR2;BTG2;RHEB;BAX;COX7B;RRAGA;PPP2R1A;POLR2G;POLR2F;LAMTOR3;CYCS;TRIAP1;PML;PPP2CA;CHD3;YWHAZ;POLR2I;YWHAQ;COX20;CSNK2B;PRDX1;NPM1;TCEA1;RBBP7;SCO2;POLR2E;POLR2C;CDK5R1;COX14;TAF11;PIP4K2A;TAF10;PCNA;RRAGD;RFC3;PHF20;CNOT8;PRELID3A;RPA3;PRELID1;DDB2;PIP4P1;COX19;BRD7;SURF1;SESN3;RAD50;CDKN1B;MAPKAPK5;POLR2L;ELOC;HIPK1;GTF2H5;UBC;RRM2B;TAF5;TXNRD1;KMT5A;SSRP1;ERCC3;KAT6A;POLR2J;RRAGC;GSR;GTF2H4
gsea,"Platelet Activation, Signaling And Aggregation R-HSA-76002",-0.3691103142201716,-1.7392603152510047,0.0,0.015264507247462374,0.714,39/161,13.57%,CALM1;PPIA;TMSB4X;TTR;TUBA4A;APLP2;RASGRP1;GNB2;CDC42;FAM3C;GNG2;VEGFC;TIMP3;SOD1;P2RY12;MANF;PDGFA;PFN1;VTI1B;YWHAZ;GNAI1;GNG13;MAGED2;GNA11;VEGFB;OLA1;SCCPDH;CLU;CD63;TAGLN2;GNAI2;GNG10;ADRA2C;TLN1;MAPK3;LYN;ENDOD1;PTPN1;CHID1
gsea,Protein Ubiquitination R-HSA-8852135,-0.42670642216819143,-1.7356356823433672,0.001876172607879925,0.01568765142268471,0.726,24/61,25.67%,UBB;RPS27A;UBA52;RRAGA;H2BC4;UBE2N;UBA1;PEX12;PCNA;UBE2S;OTULIN;UBE2Z;VCP;BCL10;RTF1;CDC73;UCHL3;UBC;SKIC8;DERL1;UBE2E3;UBE2H;PEX5;CDC34
gsea,Thromboxane Signaling Thru TP Receptor R-HSA-428930,-0.5937223060064635,-1.7353082834080076,0.005825242718446602,0.015669258570413493,0.726,10/16,29.46%,GNB2;GNG2;GNG13;GNA11;GNG10;GNG3;GNG7;GNG11;GNB4;AAMP
gsea,Signaling By WNT R-HSA-195721,-0.36038216554730873,-1.7347924945675701,0.001876172607879925,0.015682969598354347,0.728,56/210,15.66%,CALM1;UBB;PPP3CA;RPS27A;CLTA;TLE5;PSMA7;H2AZ1;GNB2;PSMB5;UBA52;VPS29;AP2M1;GNG2;PSMC3;SEM1;TLE4;PSMC2;PSMA4;PPP2R1A;CSNK1E;PSMA5;PPP3R1;H2BC4;PPP3CB;RBX1;PPP2CA;PSMD2;PSMD4;PSMC5;PFN1;YWHAZ;SNX3;H2AJ;CSNK2B;GNG13;PSMB1;PSMA3;PSMD6;RUVBL1;PSMA1;PSMB3;PSMC1;GNG10;PSMD7;PSMC4;PSME3;PSMA2;PPP2R5D;GSK3B;PSMC6;AP2S1;SOX4;GNG3;VPS35;GNG7
gsea,Biological Oxidations R-HSA-211859,-0.40662851232099473,-1.734416757864346,0.0,0.015670033350139955,0.728,34/84,31.24%,HSP90AB1;PRNP;GSTM5;AURKAIP1;GSTM1;TRMT112;PTGES3;MAT2B;GSTP1;COMT;GCLM;CYB5R3;VDAC2;HPGDS;PAOX;FDX2;ARNT2;SLC35B3;AKR1A1;MIA3;SULT4A1;N6AMT1;ESD;ADH5;BPHL;CYP46A1;GSTO1;GCLC;PODXL2;CYB5B;CHAC2;AHR;PTGIS;ABHD10
gsea,O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,0.5269037830201441,1.730409933023974,0.0041928721174004195,0.06999093920354113,0.732,15/24,26.50%,ADAMTS17;SEMA5B;ADAMTS20;SPON1;ADAMTS18;ADAMTS3;CFP;THSD1;ADAMTS1;POFUT2;THSD7B;ADAMTS13;SBSPON;ADAMTS15;ADAMTS9
gsea,Potential Therapeutics For SARS R-HSA-9679191,-0.4235587037417211,-1.7213511217694648,0.005847953216374269,0.01755679298922461,0.763,20/76,14.71%,ATP1B1;HSP90AB1;FKBP1A;HSP90AA1;AP2M1;ATP1A3;PTGES3;SAP18;RBX1;ATP1B2;IFNGR2;CHD3;NCK1;COMT;RBBP7;FXYD1;FKBP4;IMPDH2;ATP1A2;AP2S1
gsea,Chromosome Maintenance R-HSA-73886,-0.41698952125952926,-1.7182803664154318,0.0017857142857142857,0.017959197662562442,0.767,43/76,34.71%,H2AZ1;POLR2G;POLR2F;H2BC4;CENPX;POLR2I;H2AJ;NOP10;NPM1;HJURP;RBBP7;TERF1;POLR2E;POLR2C;RUVBL1;PCNA;RFC3;GAR1;ANKRD28;RPA3;POLD4;CENPW;DKC1;H2AX;POLR2L;CENPP;ITGB3BP;POLR2J;POLD2;POLR2B;DAXX;RSF1;NHP2;SMARCA5;TINF2;POLR2K;H2BC21;POLD3;PRIM1;POLR2D;H2AZ2;POLR2A;LRIG1
gsea,Defective B3GALTL Causes PpS R-HSA-5083635,0.531063543819514,1.7179098736671496,0.006342494714587738,0.07472716817220182,0.768,7/23,8.58%,ADAMTS17;SEMA5B;ADAMTS20;SPON1;ADAMTS18;ADAMTS3;CFP
gsea,RHOBTB GTPase Cycle R-HSA-9706574,-0.48243328783596406,-1.7172880523089242,0.007827788649706457,0.01805403453289023,0.768,10/34,12.87%,HSP90AB1;HSP90AA1;ACTG1;CCT2;CCT6A;CDC37;TXNL1;GPS1;CCT7;TWF1
gsea,Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,-0.6087583816151069,-1.7149605064529254,0.007984031936127744,0.0183210007519751,0.772,5/15,8.74%,UBB;RPS27A;UBA52;VPS28;TSG101
gsea,Nucleotide Excision Repair R-HSA-5696398,-0.3922941658275581,-1.708787174426933,0.001834862385321101,0.019160080594931378,0.792,36/102,22.63%,UBB;RPS27A;UBA52;CETN2;SUMO2;HMGN1;POLR2G;POLR2F;RBX1;COPS6;UBE2N;POLR2I;TCEA1;POLR2E;POLR2C;RUVBL1;PCNA;PARP1;GPS1;RFC3;COPS8;RPA3;DDB2;POLD4;ACTR8;POLR2L;GTF2H5;PRPF19;UBC;PPIE;YY1;ERCC3;POLR2J;GTF2H4;POLD2;SUMO1
gsea,Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,-0.420196589759206,-1.7086921328950069,0.0018587360594795538,0.019104182402002276,0.792,27/72,22.02%,UBB;RPS27A;UBA52;HMGN1;POLR2G;POLR2F;RBX1;COPS6;POLR2I;TCEA1;POLR2E;POLR2C;PCNA;GPS1;RFC3;COPS8;RPA3;POLD4;POLR2L;GTF2H5;PRPF19;UBC;PPIE;ERCC3;POLR2J;GTF2H4;POLD2
gsea,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,-0.4558092076356077,-1.7081960188670744,0.005474452554744526,0.01910048872830752,0.794,15/42,22.38%,UBB;RPS27A;UBA52;RRAGA;H2BC4;UBE2N;PEX12;PCNA;VCP;BCL10;RTF1;CDC73;UBC;SKIC8;DERL1
gsea,Signaling By ERBB4 R-HSA-1236394,-0.4388259721718679,-1.705213834058425,0.001996007984031936,0.019556424826630312,0.8,11/51,7.96%,UBB;APOE;RPS27A;UBA52;GABRG2;PSENEN;NRG3;NRG4;STMN1;HRAS;APH1A
gsea,Dual Incision In GG-NER R-HSA-5696400,-0.4820243386023184,-1.7049203231832137,0.0018450184501845018,0.019540914858703854,0.8,15/38,22.02%,UBB;RPS27A;UBA52;RBX1;PCNA;PARP1;RFC3;RPA3;DDB2;POLD4;GTF2H5;UBC;ERCC3;GTF2H4;POLD2
gsea,Signaling By NOTCH3 R-HSA-9012852,-0.4597286994319981,-1.7048957050953553,0.0018115942028985507,0.01947935116095814,0.8,13/41,20.12%,UBB;RPS27A;UBA52;SNW1;PSENEN;YBX1;APH1A;JAG1;FABP7;HEY1;UBC;MAMLD1;PBX1
gsea,Negative Regulation Of FGFR1 Signaling R-HSA-5654726,-0.5343686604066376,-1.7030937932949055,0.009708737864077669,0.019796449818372478,0.804,12/23,20.74%,UBB;RPS27A;UBA52;SPRY2;PPP2R1A;FGF13;PPP2CA;FGFR1;MAPK3;MAPK1;UBC;FGF5
gsea,Regulation Of TNFR1 Signaling R-HSA-5357905,-0.5095780000460911,-1.7009432188619082,0.007889546351084813,0.020075740146128167,0.808,6/28,6.62%,UBB;RACK1;RPS27A;UBA52;USP2;CLIP3
gsea,Apoptotic Factor-Mediated Response R-HSA-111471,-0.5938683320670693,-1.700934875322589,0.009009009009009009,0.020007916699688544,0.808,8/15,23.69%,BAX;CYCS;C1QBP;MAPK3;GSDME;MAPK1;SEPTIN4;DIABLO
gsea,Signaling By NOTCH R-HSA-157118,-0.3602103558848798,-1.698470554597661,0.0018726591760299626,0.020375690118383485,0.814,50/157,20.17%,UBB;RPS27A;JUN;PSMA7;H2AZ1;PSMB5;UBA52;SNW1;PSMC3;SEM1;TLE4;PSMC2;PSMA4;PSENEN;PSMA5;H2BC4;RBX1;RAB6A;PSMD2;PSMD4;PSMC5;YWHAZ;YBX1;APH1A;H2AJ;PSMB1;PSMA3;PSMD6;TMED2;TBL1XR1;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;SIRT6;PSMC6;JAG1;H2AX;FABP7;TBL1X;HEY1;PSMB7;UBC;MAMLD1;TLE1;PBX1;FBXW7
gsea,Signaling By Hedgehog R-HSA-5358351,-0.3839573074320767,-1.6983659073574235,0.0018796992481203006,0.020312358109325857,0.814,39/116,18.89%,UBB;GNAS;RPS27A;PSMA7;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;RBX1;PSMD2;PSMD4;PSMC5;HHIP;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PRKAR1B;P4HB;PSMC4;PSME3;PSMA2;GAS8;VCP;GSK3B;PSMC6;FUZ;PRKACB;OS9;ADCY10;CDC73;PSMB7;UBC
gsea,RHO GTPases Activate PAKs R-HSA-5627123,-0.5656350925658197,-1.6964345630209494,0.011741682974559686,0.02068670515541676,0.82,4/18,3.03%,CALM1;MYL6;MYL12B;CDC42
gsea,Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,0.5018476804181785,1.695540595471524,0.01050420168067227,0.08608634358378131,0.816,14/28,20.83%,COL23A1;P3H2;COL11A1;COL19A1;ADAMTS3;P3H1;COLGALT2;COL5A2;BMP1;COL4A1;COL5A1;COL25A1;COL4A2;COL13A1
gsea,NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,-0.5496679850050444,-1.6947949924005723,0.009140767824497258,0.020893253898420595,0.822,5/20,7.96%,UBB;RPS27A;UBA52;PSENEN;APH1A
gsea,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,-0.4895596917510938,-1.6922098855646475,0.007633587786259542,0.021253198643117158,0.825,12/28,25.67%,UBB;RPS27A;UBA52;UBA1;UBE2S;OTULIN;UBE2Z;UCHL3;UBC;UBE2E3;UBE2H;CDC34
gsea,Stimuli-sensing Channels R-HSA-2672351,0.41677135325123726,1.6918416783053187,0.0,0.08516632018645996,0.82,20/60,8.74%,RYR2;UNC80;ANO4;ASIC2;ANO3;CLCN5;ANO6;RYR3;TRPM7;TRPC5;WNK1;TRPM3;TRPC1;TRPC6;WNK2;ASIC4;UNC79;ANO2;BEST3;WNK3
gsea,Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,-0.5289346693678296,-1.6910190506088156,0.011834319526627219,0.021391815732400985,0.825,9/22,16.37%,GNB2;GNG2;GNG13;GNA11;GNG10;MAPK3;GNG3;GNG7;MAPK1
gsea,HIV Life Cycle R-HSA-162587,-0.36698131807830847,-1.6853230752781367,0.0018832391713747645,0.02234288826251624,0.836,53/134,26.22%,UBB;PPIA;RPS27A;RAN;ELOB;PSIP1;BANF1;UBA52;POLR2G;POLR2F;CHMP4B;VPS28;POLR2I;RANBP1;GTF2B;NUP50;TSG101;TCEA1;CHMP2A;POLR2E;POLR2C;TAF11;TAF10;SEC13;CHMP6;NUP62;NUP37;NUP205;NUP35;VPS4A;NCBP2;POLR2L;ELOC;GTF2H5;CHMP7;NUP107;CHMP4C;UBC;TAF5;SSRP1;ERCC3;POLR2J;GTF2H4;NMT1;SEH1L;UBAP1;TAF7L;HMGA1;TAF12;NUP85;TAF7;POLR2B;XRCC6
gsea,Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,-0.5544705535496554,-1.6822184891411842,0.027985074626865673,0.022842810224246102,0.841,7/19,18.35%,PRNP;VAMP2;VAPA;SEC61G;EMD;CYB5A;SEC61B
gsea,Diseases Of Carbohydrate Metabolism R-HSA-5663084,-0.5201006724691302,-1.6814931088761544,0.013059701492537313,0.02291572737949877,0.843,7/26,14.62%,UBB;RPS27A;UBA52;DCXR;LCT;GUSB;G6PC3
gsea,Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,-0.4473534394177473,-1.6795724071344222,0.0018181818181818182,0.02314040747489854,0.847,18/45,19.98%,UBB;RPS27A;JUN;H2AZ1;UBA52;IGFBP7;H2BC4;H2AJ;CDK4;UBE2S;CEBPB;MAPK3;ANAPC11;MAPK1;CDKN1B;H2AX;UBC;CDKN2D
gsea,Late Phase Of HIV Life Cycle R-HSA-162599,-0.36713025243954,-1.6775997781244538,0.003795066413662239,0.023437048192765264,0.85,44/124,22.20%,UBB;PPIA;RPS27A;RAN;ELOB;UBA52;POLR2G;POLR2F;CHMP4B;VPS28;POLR2I;RANBP1;GTF2B;NUP50;TSG101;TCEA1;CHMP2A;POLR2E;POLR2C;TAF11;TAF10;SEC13;CHMP6;NUP62;NUP37;NUP205;NUP35;VPS4A;NCBP2;POLR2L;ELOC;GTF2H5;CHMP7;NUP107;CHMP4C;UBC;TAF5;SSRP1;ERCC3;POLR2J;GTF2H4;NMT1;SEH1L;UBAP1
gsea,Metabolism Of Cofactors R-HSA-8978934,-0.5711781591698502,-1.677393770029657,0.01289134438305709,0.023399986384846166,0.851,7/17,24.73%,CALM1;HSP90AA1;DHFR;GCH1;COQ3;COQ9;COQ7
gsea,TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,-0.3964141827407492,-1.6773568302627373,0.0019230769230769232,0.02318875903791077,0.851,21/78,17.23%,UBB;HMGB1;RPS27A;JUN;UBA52;MEF2C;DUSP3;DUSP7;NDUFA2;PPP2R1A;USP14;PPP2CA;NFKB2;UBE2N;UBE2V1;MAPK3;NFKBIB;PPP2R5D;NKIRAS1;MAPK1;VRK3
gsea,Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,-0.3964141827407492,-1.6773568302627373,0.0019230769230769232,0.02318875903791077,0.851,21/78,17.23%,UBB;HMGB1;RPS27A;JUN;UBA52;MEF2C;DUSP3;DUSP7;NDUFA2;PPP2R1A;USP14;PPP2CA;NFKB2;UBE2N;UBE2V1;MAPK3;NFKBIB;PPP2R5D;NKIRAS1;MAPK1;VRK3
gsea,MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,-0.3964141827407492,-1.6773568302627373,0.0019230769230769232,0.02318875903791077,0.851,21/78,17.23%,UBB;HMGB1;RPS27A;JUN;UBA52;MEF2C;DUSP3;DUSP7;NDUFA2;PPP2R1A;USP14;PPP2CA;NFKB2;UBE2N;UBE2V1;MAPK3;NFKBIB;PPP2R5D;NKIRAS1;MAPK1;VRK3
gsea,Phase II - Conjugation Of Compounds R-HSA-156580,-0.4398503375059118,-1.6740431078866316,0.0057692307692307696,0.023803197159414497,0.857,23/49,35.50%,PRNP;GSTM5;GSTM1;TRMT112;MAT2B;GSTP1;COMT;GCLM;HPGDS;SLC35B3;AKR1A1;SULT4A1;N6AMT1;ESD;GSTO1;GCLC;PODXL2;CHAC2;ABHD10;MTRR;SULT2B1;PAPSS2;GSTO2
gsea,MAP2K And MAPK Activation R-HSA-5674135,-0.47563200076670187,-1.6737350058198606,0.007858546168958742,0.023803966570110822,0.857,11/29,19.36%,PEBP1;YWHAB;LAMTOR2;LAMTOR3;HRAS;TLN1;MAPK3;CNKSR2;MAPK1;VCL;NRAS
gsea,MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,-0.3970205064853988,-1.6732932063607955,0.003861003861003861,0.023795159415011567,0.857,23/79,18.89%,UBB;HMGB1;RPS27A;JUN;UBA52;MEF2C;DUSP3;DUSP7;NDUFA2;PPP2R1A;USP14;PPP2CA;NFKB2;UBE2N;UBE2V1;MAPK3;NFKBIB;PPP2R5D;NKIRAS1;MAPK1;VRK3;S100A1;UBC
gsea,L1CAM Interactions R-HSA-373760,0.3953531397366789,1.6725784758243516,0.001984126984126984,0.0952206774306948,0.862,22/78,10.48%,ANK3;SPTBN4;SCN1A;NRP1;SCN8A;RPS6KA2;SPTB;SHTN1;DNM3;DNM1;LAMB1;NFASC;KCNQ2;KCNQ3;CSNK2A2;LAMC1;SPTAN1;MPP3;DNM2;EPHB2;L1CAM;RPS6KA6
gsea,Formation Of Incision Complex In GG-NER R-HSA-5696395,-0.45259767468383033,-1.669892737279844,0.002012072434607646,0.024463838976858537,0.862,15/42,22.63%,UBB;RPS27A;UBA52;CETN2;SUMO2;RBX1;UBE2N;PARP1;RPA3;DDB2;GTF2H5;UBC;ERCC3;GTF2H4;SUMO1
gsea,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,-0.5051373235140831,-1.6685298093951182,0.01037344398340249,0.024666998770391923,0.866,9/26,18.89%,UBB;RPS27A;UBA52;SNW1;SKIL;PARP1;MAPK3;MAPK1;UBC
gsea,RAF/MAP Kinase Cascade R-HSA-5673001,-0.3538092653841043,-1.6672287619797954,0.0,0.024878357880175634,0.866,73/197,23.88%,CALM1;UBB;PEBP1;NEFL;RPS27A;YWHAB;PSMA7;RASAL2;RASGRP1;PSMB5;UBA52;PSMC3;LAMTOR2;DUSP7;SEM1;PSMC2;PSMA4;PPP2R1A;FGFR2;NRG3;LAMTOR3;PSMA5;NRG4;FGF13;PDGFA;RBX1;IRS2;PPP2CA;PSMD2;PSMD4;PSMC5;HRAS;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;CAMK2B;ABHD17A;FGFR1;PSMC1;PSMD7;TLN1;MAPK3;PSMC4;PSME3;PSMA2;PPP2R5D;PSMC6;TEK;CNKSR2;PPP1CC;LYPLA1;MAPK1;ABHD17C;PSMB7;VCL;UBC;PDGFB;NRAS;KBTBD7;PIK3R2;FGF5;DUSP8;JAK1;PSMB6;MRAS;NCAM1;GPRIN1;PIK3CB;PSMD10;PSMB10;MAP2K1
gsea,MAPK1/MAPK3 Signaling R-HSA-5684996,-0.35148060041093543,-1.664656934483653,0.0,0.025452261458700307,0.869,73/200,23.88%,CALM1;UBB;PEBP1;NEFL;RPS27A;YWHAB;PSMA7;RASAL2;RASGRP1;PSMB5;UBA52;PSMC3;LAMTOR2;DUSP7;SEM1;PSMC2;PSMA4;PPP2R1A;FGFR2;NRG3;LAMTOR3;PSMA5;NRG4;FGF13;PDGFA;RBX1;IRS2;PPP2CA;PSMD2;PSMD4;PSMC5;HRAS;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;CAMK2B;ABHD17A;FGFR1;PSMC1;PSMD7;TLN1;MAPK3;PSMC4;PSME3;PSMA2;PPP2R5D;PSMC6;TEK;CNKSR2;PPP1CC;LYPLA1;MAPK1;ABHD17C;PSMB7;VCL;UBC;PDGFB;NRAS;KBTBD7;PIK3R2;FGF5;DUSP8;JAK1;PSMB6;MRAS;NCAM1;GPRIN1;PIK3CB;PSMD10;PSMB10;MAP2K1
gsea,Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,-0.48863714596701824,-1.6589866278079715,0.019963702359346643,0.026592576054677644,0.882,5/29,7.96%,UBB;RPS27A;UBA52;PSENEN;APH1A
gsea,Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,-0.5265311092790773,-1.654879733003091,0.017475728155339806,0.027519135364288697,0.886,4/20,8.42%,UBB;RPS27A;UBA52;ATG12
gsea,Termination Of Translesion DNA Synthesis R-HSA-5656169,-0.5261538828802377,-1.6541125719853043,0.01054481546572935,0.02758789443428761,0.886,7/24,14.02%,UBB;RPS27A;UBA52;PCNA;RFC3;RPA3;POLD4
gsea,Glutathione Conjugation R-HSA-156590,-0.546981014895612,-1.6539227010494688,0.022727272727272728,0.027534886252611163,0.886,11/21,29.60%,PRNP;GSTM5;GSTM1;GSTP1;GCLM;HPGDS;AKR1A1;ESD;GSTO1;GCLC;CHAC2
gsea,Citric Acid Cycle (TCA Cycle) R-HSA-71403,-0.5259994215901285,-1.6537881794794844,0.011695906432748537,0.027472901332621813,0.886,11/21,17.95%,MDH2;IDH3B;SUCLG1;SDHA;SDHD;LDHD;FAHD1;IDH2;IDH3A;SDHB;IDH3G
gsea,G-protein Beta:Gamma Signaling R-HSA-397795,-0.523993816586505,-1.6524063767689177,0.012048192771084338,0.02772205318709873,0.888,12/21,29.70%,GNB2;CDC42;GNG2;GNG13;GNG10;GNG3;GNG7;GNG11;AKT3;GNB4;AKT1;PLCB1
gsea,RAB Geranylgeranylation R-HSA-8873719,-0.43833567026658304,-1.6483518940340607,0.005649717514124294,0.028464423805103483,0.895,13/45,12.61%,RAB3A;RAB2A;RAB32;RAB40B;RAB6B;RAB1B;RAB6A;RAB14;RAB24;RAB22A;RAB11A;RAB18;RAB31
gsea,Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,-0.38506746532024,-1.6444382055483118,0.0018832391713747645,0.029266775339160188,0.899,14/82,7.03%,UBB;HMGB1;RPS27A;JUN;UBA52;MEF2C;DUSP3;DUSP7;NDUFA2;PPP2R1A;USP14;PPP2CA;NFKB2;UBE2N
gsea,Downregulation Of ERBB2 Signaling R-HSA-8863795,-0.5053803288412484,-1.6416341956384946,0.011278195488721804,0.029926352421704893,0.905,9/25,13.38%,UBB;RPS27A;HSP90AA1;UBA52;NRG3;NRG4;CDC37;ERBIN;STUB1
gsea,Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,0.3859918255284659,1.6412433083552966,0.01079913606911447,0.11795315122617826,0.911,26/82,19.91%,DOCK9;PHF21A;DOCK3;DOCK11;DOCK10;KIF26B;DOCK7;DOCK4;HDAC1;VPS45;CARMIL1;JAK2;KIF1B;CABLES1;KIF3C;KIFC1;KIF1C;AKAP10;CABLES2;IRF2;KIF5A;CENPE;RBSN;ZFPM2;KIF27;SH2B3
gsea,EGFR Downregulation R-HSA-182971,-0.49147992203551144,-1.6409073762459803,0.024761904761904763,0.030013794351361898,0.906,5/27,3.61%,UBB;RPS27A;UBA52;CDC42;SPRY2
gsea,Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.40814596977410716,-1.6336890860114368,0.0035971223021582736,0.031617159038825914,0.913,17/63,20.10%,ATP1B1;PPIA;TSPAN7;BSG;ATP1B2;CD47;ANGPT2;HRAS;SELPLG;ITGAV;LYN;SLC16A1;TEK;JAM2;GPC1;NRAS;PIK3R2
gsea,MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,-0.3864911653979174,-1.6326104000943429,0.0038240917782026767,0.03181279216546419,0.915,20/76,17.23%,UBB;HMGB1;RPS27A;JUN;UBA52;MEF2C;DUSP3;DUSP7;PPP2R1A;USP14;PPP2CA;NFKB2;UBE2N;UBE2V1;MAPK3;NFKBIB;PPP2R5D;NKIRAS1;MAPK1;VRK3
gsea,Golgi Associated Vesicle Biogenesis R-HSA-432722,-0.4243617205804381,-1.6304655384249345,0.011363636363636364,0.032334125702766725,0.92,5/48,2.10%,FTH1;HSPA8;VAMP2;CLTA;NECAP1
gsea,Ephrin Signaling R-HSA-3928664,0.5523323271485993,1.6255696873931216,0.03313840155945419,0.12790348252226066,0.932,6/15,12.55%,EPHB1;NCK2;EPHB2;EFNB2;FYN;ARHGEF7
gsea,Activation Of G Protein Gated Potassium Channels R-HSA-1296041,-0.5233094981308034,-1.6220780333276867,0.025048169556840076,0.034436544570337325,0.929,9/20,15.66%,KCNJ3;GNB2;GNG2;KCNJ2;KCNJ4;GNG13;GNG10;GNG3;GNG7
gsea,TNF Signaling R-HSA-75893,-0.46291644816226635,-1.6219299426409743,0.013944223107569721,0.034373746426801466,0.929,7/37,6.62%,UBB;RACK1;RPS27A;UBA52;USP2;NSMAF;CLIP3
gsea,Cytokine Signaling In Immune System R-HSA-1280215,-0.3159418889275634,-1.6205894230233164,0.0019193857965451055,0.034608275199298384,0.932,138/383,27.04%,UBB;HMGB1;PPIA;HSPA8;RPS27A;VAMP2;HSP90AA1;EIF4A1;JUN;PSMA7;ELOB;CEBPD;PSMB5;UBA52;MEF2C;SQSTM1;NDN;CDC42;DUSP3;EIF4A2;PSMC3;AURKAIP1;DUSP7;SEM1;HNRNPA2B1;PSMC2;PSMA4;CANX;PPP2R1A;SOD1;PSMA5;IL18;TRIM35;FGF13;EGR1;CLSTN1;USP14;PML;RBX1;IRS2;PPP2CA;NFKB2;IFNGR2;PSMD2;PSMD4;PSMC5;YWHAZ;UBE2N;HRAS;UBA3;IL17RB;SNAP25;NUP50;PSMB1;PSMA3;RPLP0;PSMD6;PSMA1;PSMB3;RALA;CAMK2B;RNF7;UBE2V1;HNRNPF;PSMC1;SEC13;PSMD7;SAMHD1;MAPK3;P4HB;NUP62;NUP37;PSMC4;PSME3;LYN;PSMA2;PTPN1;NFKBIB;PPP2R5D;IL1RAPL1;PSMC6;IL1R2;EIF4G2;HCK;NUP205;NUP35;NKIRAS1;MAPK1;CDKN1B;CRLF2;VRK3;TRIM45;ELOC;PSMB7;NUP107;OPRM1;UBC;HSP90B1;NRAS;TBK1;PIK3R2;IL27;CSF1R;JAK1;HSPA9;SKP1;PSMB6;VIM;KPNA3;SEH1L;NFKBIA;TALDO1;NCAM1;SUMO1;IL10RB;PIK3CB;PSMD10;PSMB10;MTAP;SMAD7;MAP2K1;IFI27;IL13RA1;NUP85;MAP3K8;PSMD5;RNASEH2A;KPNA2;IL1RAP;CREB1;EIF4A3;PELI2;PDZD2;B2M;AKT3;GSTO1;FSCN1;TPR
gsea,Metalloprotease DUBs R-HSA-5689901,-0.5277250046447337,-1.614532240759627,0.005780346820809248,0.03610192066210307,0.937,4/19,5.54%,UBB;RPS27A;UBA52;H2AC25
gsea,Collagen Formation R-HSA-1474290,0.4512363984911098,1.613536377922987,0.017699115044247787,0.1352748854197096,0.94,12/37,12.02%,COL23A1;DST;P3H2;COL11A1;COL19A1;ADAMTS3;LAMB3;P3H1;COLGALT2;COL5A2;BMP1;COL4A1
gsea,Inwardly Rectifying K+ Channels R-HSA-1296065,-0.5052314715593156,-1.609903405713027,0.036893203883495145,0.03733174433377503,0.942,9/22,15.66%,KCNJ3;GNB2;GNG2;KCNJ2;KCNJ4;GNG13;GNG10;GNG3;GNG7
gsea,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,0.3944219135667211,1.6096012669063964,0.0020491803278688526,0.1342424898304761,0.94,18/68,6.45%,GRIA3;GRIN2A;NBEA;GRIA1;LRRC7;GRIA4;ADCY8;RPS6KA2;PRKAG2;ACTN2;NRG1;ERBB4;PPM1E;CAMK2A;MAPT;CASK;CAMK2G;RASGRF2
gsea,Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,-0.5200114777830516,-1.6089773880155291,0.021235521235521235,0.03745730540464853,0.943,10/21,17.55%,H2AZ1;DEK;H2BC4;PML;H2AJ;CEBPA;CDK4;CEBPB;H2AX;CBFB
gsea,Drug ADME R-HSA-9748784,-0.4874036360113302,-1.6082420319251376,0.013725490196078431,0.03755544744990958,0.944,7/24,14.36%,NME2;BSG;GSTM1;GSTP1;IMPDH2;SLC16A1;GMPS
gsea,MyD88-independent TLR4 Cascade R-HSA-166166,-0.3786177770366036,-1.6065316083990235,0.007782101167315175,0.03797661182411409,0.949,14/82,7.03%,UBB;HMGB1;RPS27A;JUN;UBA52;MEF2C;DUSP3;DUSP7;NDUFA2;PPP2R1A;USP14;PPP2CA;NFKB2;UBE2N
gsea,Signaling By Nuclear Receptors R-HSA-9006931,-0.33970616789518315,-1.599673675468748,0.0,0.039800813323496435,0.955,51/172,21.57%,CALM1;HSP90AB1;DDX5;APOE;HSP90AA1;JUN;H2AZ1;GNB2;GNG2;JUND;POLR2G;POLR2F;PTGES3;H2BC4;SMC1A;DLAT;GPS2;POLR2I;HRAS;GNAI1;H2AJ;KDM1B;GNG13;RAD21;TBL1XR1;POLR2E;POLR2C;GNAI2;GNG10;FKBP4;MAPK3;CXXC5;LDHD;GNG3;RDH14;GNG7;MAPK1;CDKN1B;H2AX;TBL1X;CBFB;POLR2L;ANGPTL3;NR1H2;NRAS;PLTP;YY1;PIK3R2;POLR2J;S1PR3;CXCL12
gsea,VEGFR2 Mediated Vascular Permeability R-HSA-5218920,-0.5059761588127043,-1.599248453128452,0.020202020202020204,0.03981189536992929,0.955,2/19,1.03%,CALM1;HSP90AA1
gsea,Condensation Of Prophase Chromosomes R-HSA-2299718,-0.5480738227006429,-1.5988960992135506,0.03815261044176707,0.03976579047910308,0.955,7/17,20.07%,SET;H2AZ1;H2BC4;H2AJ;NCAPH2;H2AX;KMT5A
gsea,Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,0.4830640988417174,1.5972845306539065,0.03333333333333333,0.14122037506268031,0.956,8/23,7.87%,GRIN2A;NBEA;LRRC7;ACTN2;CAMK2A;CASK;CAMK2G;MPP3
gsea,Signaling By FGFR2 IIIa TM R-HSA-8851708,-0.5260242605707778,-1.5960959022825243,0.021739130434782608,0.04056552591973238,0.959,10/18,21.26%,FGFR2;POLR2G;POLR2F;FGF13;POLR2I;POLR2E;POLR2C;NCBP2;POLR2L;POLR2J
gsea,Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,-0.5496647008932969,-1.5946424467012563,0.026168224299065422,0.04086697536834999,0.959,4/18,9.03%,ICAM5;PIANP;CD81;NPDC1
gsea,Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.4139517379061752,-1.594246884667765,0.01073345259391771,0.040922752415886395,0.959,16/49,20.78%,UBB;RPS27A;UBA52;SUMO2;H2BC4;UBE2N;PPP4C;RFC3;RNF168;RPA3;SIRT6;RAD50;H2AX;UBC;BABAM2;UIMC1
gsea,PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,-0.5388825580528404,-1.593244842249336,0.03007518796992481,0.04107810093321115,0.959,11/19,25.83%,HSP90AA1;POLR2G;POLR2F;POLR2I;POLR2E;POLR2C;MOV10L1;POLR2L;POLR2J;HENMT1;POLR2B
gsea,Regulation Of TP53 Degradation R-HSA-6804757,-0.46759105422048347,-1.5888347963319762,0.025590551181102362,0.042223860278845844,0.961,6/29,6.26%,UBB;RPS27A;UBA52;USP2;PPP2R1A;PPP2CA
gsea,Regulation Of TP53 Expression And Degradation R-HSA-6806003,-0.46759105422048347,-1.5888347963319762,0.025590551181102362,0.042223860278845844,0.961,6/29,6.26%,UBB;RPS27A;UBA52;USP2;PPP2R1A;PPP2CA
gsea,FCGR3A-mediated Phagocytosis R-HSA-9664422,-0.42650753726917845,-1.5884180713617515,0.017964071856287425,0.04224496897957677,0.961,15/44,16.37%,ACTG1;CDC42;BRK1;ARPC5;WASL;ARPC2;ARPC1A;ABI1;NCK1;ARPC3;ACTR2;MAPK3;LYN;HCK;MAPK1
gsea,ER To Golgi Anterograde Transport R-HSA-199977,-0.3509900208856538,-1.5882464569278658,0.007547169811320755,0.04217579197400805,0.961,41/116,21.84%,CNIH2;DYNLL1;DYNLL2;TMED9;TRAPPC6B;CAPZA2;CNIH1;ARF4;DCTN6;NAPG;RAB1B;BET1L;ARF3;ANK1;TRAPPC2L;TRAPPC2;TMED2;DCTN3;ACTR10;ARF5;COPG2;MCFD2;TRAPPC1;SEC13;LMAN2;ANKRD28;LMAN1;TMED7;DCTN5;NSF;COPB2;COPG1;ARFGAP2;DCTN1;MIA3;GOSR1;TRAPPC6A;COPE;TRAPPC4;TBC1D20;TRAPPC10
gsea,Extra-nuclear Estrogen Signaling R-HSA-9009391,-0.4049590945469967,-1.587313973014903,0.0076481835564053535,0.04234676435159293,0.962,24/53,29.59%,CALM1;HSP90AA1;GNB2;GNG2;HRAS;GNAI1;GNG13;GNAI2;GNG10;MAPK3;GNG3;GNG7;MAPK1;CDKN1B;NRAS;PIK3R2;S1PR3;GNG11;CREB1;PRMT1;AKT3;GNB4;AKT1;PIK3R1
gsea,RHO GTPase Effectors R-HSA-195258,-0.3366347876851469,-1.586048719159381,0.001953125,0.042721685943288394,0.962,32/181,8.88%,CALM1;DYNLL1;PFN2;DYNLL2;YWHAG;YWHAH;ACTG1;MYL6;RPS27;YWHAB;H2AZ1;YWHAE;MYL12B;CDC42;BRK1;ARPC5;WASL;PPP2R1A;ARPC2;H2BC4;PAFAH1B1;PPP2CA;ARPC1A;PFN1;ABI1;NCK1;YWHAZ;LIN7B;YWHAQ;ARPC3;H2AJ;ACTR2
gsea,Glutamate Neurotransmitter Release Cycle R-HSA-210500,-0.5063468251973271,-1.5854781297016096,0.031185031185031187,0.04280074438736657,0.962,6/22,8.52%,RAB3A;VAMP2;PPFIA2;ARL6IP5;SLC38A2;SNAP25
gsea,Neurotransmitter Release Cycle R-HSA-112310,-0.4342431939965648,-1.5845707223948766,0.023809523809523808,0.042960012323187226,0.964,9/42,8.52%,RAB3A;HSPA8;VAMP2;LIN7C;PPFIA2;ARL6IP5;SLC38A2;LIN7B;SNAP25
gsea,Telomere Maintenance R-HSA-157579,-0.39972694235297057,-1.583447986499721,0.01079136690647482,0.04323690984736351,0.965,34/62,34.71%,H2AZ1;POLR2G;POLR2F;H2BC4;POLR2I;H2AJ;NOP10;TERF1;POLR2E;POLR2C;RUVBL1;PCNA;RFC3;GAR1;ANKRD28;RPA3;POLD4;DKC1;H2AX;POLR2L;POLR2J;POLD2;POLR2B;DAXX;NHP2;TINF2;POLR2K;H2BC21;POLD3;PRIM1;POLR2D;H2AZ2;POLR2A;LRIG1
gsea,Effects Of PIP2 Hydrolysis R-HSA-114508,0.5162214393552783,1.5820800984017,0.021825396825396824,0.15272145725334085,0.968,9/19,15.53%,DGKG;PRKCE;DGKH;DGKB;DGKQ;TRPC6;DGKI;DGKA;MGLL
gsea,Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,-0.5094775322572556,-1.5805234092691756,0.0273972602739726,0.04397236385930825,0.967,3/19,2.81%,UBB;RPS27A;UBA52
gsea,MAPK Family Signaling Cascades R-HSA-5683057,-0.3266709760771039,-1.5791779652361262,0.004048582995951417,0.044341690336026175,0.968,72/227,21.35%,CALM1;UBB;PEBP1;NEFL;RPS27A;JUN;YWHAB;PSMA7;RASAL2;RASGRP1;PSMB5;UBA52;CDC42;PSMC3;LAMTOR2;DUSP7;SEM1;PSMC2;PSMA4;PPP2R1A;FGFR2;NRG3;LAMTOR3;PSMA5;NRG4;FGF13;PDGFA;RBX1;IRS2;PPP2CA;PSMD2;PSMD4;PSMC5;HRAS;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;CAMK2B;SEPTIN7;ABHD17A;FGFR1;PSMC1;PSMD7;TLN1;MAPK3;PSMC4;PSME3;PSMA2;PPP2R5D;PSMC6;TEK;CNKSR2;PPP1CC;PRKACB;LYPLA1;MAPK1;MAPKAPK5;ABHD17C;PSMB7;VCL;UBC;PDGFB;NRAS;CCND3;KBTBD7;PIK3R2;FGF5;DUSP8;JAK1;PSMB6
gsea,HDR Thru Homologous Recombination (HRR) R-HSA-5685942,-0.41672592419521626,-1.578515360755979,0.0136986301369863,0.044478083904894924,0.968,12/47,18.89%,UBB;RPS27A;UBA52;SEM1;PCNA;RFC3;RPA3;POLD4;XRCC2;RAD50;RAD51;UBC
gsea,Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,-0.30944291745947117,-1.5765528446314434,0.0,0.044965336337484924,0.969,98/340,21.35%,CALM1;UBB;PEBP1;RPS27A;FKBP1A;HSP90AA1;RPS6;YWHAB;PSMA7;EEF1G;PSMB5;UBA52;SQSTM1;SNW1;PSMC3;DUSP7;SEM1;PSMC2;PSMA4;PSENEN;PPP2R1A;FGFR2;NRG3;POLR2G;POLR2F;PSMA5;NRG4;FGF13;CLSTN1;PDGFA;RBX1;IRS2;PPP2CA;PSMD2;PSMD4;PSMC5;CDC37;POLR2I;HRAS;APH1A;NPM1;PSMB1;PSMA3;ATIC;FAM131B;PSMD6;TBL1XR1;POLR2E;POLR2C;PSMA1;PSMB3;CAMK2B;BAD;FGFR1;PSMC1;ERBIN;TRIM24;CEBPB;PSMD7;TLN1;MAPK3;AKT1S1;PSMC4;PSME3;LYN;PSMA2;PPP2R5D;BAG4;VCP;GSK3B;PSMC6;CNKSR2;PPP1CC;OS9;JAG1;NCBP2;MAPK1;CDKN1B;FOXO4;TBL1X;HEY1;POLR2L;PSMB7;DCTN1;VCL;UBC;PDGFB;MAMLD1;NRAS;PIK3R2;FBXW7;PRKAR1A;FGF5;DUSP8;NR4A1;POLR2J;SKP1;PSMB6
gsea,Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,-0.5310427738878366,-1.5746787382994079,0.024714828897338403,0.04541648733613364,0.971,3/17,2.81%,UBB;RPS27A;UBA52
gsea,Peroxisomal Protein Import R-HSA-9033241,-0.414227843993815,-1.574365679533777,0.007285974499089253,0.045386423057202065,0.971,12/48,25.18%,UBB;RPS27A;UBA52;MPV17;PEX12;PAOX;ZFAND6;NUDT19;UBC;CROT;ACOX1;PEX5
gsea,PIP3 Activates AKT Signaling R-HSA-1257604,-0.32418656439920024,-1.5738777218900513,0.0019723865877712033,0.045439549819546926,0.971,59/208,16.78%,UBB;RPS27A;JUN;PSMA7;PSMB5;UBA52;PSMC3;LAMTOR2;SEM1;RHEB;PSMC2;PSMA4;VAPA;RRAGA;PPP2R1A;FGFR2;NRG3;LAMTOR3;PSMA5;NRG4;FGF13;EGR1;CLSTN1;PDGFA;PML;IRS2;PPP2CA;PSMD2;PSMD4;PSMC5;CHD3;CSNK2B;PSMB1;PSMA3;RBBP7;PSMD6;PSMA1;PSMB3;PIP4K2A;BAD;RRAGD;FGFR1;PSMC1;PSMD7;MAPK3;MKRN1;AKT1S1;PSMC4;PSME3;STUB1;PSMA2;PPP2R5D;GSK3B;PSMC6;CBX6;RING1;MAPK1;CDKN1B;FOXO4
gsea,Adaptive Immune System R-HSA-1280218,-0.30043834402029773,-1.5718942420182975,0.0,0.04595604271254431,0.974,97/477,15.12%,CALM1;UBB;HMGB1;PPIA;DYNLL1;PPP3CA;RPS27A;DYNLL2;FKBP1A;ICAM5;CALR;CLTA;YWHAB;PSMA7;UBE3A;ELOB;RASGRP1;PIANP;PSMB5;PJA1;CAPZA2;UBA52;CDC42;CD81;AP2M1;KLHL9;ORAI2;PSMC3;RNF220;SEM1;NDUFA2;DCTN6;PSMC2;PSMA4;FBXL16;CANX;UBE2J1;PPP2R1A;PDIA3;CTSB;PSMA5;PPP3R1;CLSTN1;PPP3CB;RBX1;PPP2CA;PSMD2;PSMD4;ACTR1B;RNF6;PSMC5;NCK1;YWHAZ;UBE2N;ANAPC13;HRAS;CTSO;SEC61G;UBA3;UBA1;FBXW2;PSMB1;PSMA3;FBXO32;NPDC1;PSMD6;DCTN3;PSMA1;PSMB3;ASB13;FBXO9;ACTR10;UBE2S;RNF7;UBE2V1;PSMC1;SEC13;PSMD7;ITGAV;FBXO6;MKRN1;ASB5;PSMC4;PSME3;PJA2;STUB1;LYN;PSMA2;NFKBIB;PPP2R5D;ANAPC11;UBE2Z;PSMC6;KIF15;AP2S1;DCTN5;PRKACB
gsea,DNA Damage Bypass R-HSA-73893,-0.44320073174067653,-1.5716392823883056,0.012589928057553957,0.045912358607246684,0.974,9/39,14.15%,UBB;RPS27A;UBA52;RBX1;PCNA;RFC3;RPA3;POLD4;VCP
gsea,G2/M DNA Damage Checkpoint R-HSA-69473,-0.4100140283435101,-1.571218941437391,0.011090573012939002,0.04591420226584469,0.974,15/47,20.78%,YWHAG;YWHAH;YWHAB;YWHAE;H2BC4;YWHAZ;UBE2N;YWHAQ;RFC3;RNF168;RPA3;RAD50;H2AX;BABAM2;UIMC1
gsea,Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,-0.37745951963820046,-1.5703561848075696,0.005639097744360902,0.046150070906895685,0.975,25/78,22.63%,UBB;RPS27A;UBA52;CETN2;SUMO2;RBX1;COPS6;UBE2N;RUVBL1;PCNA;PARP1;GPS1;RFC3;COPS8;RPA3;DDB2;POLD4;ACTR8;GTF2H5;UBC;YY1;ERCC3;GTF2H4;POLD2;SUMO1
gsea,Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,-0.46469344613666286,-1.5697107101846741,0.017921146953405017,0.04626590813530579,0.975,8/31,14.15%,UBB;RPS27A;UBA52;PCNA;RFC3;RPA3;POLD4;VCP
gsea,HCMV Infection R-HSA-9609646,-0.3595695912724622,-1.5670298054999126,0.007797270955165692,0.04707532163221844,0.976,27/87,19.60%,DYNLL1;DYNLL2;CEBPD;CHMP4B;H2BC4;H2AC25;PML;VPS28;GPS2;NUP50;TSG101;RBBP7;CHMP2A;TBL1XR1;SEC13;CHMP6;NUP62;HNRNPK;NUP37;NUP205;NUP35;VPS4A;TBL1X;CHMP7;NUP107;CHMP4C;DUT
gsea,Transmission Across Chemical Synapses R-HSA-112315,0.3267853463132358,1.56459107679567,0.0,0.16658497096089003,0.977,38/188,6.45%,GRIK4;GRIA3;GRIN2A;NBEA;CACNA1E;CACNB2;GRIA1;LRRC7;CACNA2D3;GABRA2;CACNA1A;GABRG3;GABBR2;GRIA4;ADCY8;RPS6KA2;PRKAG2;CHRNA4;UNC13B;SLC6A1;KCNJ6;CACNA1B;ADCY2;ACTN2;NRG1;ERBB4;PPM1E;CAMK2A;MAPT;PRKCG;CASK;EPB41L1;CAMK2G;ADCY9;RIMS1;SYN2;GRIK5;RASGRF2
gsea,Deubiquitination R-HSA-5688426,-0.32299257275411997,-1.5637590418099054,0.003875968992248062,0.04814506037372416,0.976,58/201,19.07%,UBB;RPS27A;PSMA7;PSMB5;UBA52;VDAC1;USP2;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;H2BC4;MAT2B;NEDD8;H2AC25;USP14;PSMD2;SENP8;PSMD4;PSMC5;SNX3;OTUB1;KDM1B;USP22;PSMB1;PSMA3;PSMD6;RUVBL1;TOMM20;PSMA1;PSMB3;TAF10;VCPIP1;TADA3;UCHL1;ADRM1;PSMC1;PSMD7;VDAC2;TADA2B;PSMC4;DDB2;PSME3;PSMA2;VCP;PSMC6;USP20;ACTR8;FOXK1;FOXO4;PTRH2;UCHL3;USP30;PSMB7;UBC;STAM2;MUL1
gsea,"Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",0.5089363496674014,1.5616741016551121,0.04722792607802875,0.16453050963266638,0.978,9/20,7.87%,GRIA3;GRIN2A;GRIA1;LRRC7;GRIA4;ACTN2;CAMK2A;CAMK2G;MPP3
gsea,Homology Directed Repair R-HSA-5693538,-0.3710818683375243,-1.5558670100259981,0.0034602076124567475,0.050711768162864476,0.98,23/79,22.02%,UBB;RPS27A;UBA52;SUMO2;SEM1;H2BC4;UBE2N;PPP4C;PCNA;PARP1;RFC3;RNF168;RPA3;SIRT6;POLD4;XRCC2;RAD50;H2AX;RAD51;UBC;BABAM2;UIMC1;POLD2
gsea,ESR-mediated Signaling R-HSA-8939211,-0.3422392529070435,-1.5548338271706708,0.005825242718446602,0.05092747599388451,0.981,40/133,21.57%,CALM1;HSP90AB1;DDX5;HSP90AA1;JUN;H2AZ1;GNB2;GNG2;JUND;POLR2G;POLR2F;PTGES3;H2BC4;SMC1A;POLR2I;HRAS;GNAI1;H2AJ;GNG13;RAD21;POLR2E;POLR2C;GNAI2;GNG10;FKBP4;MAPK3;CXXC5;GNG3;GNG7;MAPK1;CDKN1B;H2AX;CBFB;POLR2L;NRAS;YY1;PIK3R2;POLR2J;S1PR3;CXCL12
gsea,RHO GTPase Cycle R-HSA-9012999,0.29803252081268605,1.5547850625206792,0.002079002079002079,0.1675819736512219,0.987,93/350,15.80%,PLEKHG5;DOCK9;KALRN;IQGAP2;TRIO;CYFIP1;DST;ARHGEF28;SHKBP1;FMNL2;DOCK3;DOCK11;DOCK10;WDR11;ARHGAP15;MYO9B;DLC1;FGD4;ABR;TJP2;MYO9A;ROCK1;SRGAP2;SH3PXD2A;DOCK7;FNBP1;DLG5;DOCK4;ITSN1;FMNL1;STK10;PKP4;RALGAPA1;CCDC88A;OCRL;PIK3R3;PREX2;ABL2;TIAM1;LCK;NCK2;RASGRF2;CDC42BPA;GMIP;SPTAN1;CPSF7;LBR;MTMR1;CPNE8;ARAP2;PRPF38B;FAM135A;ARHGAP18;SH3BP1;FGD1;SLC4A7;ARHGEF18;FAM169A;ITSN2;DHDDS;FARP2;ARHGEF17;SOS1;COPS4;FARP1;ANKRD26;PRAG1;STEAP3;DAAM1;ARHGEF7;SENP1;SPATA13;PARD6B;RNF20;VANGL1;TRA2B;PREX1;WDR81;ARHGEF2;SCFD1;WIPF2;ARHGEF4;ARHGEF3;SRGAP1;ARFGAP3;FRS2;RND1;LEMD3;ARHGAP32;OBSCN;HGS;SRRM1;GIT2
gsea,HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,-0.3735057868348531,-1.553855225132981,0.008635578583765112,0.05109758790750305,0.981,22/74,22.02%,UBB;RPS27A;UBA52;SUMO2;SEM1;H2BC4;UBE2N;PPP4C;PCNA;RFC3;RNF168;RPA3;SIRT6;POLD4;XRCC2;RAD50;H2AX;RAD51;UBC;BABAM2;UIMC1;POLD2
gsea,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,-0.3691873774303504,-1.5535997799659629,0.011695906432748537,0.05104117353880789,0.981,13/79,7.03%,UBB;HMGB1;RPS27A;JUN;UBA52;MEF2C;DUSP3;DUSP7;PPP2R1A;USP14;PPP2CA;NFKB2;UBE2N
gsea,ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,-0.5258585526012401,-1.550733622991372,0.03877551020408163,0.05190117668967781,0.983,7/16,15.66%,GNB2;GNG2;GNG13;GNA11;GNG10;GNG3;GNG7
gsea,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,-0.37815377826535646,-1.5489628038954169,0.011764705882352941,0.05248409423305961,0.984,13/66,8.88%,HSP90AB1;HSP90AA1;ACTG1;CDC42;BRK1;ARPC5;WASL;ARPC2;ARPC1A;ABI1;NCK1;ARPC3;ACTR2
gsea,Base Excision Repair R-HSA-73884,-0.414009009154762,-1.5446716396163975,0.020618556701030927,0.05389522044694402,0.986,15/45,22.02%,H2AZ1;H2BC4;H2AJ;TERF1;PCNA;PARP1;RFC3;RPA3;APEX1;MPG;POLD4;H2AX;ADPRS;TDG;POLD2
gsea,Early SARS-CoV-2 Infection Events R-HSA-9772572,-0.45134494022440996,-1.5411693428874027,0.034623217922606926,0.05517130608299687,0.986,10/28,18.89%,DDX5;CHMP4B;ZCRB1;MAP1LC3B;CHMP2A;CHMP6;VCP;CHMP7;GPC1;CHMP4C
gsea,Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,-0.4072824701962524,-1.5407357649686135,0.02240325865580448,0.05520027369242083,0.986,17/48,17.23%,CDK5R2;MEF2C;DUSP3;JUND;DUSP7;PPP2R1A;EGR1;PPP2CA;CDK5R1;MAPK3;PPP2R5D;VGF;EGR3;MAPK1;EGR4;ASCL1;VRK3
gsea,Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,0.3349409353357238,1.5399219021703483,0.002053388090349076,0.17966327389206208,0.99,29/135,6.45%,GRIK4;GRIA3;GRIN2A;NBEA;GRIA1;LRRC7;GABRA2;GABRG3;GABBR2;GRIA4;ADCY8;RPS6KA2;PRKAG2;CHRNA4;KCNJ6;ADCY2;ACTN2;NRG1;ERBB4;PPM1E;CAMK2A;MAPT;PRKCG;CASK;EPB41L1;CAMK2G;ADCY9;GRIK5;RASGRF2
gsea,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,-0.5191920207332604,-1.5385491307620305,0.04085603112840467,0.05583970511012853,0.986,5/19,9.80%,JUN;YWHAE;C1QBP;PRDX1;CDK5R1
gsea,InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,-0.5383847044958301,-1.5384757894744396,0.04518664047151277,0.055712531562723065,0.986,3/15,2.81%,UBB;RPS27A;UBA52
gsea,Asparagine N-linked Glycosylation R-HSA-446203,-0.31102030918393025,-1.5372801668450735,0.0,0.05597650430822215,0.986,76/244,22.55%,UBB;CNIH2;DYNLL1;RPS27A;DYNLL2;CALR;TMED9;TRAPPC6B;CAPZA2;UBA52;PMM1;CNIH1;ARF4;DPM3;DCTN6;CANX;NAPG;PDIA3;RAB1B;BET1L;ARF3;DAD1;ANK1;TRAPPC2L;CMAS;UBXN1;TRAPPC2;TMED2;DCTN3;FUCA1;ACTR10;ARF5;COPG2;RNF5;MCFD2;TRAPPC1;SLC35A1;DDOST;PSMC1;CHGA;SEC13;LMAN2;ANKRD28;LMAN1;TMED7;VCP;NANP;ALG13;DCTN5;DPM2;RNF185;OS9;NSF;EGFL7;COPB2;COPG1;RNF103;ALG14;STT3A;ARFGAP2;DCTN1;MIA3;UBC;GOSR1;GFPT2;TRAPPC6A;COPE;GNPNAT1;TRAPPC4;AMDHD2;MANEA;TBC1D20;TRAPPC10;RNF139;DERL1;GNE
gsea,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,-0.46869580687310214,-1.532408300985796,0.04263565891472868,0.057730044703956054,0.989,7/25,14.96%,UBB;RPS27A;UBA52;PPP1CA;BAMBI;STUB1;PPP1CC
gsea,G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,-0.5095666935592634,-1.531379690584167,0.03346456692913386,0.05796775317862411,0.989,10/17,29.06%,GNB2;GNG2;GNG13;GNG10;GNG3;GNG7;GNG11;AKT3;GNB4;AKT1
gsea,RHOC GTPase Cycle R-HSA-9013106,0.37152143567721296,1.5310259994781632,0.014112903225806451,0.18533127078200826,0.99,22/61,20.47%,ARHGEF28;FMNL2;MYO9B;DLC1;ABR;TJP2;ROCK1;STK10;LBR;ARHGAP18;DHDDS;ARHGEF17;DAAM1;VANGL1;PREX1;ARHGAP32;ARHGEF10L;ABCD3;FLOT2;IQGAP1;FMNL3;ACBD5
gsea,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,-0.46076679646717467,-1.5298305882113779,0.039525691699604744,0.05850555655519282,0.989,17/27,34.20%,ELOB;POLR2G;POLR2F;POLR2I;TCEA1;POLR2E;POLR2C;POLR2L;ELOC;SSRP1;POLR2J;POLR2B;ELOA;POLR2K;ELL;POLR2D;POLR2A
gsea,Complement Cascade R-HSA-166658,-0.5151552785711929,-1.5280089038144467,0.04554079696394687,0.0591069214054588,0.989,5/17,10.78%,PSMA7;CD81;VTN;CLU;MASP2
gsea,MTOR Signaling R-HSA-165159,-0.4272990618383997,-1.5266735579325559,0.020618556701030927,0.05944822324181695,0.989,10/39,13.22%,FKBP1A;RPS6;YWHAB;LAMTOR2;RHEB;RRAGA;LAMTOR3;RRAGD;AKT1S1;CAB39
gsea,Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,-0.4830591041207628,-1.522947238029201,0.0425531914893617,0.060851724781510796,0.99,8/22,22.02%,PCNA;PARP1;RFC3;RPA3;APEX1;POLD4;ADPRS;POLD2
gsea,Interleukin-17 Signaling R-HSA-448424,-0.3797243865832929,-1.5202396265119569,0.02095238095238095,0.06188005006371914,0.99,14/57,13.65%,UBB;RPS27A;JUN;UBA52;MEF2C;DUSP3;DUSP7;PPP2R1A;PPP2CA;UBE2N;IL17RB;UBE2V1;MAPK3;PPP2R5D
gsea,HIV Elongation Arrest And Recovery R-HSA-167287,-0.4466864295798562,-1.5197709014719702,0.03262955854126679,0.061883226180796565,0.99,17/29,34.20%,ELOB;POLR2G;POLR2F;POLR2I;TCEA1;POLR2E;POLR2C;POLR2L;ELOC;SSRP1;POLR2J;POLR2B;ELOA;POLR2K;ELL;POLR2D;POLR2A
gsea,Inhibition Of DNA Recombination At Telomere R-HSA-9670095,-0.4694544573139971,-1.5189406311440325,0.044573643410852716,0.0620944592835232,0.99,20/26,34.20%,H2AZ1;POLR2G;POLR2F;H2BC4;POLR2I;H2AJ;TERF1;POLR2E;POLR2C;H2AX;POLR2L;POLR2J;POLR2B;DAXX;TINF2;POLR2K;H2BC21;POLR2D;H2AZ2;POLR2A
gsea,Synthesis Of PC R-HSA-1483191,0.4681857374564034,1.5181872853698686,0.041237113402061855,0.1964785849973676,0.996,7/22,14.63%,SLC44A5;CSNK2A2;CHKA;CHKB;SLC44A2;STARD10;LPIN1
gsea,APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,-0.47250536182720404,-1.5180222712769984,0.05426356589147287,0.06233151538811436,0.99,10/21,28.29%,UBB;RPS27A;UBA52;UBE2S;ANAPC11;UBC;BUB3;CDC26;ANAPC16;CDC16
gsea,RAF Activation R-HSA-5673000,-0.445343540511714,-1.516033467579121,0.04296875,0.06292771567943148,0.991,8/30,14.96%,CALM1;YWHAB;PPP2R1A;PPP2CA;HRAS;CAMK2B;PPP2R5D;PPP1CC
gsea,COPI-mediated Anterograde Transport R-HSA-6807878,-0.3678896954663873,-1.5159821610187656,0.02390438247011952,0.06280583221508713,0.991,24/70,18.92%,DYNLL1;DYNLL2;TMED9;CAPZA2;ARF4;DCTN6;NAPG;RAB1B;BET1L;ARF3;ANK1;TMED2;DCTN3;ACTR10;ARF5;COPG2;TMED7;DCTN5;NSF;COPB2;COPG1;ARFGAP2;DCTN1;GOSR1
gsea,Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,-0.4589279856762849,-1.5137754795974168,0.05152671755725191,0.06355417994492715,0.993,9/26,16.48%,TUBA1A;TUBB2A;TUBB4A;TUBB4B;TUBB2B;TPGS1;AGBL2;TUBA1B;NICN1
gsea,GPCR Ligand Binding R-HSA-500792,-0.33643834609766693,-1.513067988205687,0.005008347245409015,0.06365959366492663,0.993,57/129,33.76%,PLPPR4;GNAS;GLP2R;GNB2;NPY1R;GRM3;GNG2;P2RY14;P2RY12;PROKR2;RAMP2;GNG13;NPY5R;CX3CL1;CXCR6;CHGA;GNG10;ADRA2C;SSTR2;ADRB1;GNG3;PLPPR5;HEBP1;GNG7;PTRH2;GRM2;NPY;RAMP1;GPR37;MC4R;OPRM1;WNT16;SSTR1;GRM1;S1PR3;CXCL12;GPNMB;PDYN;GNG11;TAC1;OPRL1;PLPPR3;GNB4;HTR1F;S1PR1;ACKR4;GPR37L1;OPRD1;FZD8;ADORA1;PTGER4;DHX34;PENK;NPFF;GNB1;GPR39;DRD5
gsea,Glucose Metabolism R-HSA-70326,-0.36746627283745165,-1.5107729115359623,0.010040160642570281,0.06447790243384414,0.994,25/72,18.71%,MDH2;PKM;MDH1;ALDOC;PPP2R1A;TPI1;ENO2;PPP2CA;NUP50;PGK1;GOT2;PGAM2;SEC13;NUP62;NUP37;PPP2R5D;G6PC3;PGP;PRKACB;PFKFB3;NUP205;PFKL;NUP35;ENO1;NUP107
gsea,Diseases Of Programmed Cell Death R-HSA-9645723,-0.4122798218534964,-1.5078392928366264,0.0375234521575985,0.06558355438095147,0.994,10/42,13.23%,JUN;H2AZ1;YWHAE;H2BC4;C1QBP;H2AJ;PRDX1;RBBP7;CDK5R1;GSDME
gsea,Mitotic Prophase R-HSA-68875,-0.3536966813941807,-1.507046385858256,0.011494252873563218,0.06577746852779576,0.994,23/81,17.09%,SET;RAB2A;H2AZ1;BANF1;PPP2R1A;RAB1B;H2BC4;PPP2CA;ENSA;H2AJ;EMD;NUP50;NCAPH2;SEC13;MAPK3;NUP62;NUP37;NUP205;NUP35;MAPK1;CTDNEP1;NEK6;H2AX
gsea,GPER1 Signaling R-HSA-9634597,-0.42689256567120193,-1.506789673061471,0.027237354085603113,0.06574066672259612,0.994,11/32,15.66%,GNAS;GNB2;GNG2;GNAI1;GNG13;GNAI2;GNG10;PRKAR1B;GNG3;PRKACB;GNG7
gsea,NCAM Signaling For Neurite Out-Growth R-HSA-375165,0.4128635023376657,1.5029625794463068,0.02834008097165992,0.2114288880030157,0.998,14/38,17.92%,CACNA1C;SPTBN4;CACNB2;SPTB;PTK2;SPTAN1;SOS1;COL4A1;FYN;CACNA1H;PTPRA;NCAN;SPTBN1;GFRA2
gsea,ER Quality Control Compartment (ERQC) R-HSA-901032,-0.4863705711296511,-1.5027719054451458,0.05156537753222836,0.06741718554432227,0.994,9/21,22.24%,UBB;RPS27A;UBA52;RNF5;RNF185;OS9;RNF103;UBC;RNF139
gsea,Transport Of Small Molecules R-HSA-382551,-0.2858963116279204,-1.5012280509069382,0.0,0.06787864452906793,0.994,95/444,16.03%,FTH1;CALM1;ATP1B1;UBB;ATP6V0C;SLC25A4;GNAS;APOE;ATP6V1D;RPS27A;ATP6V1A;CLTA;PSMA7;ATP6V1G2;NCEH1;GNB2;SLC22A17;ATP6V0E2;PSMB5;SLC25A5;BSG;UBA52;VDAC1;SLC15A2;AP2M1;SMDT1;GNG2;ATP1A3;PSMC3;SEM1;ATP6V0B;PSMC2;PSMA4;ATP6V1F;PSMA5;NEDD8;ATP1B2;PSMD2;PSMD4;PSMC5;SLC39A3;SLC38A2;CUTC;ADD2;EIF2S2;GNG13;PSMB1;PSMA3;ATP2B1;PSMD6;PSMA1;PSMB3;SLC3A1;CAMK2B;RAB11A;HMOX2;RNF5;ALAD;CLCN4;SLC35A1;PSMC1;ATP6V1C1;GNG10;PSMD7;FXYD1;SLC18A2;VDAC2;PRKAR1B;P4HB;SRI;ATP6V1E1;ATP6V1B2;PSMC4;PSME3;PSMA2;SLC24A5;ARL2BP;SLC41A1;SLC16A1;VCP;PSMC6;PHB2;SLC38A5;ATP1A2;AP2S1;GNG3;ABCB10;PRKACB;SLC8A2;RNF185;SLC30A6;OS9;GNG7;PEX19;ATP6V1G1
gsea,Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,-0.424303916130601,-1.4994610021448926,0.03766478342749529,0.06867798277047689,0.995,11/32,19.36%,CALM1;PEBP1;YWHAB;HRAS;CAMK2B;TLN1;MAPK3;CNKSR2;MAPK1;VCL;NRAS
gsea,"Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",0.44558561723526074,1.498561617690996,0.04722792607802875,0.21163292125862984,0.998,8/28,8.57%,GRIA3;GRIA1;GRIA4;CAMK2A;PRKCG;EPB41L1;CAMK2G;CACNG3
gsea,APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,-0.4766803797044423,-1.4984813639118377,0.05048543689320388,0.06894011969816402,0.995,3/20,2.81%,UBB;RPS27A;UBA52
gsea,TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,-0.39995116006511466,-1.4980430980464277,0.0260707635009311,0.06899637642309883,0.995,10/39,14.96%,UBB;RPS27A;FKBP1A;UBA52;NEDD8;PPP1CA;ITGAV;BAMBI;STUB1;PPP1CC
gsea,EPH-Ephrin Signaling R-HSA-2682334,-0.3550026403932964,-1.49469344463271,0.017786561264822136,0.07044379183631512,0.996,17/77,8.88%,EPHA5;EPHA7;ACTG1;MYL6;CLTA;MYL12B;CDC42;AP2M1;ARPC5;WASL;PSENEN;ARPC2;ARPC1A;HRAS;APH1A;ARPC3;ACTR2
gsea,Transcriptional Regulation By VENTX R-HSA-8853884,0.4236962182901567,1.494572133953967,0.04474708171206226,0.21167300236860417,0.999,9/32,14.51%,TNRC6C;CDC27;EHMT1;MOV10;TNRC6B;AGO1;ANAPC5;EHMT2;AGO4
gsea,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,-0.3174000955947346,-1.494188593020605,0.015533980582524271,0.07052567867397323,0.996,43/150,20.90%,DYNLL1;DYNLL2;TMED9;CAPZA2;ARF4;DCTN6;RAB6B;NAPG;STX16;RAB1B;BET1L;PAFAH1B1;RAB6A;ARF3;CYTH2;TMED2;DCTN3;ACTR10;RAB18;ARF5;COPG2;SNAP29;TMED7;NAA38;UBE2Z;SCOC;PAFAH1B2;KIF15;CYTH4;DCTN5;NSF;ARFRP1;COPB2;COPG1;ARFGAP2;VAMP3;DCTN1;GOSR1;BICD2;SURF4;COPE;TMF1;VPS52
gsea,"GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",-0.5189895559605786,-1.4912329243712628,0.058704453441295545,0.07176653399309749,0.996,3/17,1.00%,RAB3A;HSPA8;VAMP2
gsea,Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,-0.49141934539103005,-1.489743256984888,0.05847953216374269,0.07228307990686818,0.996,4/18,6.93%,CALM1;ORAI2;CLSTN1;NCK1
gsea,Cardiac Conduction R-HSA-5576891,0.3367491712014424,1.4880678004310093,0.0196078431372549,0.2150379513687744,0.999,15/84,5.15%,RYR2;CACNA1C;SCN1A;CACNB2;SLC8A1;ATP2B4;SCN8A;KCNK9;KCNK13;ATP2B3;KCND3;RYR3;FGF14;CAMK2A;CAMK2G
gsea,Dopamine Neurotransmitter Release Cycle R-HSA-212676,-0.4631345029550185,-1.484833601699519,0.044715447154471545,0.07444681969691733,0.996,7/23,11.97%,RAB3A;VAMP2;LIN7C;PPFIA2;LIN7B;SNAP25;SLC18A2
gsea,Phase 0 - Rapid Depolarisation R-HSA-5576892,0.4510030672634119,1.4842881578319513,0.05165289256198347,0.21508287494977799,0.999,7/25,5.15%,CACNA1C;SCN1A;CACNB2;SCN8A;FGF14;CAMK2A;CAMK2G
gsea,Degradation Of Extracellular Matrix R-HSA-1474228,0.3756826480165716,1.4825945878513433,0.032397408207343416,0.21223129716512365,0.999,19/50,19.03%,COL23A1;ERC2;LAMB1;COL19A1;ADAMTS18;LAMB3;LAMC1;BMP1;CAPN15;ADAM17;PSEN1;MMP24;COL25A1;SPOCK3;DCN;CTSK;ADAMTS1;TIMP2;MMP16
gsea,Formation Of RNA Pol II Elongation Complex R-HSA-112382,-0.37872372818667266,-1.480170737241782,0.03495145631067961,0.0765450259482634,0.996,19/53,21.65%,ELOB;POLR2G;POLR2F;POLR2I;TCEA1;POLR2E;POLR2C;NCBP2;RTF1;CDC73;POLR2L;ELOC;GTF2H5;DMAP1;SKIC8;SSRP1;ERCC3;POLR2J;GTF2H4
gsea,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,-0.39439303186874025,-1.478646153418906,0.03838383838383838,0.07711198888356526,0.996,8/43,12.46%,UBB;RPS27A;UBA52;SNW1;SKIL;YBX1;PARP1;MAPK3
gsea,COPII-mediated Vesicle Transport R-HSA-204005,-0.36906085169885045,-1.4782059334877191,0.02131782945736434,0.07715461352076593,0.996,14/56,12.67%,CNIH2;TRAPPC6B;CNIH1;NAPG;RAB1B;TRAPPC2L;TRAPPC2;TMED2;MCFD2;TRAPPC1;SEC13;LMAN2;ANKRD28;LMAN1
gsea,CRMPs In Sema3A Signaling R-HSA-399956,0.5227247193504898,1.4780448270682418,0.07809523809523809,0.2135708830286757,0.999,6/15,12.43%,PLXNA4;NRP1;PLXNA2;PLXNA3;FYN;DPYSL3
gsea,Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,-0.35349761109857225,-1.4771582067056612,0.022684310018903593,0.07744445812705113,0.997,22/77,18.28%,CALM1;GNAS;GLP2R;GNB2;GNG2;PLK2;RAMP2;GNAI1;GNG13;GNAI2;CHGA;GNG10;PRKAR1B;LYN;ADRB1;GNG3;PRKACB;HCK;GNG7;PTRH2;RAMP1;MC4R
gsea,MAP Kinase Activation R-HSA-450294,-0.37112042076049095,-1.4759833260412987,0.029411764705882353,0.07782727821084089,0.997,10/55,7.03%,UBB;RPS27A;JUN;UBA52;MEF2C;DUSP3;DUSP7;PPP2R1A;PPP2CA;UBE2N
gsea,Meiotic Recombination R-HSA-912446,-0.460518875588606,-1.4731440891443486,0.04251386321626617,0.0789795450708336,0.997,13/25,33.87%,H2AZ1;H2BC4;H2AJ;CDK4;RPA3;RAD50;H2AX;RAD51;MLH1;PSMC3IP;MLH3;H2BC21;H2AZ2
gsea,Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,0.48736232727001205,1.4705967714638133,0.06451612903225806,0.2184495910488513,0.999,7/18,14.88%,DST;COL11A1;LAMB3;COL5A2;BMP1;COL4A1;COL5A1
gsea,Apoptotic Execution Phase R-HSA-75153,0.40003086469367993,1.4685041506099656,0.04483430799220273,0.21619423442871596,0.999,7/35,6.76%,TJP2;ROCK1;SATB1;TJP1;MAPT;PTK2;SPTAN1
gsea,MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,-0.504790031564678,-1.468207483667752,0.04259259259259259,0.08143034252845835,0.998,3/16,2.81%,UBB;RPS27A;UBA52
gsea,Signaling By ERBB2 R-HSA-1227986,-0.39240614449294803,-1.465317094178168,0.04431599229287091,0.08275223222860004,0.998,8/42,7.58%,UBB;RPS27A;HSP90AA1;UBA52;NRG3;NRG4;CDC37;HRAS
gsea,Vesicle-mediated Transport R-HSA-5653656,-0.27740196623562885,-1.4648584415616166,0.0018552875695732839,0.08278434672286046,0.998,132/496,22.35%,FTH1;CALM1;UBB;CNIH2;RAB3A;DYNLL1;HSPA8;APOE;RPS27A;DYNLL2;YWHAG;YWHAH;VAMP2;HSP90AA1;CALR;CLTA;YWHAB;TMED9;TRAPPC6B;NECAP1;CAPZA2;UBA52;YWHAE;AP2M1;GABARAPL2;CNIH1;RAB32;ARF4;ARPC5;DCTN6;RAB6B;WASL;NAPG;ARPC2;STX16;CHMP4B;RAB1B;NEDD8;BET1L;PAFAH1B1;C1D;VPS28;RAB6A;MAP1LC3B;ARF3;ARPC1A;CYTH2;COPS6;YWHAZ;ANK1;YWHAQ;RAB14;ARPC3;GABARAP;TRAPPC2L;TSG101;ACTR2;TRAPPC2;UBQLN2;TMED2;CHMP2A;DCTN3;PACSIN2;RALA;RAB11A;GPS1;HIP1R;ACTR10;RAB18;ARF5;COPG2;MCFD2;TRAPPC1;SEC13;LMAN2;ANKRD28;SNAP29;CHMP6;BLOC1S4;RAB31;LMAN1;COPS8;EPN1;TMED7;SBF1;NAA38;UBE2Z;SCOC;PAFAH1B2;KIF15;AP2S1;CYTH4;DCTN5;TBC1D10B;NSF;ARFRP1;HSPH1;VPS4A;COPB2;COPG1;SSC5D;TBC1D7;ARFGAP2;AP2B1;VAMP3;CHMP7;DCTN1;ACBD3;MIA3;CHMP4C;UBC;GOSR1;STAM2;BICD2;HSP90B1;SURF4;TRAPPC6A;COPE;RAB5A;TMF1;VPS52;TRAPPC4;SNX5;DENND5B;PUM1;SH3GL2;TBC1D20;TRAPPC10;RAB39B;UBAP1;STX6;M6PR
gsea,Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,-0.49787458258442446,-1.4641008773199045,0.08519269776876268,0.08298487431429122,0.998,5/16,11.97%,RAB3A;VAMP2;PPFIA2;SNAP25;SLC18A2
gsea,G Alpha (I) Signaling Events R-HSA-418594,-0.32595815047758,-1.4629630149076673,0.012750455373406194,0.08340628174574141,0.998,37/132,17.94%,CALM1;GNAS;PPP3CA;GNB2;NPY1R;GRM3;GNG2;P2RY14;RGS4;PPP2R1A;P2RY12;PPP3R1;PPP3CB;PPP2CA;PPP1CA;GNAI1;GNG13;GNA11;NPY5R;CAMK2B;CX3CL1;CXCR6;GNAI2;GNG10;ADRA2C;PRKAR1B;SSTR2;PPP2R5D;GNG3;PRKACB;HEBP1;GNG7;MAPK1;GRM2;NPY;GPR37;PPP1R1B
gsea,RHOF GTPase Cycle R-HSA-9035034,0.4134524703428536,1.4589981102560294,0.056,0.2240370724133945,0.999,10/32,15.33%,MYO9B;SRGAP2;MTMR1;SLC4A7;FAM169A;FARP1;STEAP3;SENP1;VANGL1;ARHGAP32
gsea,Other Semaphorin Interactions R-HSA-416700,0.5111915369231262,1.4583033469822788,0.07392197125256673,0.2202990284057707,0.999,4/15,4.78%,PLXNA4;PLXNC1;PLXNA2;SEMA4D
gsea,RHOQ GTPase Cycle R-HSA-9013406,0.37997238185279214,1.4562727052023896,0.059322033898305086,0.21836674192574107,0.999,16/48,19.26%,DLC1;SRGAP2;FNBP1;ITSN1;CDC42BPA;CPNE8;SLC4A7;STEAP3;ARHGEF7;VANGL1;PREX1;ARHGAP32;OBSCN;GIT2;IQGAP1;SCRIB
gsea,Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,0.477669800389964,1.4560128029018644,0.06483300589390963,0.214201593475499,0.999,5/18,4.45%,PTPRS;IL1RAPL2;PTPRD;NTRK3;PTPRF
gsea,DAG And IP3 Signaling R-HSA-1489509,0.4115290264535965,1.4530982173866773,0.054,0.2134263179002718,0.999,9/34,5.22%,NBEA;PDE1A;ADCY8;PRKCE;ADCY2;CAMK2A;PRKCG;CAMK2G;ADCY9
gsea,Muscle Contraction R-HSA-397014,0.31277874063230543,1.4525260300647413,0.02575107296137339,0.21006310519989527,0.999,18/117,3.92%,RYR2;CACNA1C;SORBS1;SCN1A;CACNB2;SLC8A1;GUCY1A2;ATP2B4;SCN8A;KCNK9;KCNK13;ATP2B3;DMD;KCND3;ACTN2;RYR3;FGF14;CAMK2A
gsea,Transcriptional Regulation By Small RNAs R-HSA-5578749,-0.3713869993272318,-1.4521271389212311,0.04263565891472868,0.08930484027843848,0.999,19/50,18.71%,RAN;H2AZ1;POLR2G;POLR2F;H2BC4;POLR2I;H2AJ;NUP50;POLR2E;POLR2C;SEC13;NUP62;NUP37;NUP205;NUP35;H2AX;POLR2L;IPO8;NUP107
gsea,VEGFR2 Mediated Cell Proliferation R-HSA-5218921,-0.5016197115956225,-1.4518324539880036,0.07142857142857142,0.08924990241627453,0.999,2/15,7.58%,CALM1;HRAS
gsea,Estrogen-dependent Gene Expression R-HSA-9018519,-0.345543402512926,-1.450828929026768,0.029585798816568046,0.08956114250187179,0.999,16/82,9.79%,HSP90AB1;DDX5;HSP90AA1;JUN;H2AZ1;JUND;POLR2G;POLR2F;PTGES3;H2BC4;SMC1A;POLR2I;H2AJ;RAD21;POLR2E;POLR2C
gsea,Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,-0.4002097244881092,-1.4488448218972296,0.03346456692913386,0.09048760963174123,0.999,14/39,22.63%,UBB;RPS27A;UBA52;H2BC4;EYA1;UBE2N;UBXN1;RNF168;RAD50;H2AX;UBC;BABAM2;UIMC1;SUMO1
gsea,Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,-0.3306878735013364,-1.4430801800941557,0.023622047244094488,0.09346760238918866,0.999,14/93,7.03%,UBB;HMGB1;RPS27A;JUN;UBA52;MEF2C;DUSP3;DUSP7;NDUFA2;PPP2R1A;USP14;PPP2CA;NFKB2;UBE2N
gsea,Translation Of Structural Proteins R-HSA-9683701,-0.4480632108925496,-1.4406614160784688,0.07017543859649122,0.09470508767966909,0.999,4/23,4.39%,UBB;RPS27A;UBA52;CANX
gsea,Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,-0.4261935094328715,-1.4390523067384404,0.05019305019305019,0.09546518734777215,0.999,9/25,19.36%,PEBP1;YWHAB;HRAS;TLN1;MAPK3;CNKSR2;MAPK1;VCL;NRAS
gsea,TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,-0.40699245775308857,-1.4367437627286381,0.058823529411764705,0.09676595587251398,0.999,11/35,27.09%,PLK2;BTG2;BAX;NPM1;PCNA;CNOT8;CDKN1B;E2F4;CNOT11;PRMT1;CNOT6L
gsea,SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,-0.4216491162862652,-1.4351613251874427,0.06818181818181818,0.0975457314003481,0.999,12/29,29.76%,UBB;RPS27A;UBA52;YBX1;MAPK3;MAPK1;UBC;E2F4;SMAD7;RNASEH2A;SMAD4;SMAD2
gsea,Triglyceride Metabolism R-HSA-8979227,-0.4838177789389997,-1.4348414906396523,0.07011070110701106,0.0975250723360064,0.999,8/17,20.82%,GPD2;DGAT2;PPP1CA;FABP3;PPP1CC;PRKACB;FABP7;GK
gsea,Signaling By NTRK1 (TRKA) R-HSA-187037,-0.33444757794126734,-1.433739879673012,0.0471311475409836,0.09794382857781125,0.999,29/94,20.10%,CLTA;YWHAB;CDK5R2;MEF2C;AP2M1;DUSP3;JUND;DUSP7;PPP2R1A;EGR1;IRS2;PPP2CA;HRAS;DNAL4;CDK5R1;RALA;MAPK3;PPP2R5D;VGF;AP2S1;EGR3;MAPK1;EGR4;ASCL1;VRK3;AP2B1;NRAS;ID4;PIK3R2
gsea,Fanconi Anemia Pathway R-HSA-6783310,-0.4143459171662148,-1.4331616983061963,0.06,0.09808931601595407,0.999,4/32,6.68%,UBB;RPS27A;UBA52;CENPX
gsea,Extracellular Matrix Organization R-HSA-1474244,0.30365621956001226,1.4316335949072738,0.018223234624145785,0.23397021705920598,0.999,44/139,19.03%,PTPRS;COL23A1;DST;ERC2;P3H2;COL11A1;DMD;SH3PXD2A;FBN2;LAMB1;COL19A1;LTBP4;ADAMTS18;ADAMTS3;CASK;LAMB3;TNR;LAMC1;P3H1;COLGALT2;COL5A2;BMP1;DMTF1;COL4A1;ITGA8;ADAM12;CAPN15;ADAM19;ADAM17;COL5A1;ITGA3;PSEN1;MMP24;ITGB8;COL25A1;HAPLN1;NCAN;SPOCK3;DCN;ITGA4;CTSK;ADAMTS1;TIMP2;MMP16
gsea,RAF-independent MAPK1/3 Activation R-HSA-112409,-0.5009287020663474,-1.4314564474536693,0.09037328094302555,0.09888659627611823,0.999,10/15,31.53%,DUSP7;MAPK3;MAPK1;DUSP8;JAK1;MAP2K1;DUSP6;PTPN11;DUSP16;DUSP4
gsea,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,-0.33127182980031367,-1.4305281120631834,0.0311284046692607,0.09923353208098643,0.999,12/90,5.88%,TUBA4A;DYNLL1;TUBA1A;YWHAG;HSP90AA1;YWHAE;CETN2;PPP2R1A;CSNK1E;TUBB4A;TUBB4B;PAFAH1B1
gsea,Diseases Of Glycosylation R-HSA-3781865,0.31989153296513534,1.4303934322889134,0.017897091722595078,0.23147574394239656,0.999,20/96,13.15%,ADAMTS17;SEMA5B;NOTCH2;ADAMTS20;SPON1;ADAMTS18;GPC5;ADAMTS3;LARGE1;ST3GAL3;HEXA;HEXB;ALG8;CFP;DHDDS;ALG12;GPC3;EXT1;GALE;THSD1
gsea,FGFR2 Mutant Receptor Activation R-HSA-1839126,-0.4516171223046476,-1.4299683495950064,0.06324110671936758,0.09936123291799258,0.999,11/21,21.26%,FGFR2;POLR2G;POLR2F;FGF13;POLR2I;POLR2E;POLR2C;NCBP2;POLR2L;FGF5;POLR2J
gsea,RNA Polymerase II Pre-transcription Events R-HSA-674695,-0.33823752768957277,-1.4290722996114509,0.02448210922787194,0.09963310842915657,0.999,34/73,32.74%,ELOB;POLR2G;POLR2F;POLR2I;GTF2B;TCEA1;POLR2E;POLR2C;TAF11;TAF10;NCBP2;RTF1;CDC73;POLR2L;ELOC;GTF2H5;TAF5;DMAP1;SKIC8;SSRP1;ERCC3;POLR2J;GTF2H4;TAF7L;TAF12;TAF7;POLR2B;EAF1;GTF2H3;ELOA;POLR2K;ELL;GTF2A1;POLR2D
gsea,Signaling By NOTCH2 R-HSA-1980145,-0.4223153999242825,-1.4262504792036645,0.07238095238095238,0.10121391881376861,0.999,5/27,7.96%,UBB;RPS27A;UBA52;PSENEN;APH1A
gsea,Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,-0.48714376362666273,-1.4247787286189868,0.0789980732177264,0.1018062622425282,0.999,8/17,25.36%,RPS6;RBX1;NPM1;CEBPB;MAPK3;MAPK1;SKP1;RNASEH2A
gsea,Transcriptional Regulation By RUNX1 R-HSA-8878171,-0.30928800215671215,-1.4245032475304986,0.01782178217821782,0.10173524414334907,0.999,44/145,21.68%,UBB;RPS27A;PSMA7;H2AZ1;LMO1;PSMB5;UBA52;PSMC3;SEM1;PSMC2;PSMA4;PSMA5;H2BC4;PML;PSMD2;PSMD4;PSMC5;SIN3B;H2AJ;CSNK2B;PSMB1;PSMA3;PSMD6;PSMA1;PSMB3;PSMC1;PSMD7;PSMC4;PSME3;PSMA2;PSMC6;CBX6;RING1;MYL9;H2AX;SMARCE1;CBFB;PSMB7;UBC;CCND3;SMARCB1;CBX4;PSMB6;ACTL6B
gsea,Intracellular Signaling By Second Messengers R-HSA-9006925,-0.2897560008160149,-1.4233937556603407,0.005859375,0.10229980286274146,0.999,63/241,16.78%,CALM1;UBB;RPS27A;JUN;PSMA7;PSMB5;UBA52;PSMC3;LAMTOR2;SEM1;RHEB;PSMC2;PSMA4;VAPA;RRAGA;PPP2R1A;FGFR2;NRG3;LAMTOR3;PSMA5;NRG4;FGF13;EGR1;CLSTN1;PDGFA;PML;IRS2;PPP2CA;PSMD2;PSMD4;PSMC5;CHD3;CSNK2B;PSMB1;PSMA3;RBBP7;PSMD6;PSMA1;PSMB3;PIP4K2A;CAMK2B;BAD;RRAGD;FGFR1;PSMC1;PSMD7;PRKAR1B;MAPK3;MKRN1;AKT1S1;PSMC4;PSME3;STUB1;PSMA2;PPP2R5D;GSK3B;PSMC6;PRKACB;CBX6;RING1;MAPK1;CDKN1B;FOXO4
gsea,Platelet Homeostasis R-HSA-418346,0.34988540790784517,1.4222705217688771,0.02636916835699797,0.23802717798826112,0.999,14/58,7.15%,PRKG1;PDE2A;SLC8A1;GUCY1A2;PDE1A;PDE9A;ATP2B4;MAPK14;ATP2B3;PDE10A;KCNMA1;LRP8;KCNMB4;TRPC6
gsea,PKMTs Methylate Histone Lysines R-HSA-3214841,0.3712266242515413,1.4195914004234995,0.05384615384615385,0.2376343084154679,0.999,18/43,23.79%,EHMT1;KMT2A;KMT2B;KMT2C;NSD1;SETDB1;NSD3;DPY30;EHMT2;KMT2E;EZH2;SETD2;KMT5B;SUZ12;NFKB1;AEBP2;PRDM9;SUV39H2
gsea,Cell-Cell Communication R-HSA-1500931,0.3323321720866333,1.4191859236765856,0.038696537678207736,0.23398286724341713,0.999,26/80,18.92%,DST;SDK2;ACTN2;CDH12;NECTIN1;CASK;ACTN4;SKAP2;LAMB3;NCK2;PTK2;SPTAN1;PARVB;FLNA;CDH11;FYN;PATJ;CADM1;PARD6B;CDH10;PARVA;RSU1;PIK3CA;SPTBN1;CDH13;IQGAP1
gsea,trans-Golgi Network Vesicle Budding R-HSA-199992,-0.3496525009547806,-1.4186090147595558,0.051233396584440226,0.10479731779227595,0.999,5/62,2.10%,FTH1;HSPA8;VAMP2;CLTA;NECAP1
gsea,Acetylcholine Neurotransmitter Release Cycle R-HSA-264642,-0.4955334455125834,-1.4168267649870396,0.10183299389002037,0.10562438538598759,1.0,4/15,8.52%,RAB3A;VAMP2;PPFIA2;SNAP25
gsea,DNA Double Strand Break Response R-HSA-5693606,-0.3887480424082961,-1.4160091575520515,0.048828125,0.10593549451584332,1.0,14/40,22.63%,UBB;RPS27A;UBA52;H2BC4;EYA1;UBE2N;UBXN1;RNF168;RAD50;H2AX;UBC;BABAM2;UIMC1;SUMO1
gsea,Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.37385616619973827,-1.4145320069088532,0.04570383912248629,0.10667842788758912,1.0,17/49,22.50%,UBB;RPS27A;UBA52;POLR2F;NFKB2;POLR2E;POLR3D;NFKBIB;POLR3H;NKIRAS1;POLR2L;UBC;NLRC3;TBK1;TRIM32;POLR3A;NFKBIA
gsea,Opioid Signaling R-HSA-111885,-0.35109042731693263,-1.4137847781355062,0.03488372093023256,0.10687433014644429,1.0,23/71,18.87%,CALM1;PPP3CA;GNB2;GNG2;PPP2R1A;PPP3R1;PPP3CB;PPP2CA;PPP1CA;GNAI1;GNG13;GNA11;CAMK2B;GNAI2;GNG10;PRKAR1B;PPP2R5D;GNG3;PRKACB;GNG7;MAPK1;PPP1R1B;OPRM1
gsea,Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,-0.44612330120172344,-1.413559015730206,0.07072691552062868,0.10674589173094538,1.0,9/22,22.63%,APOE;DEK;CITED2;NPM1;KCTD1;CHGA;YY1;HSPD1;SUMO1
gsea,Toll-like Receptor Cascades R-HSA-168898,-0.31855689424728284,-1.4099050730834353,0.027131782945736434,0.1090452909026967,1.0,27/105,19.71%,UBB;HMGB1;RPS27A;JUN;UBA52;MEF2C;DUSP3;DUSP7;NDUFA2;PPP2R1A;CTSB;USP14;PPP2CA;NFKB2;UBE2N;UBE2V1;MAPK3;GSDME;NFKBIB;PPP2R5D;NKIRAS1;MAPK1;VRK3;S100A1;UBC;HSP90B1;TBK1
gsea,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,-0.3885597095466315,-1.4089504841276703,0.05019305019305019,0.10941237899955737,1.0,11/38,19.36%,UBB;RPS27A;UBA52;NRG3;NRG4;HRAS;CDK4;PTPN1;CDKN1B;UBC;NRAS
gsea,Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,-0.47733381693248905,-1.4069557363599536,0.0842911877394636,0.11044051521403478,1.0,4/18,9.80%,JUN;YWHAE;PRDX1;CDK5R1
gsea,Transport To Golgi And Subsequent Modification R-HSA-948021,-0.3033690327275048,-1.4062424210593734,0.026694045174537988,0.110706027329424,1.0,44/139,21.84%,CNIH2;DYNLL1;DYNLL2;TMED9;TRAPPC6B;CAPZA2;CNIH1;ARF4;DCTN6;NAPG;RAB1B;BET1L;ARF3;ANK1;TRAPPC2L;TRAPPC2;TMED2;DCTN3;FUCA1;ACTR10;ARF5;COPG2;MCFD2;TRAPPC1;CHGA;SEC13;LMAN2;ANKRD28;LMAN1;TMED7;DCTN5;NSF;COPB2;COPG1;ARFGAP2;DCTN1;MIA3;GOSR1;TRAPPC6A;COPE;TRAPPC4;MANEA;TBC1D20;TRAPPC10
gsea,MHC Class II Antigen Presentation R-HSA-2132295,-0.34231100410167803,-1.4043931321910694,0.06237816764132553,0.11158012588712961,1.0,16/73,15.04%,DYNLL1;DYNLL2;CLTA;CAPZA2;AP2M1;DCTN6;CANX;CTSB;ACTR1B;CTSO;DCTN3;ACTR10;SEC13;KIF15;AP2S1;DCTN5
gsea,Membrane Trafficking R-HSA-199991,-0.2668415923333678,-1.4042698108013825,0.0111731843575419,0.11141638398357458,1.0,125/482,22.35%,FTH1;CALM1;UBB;CNIH2;RAB3A;DYNLL1;HSPA8;RPS27A;DYNLL2;YWHAG;YWHAH;VAMP2;CLTA;YWHAB;TMED9;TRAPPC6B;NECAP1;CAPZA2;UBA52;YWHAE;AP2M1;GABARAPL2;CNIH1;RAB32;ARF4;ARPC5;DCTN6;RAB6B;WASL;NAPG;ARPC2;STX16;CHMP4B;RAB1B;NEDD8;BET1L;PAFAH1B1;VPS28;RAB6A;MAP1LC3B;ARF3;ARPC1A;CYTH2;COPS6;YWHAZ;ANK1;YWHAQ;RAB14;ARPC3;GABARAP;TRAPPC2L;TSG101;ACTR2;TRAPPC2;UBQLN2;TMED2;CHMP2A;DCTN3;PACSIN2;RALA;RAB11A;GPS1;HIP1R;ACTR10;RAB18;ARF5;COPG2;MCFD2;TRAPPC1;SEC13;LMAN2;ANKRD28;SNAP29;CHMP6;BLOC1S4;RAB31;LMAN1;COPS8;EPN1;TMED7;SBF1;NAA38;UBE2Z;SCOC;PAFAH1B2;KIF15;AP2S1;CYTH4;DCTN5;TBC1D10B;NSF;ARFRP1;VPS4A;COPB2;COPG1;TBC1D7;ARFGAP2;AP2B1;VAMP3;CHMP7;DCTN1;ACBD3;MIA3;CHMP4C;UBC;GOSR1;STAM2;BICD2;SURF4;TRAPPC6A;COPE;RAB5A;TMF1;VPS52;TRAPPC4;SNX5;DENND5B;PUM1;SH3GL2;TBC1D20;TRAPPC10;RAB39B;UBAP1;STX6;M6PR
gsea,Phase I - Functionalization Of Compounds R-HSA-211945,-0.39993902395448294,-1.4025729981798594,0.07129455909943715,0.11226846861000953,1.0,8/35,13.04%,HSP90AB1;AURKAIP1;PTGES3;CYB5R3;VDAC2;PAOX;FDX2;ARNT2
gsea,Signaling By Receptor Tyrosine Kinases R-HSA-9006934,-0.2731544304848614,-1.402551586212565,0.015503875968992248,0.1120443514102837,1.0,90/361,19.53%,CALM1;UBB;ATP6V0C;APOE;ATP6V1D;RPS27A;HSP90AA1;ATP6V1A;CLTA;YWHAB;ATP6V1G2;ATP6V0E2;CDK5R2;UBA52;MEF2C;GABRG2;CDC42;AP2M1;BRK1;DUSP3;SPRY2;JUND;FLRT2;DUSP7;VEGFC;ATP6V0B;AXL;BAX;PSENEN;PPP2R1A;FGFR2;NRG3;POLR2G;ATP6V1F;POLR2F;NRG4;FGF13;EGR1;PDGFA;IRS2;PPP2CA;CDC37;ABI1;NCK1;STMN1;POLR2I;HRAS;APH1A;HNRNPA1;VEGFB;DNAL4;POLR2E;POLR2C;CDK5R1;FLRT3;RALA;HNRNPF;FGFR1;ERBIN;ATP6V1C1;ITGAV;MAPK3;ATP6V1E1;ATP6V1B2;EPN1;STUB1;LYN;PTPN1;PPP2R5D;VGF;AP2S1;GFAP;PRKACB;EGR3;CXXC1;ATP6V1G1;NCBP2;MAPK1;EGR4;ASCL1;VRK3;POLR2L;AP2B1;WASF1;UBC;STAM2;PDGFB;CTNNA1;NRAS;ID4
gsea,Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,0.4802537691527258,1.4021846418164687,0.10101010101010101,0.2536848411598341,1.0,4/15,4.64%,GRIA3;GRIA1;GRIA4;PRKCG
gsea,Visual Phototransduction R-HSA-2187338,-0.38076144947163343,-1.4006114186251233,0.07214428857715431,0.11329094325659746,1.0,14/42,26.45%,CALM1;TTR;APOE;C1D;METAP2;RNF7;RBP4;GPC1;LRP10;NMT1;MYO7A;RBP1;STRA6;LDLR
gsea,ERK/MAPK Targets R-HSA-198753,-0.4450240430295027,-1.4002063431555403,0.09670781893004116,0.11327977474547148,1.0,9/20,17.23%,MEF2C;DUSP3;DUSP7;PPP2R1A;PPP2CA;MAPK3;PPP2R5D;MAPK1;VRK3
gsea,Peptide Ligand-Binding Receptors R-HSA-375276,-0.36740278921118563,-1.3999945496213946,0.03466204506065858,0.11318644770380278,1.0,20/47,29.17%,NPY1R;PROKR2;NPY5R;CX3CL1;CXCR6;SSTR2;HEBP1;NPY;GPR37;MC4R;OPRM1;SSTR1;CXCL12;GPNMB;PDYN;TAC1;OPRL1;ACKR4;GPR37L1;OPRD1
gsea,RND1 GTPase Cycle R-HSA-9696273,0.3867669804763645,1.3993735749104723,0.08383233532934131,0.25335989596218333,1.0,11/33,15.13%,PLEKHG5;DST;DLG5;PKP4;CCDC88A;FAM135A;ANKRD26;VANGL1;FRS2;RND1;LEMD3
gsea,Regulation Of RUNX1 Expression And Activity R-HSA-8934593,0.48182529792398576,1.398727442642651,0.10192307692307692,0.25009585713397364,1.0,6/16,14.51%,TNRC6C;MOV10;CCND2;TNRC6B;AGO1;AGO4
gsea,Long-term Potentiation R-HSA-9620244,-0.4273851722402613,-1.395536733337185,0.10058027079303675,0.11596450526015237,1.0,3/22,0.66%,NRGN;CALM1;NEFL
gsea,Kinesins R-HSA-983189,0.40958883337578605,1.3946012140729032,0.06904231625835189,0.25235110338715344,1.0,10/29,24.92%,KIF26B;KIF1B;KIF3C;KIFC1;KIF1C;KIF5A;CENPE;KIF27;KIF16B;KIF13B
gsea,NGF-stimulated Transcription R-HSA-9031628,-0.42331897764562926,-1.394401659604808,0.07952286282306163,0.11660237863872544,1.0,11/27,26.02%,CDK5R2;JUND;EGR1;CDK5R1;VGF;EGR3;EGR4;ASCL1;ID4;RNASEH2A;CREB1
gsea,Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,-0.3939017891521841,-1.3936227416443296,0.07536764705882353,0.11687159135271442,1.0,5/32,6.96%,UBB;RPS27A;UBA52;TLE4;YWHAZ
gsea,Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,-0.46072981529174634,-1.3863065629146034,0.08914728682170543,0.1217098258981673,1.0,4/17,8.43%,BANF1;PPP2R1A;PPP2CA;EMD
gsea,Signaling By TGF-beta Receptor Complex R-HSA-170834,-0.3261846507229398,-1.3842365446721716,0.036608863198458574,0.12282878591389502,1.0,16/76,16.37%,UBB;RPS27A;FKBP1A;UBA52;SNW1;SKIL;NEDD8;PPP1CA;YBX1;PARP1;ITGAV;MAPK3;BAMBI;STUB1;PPP1CC;MAPK1
gsea,Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,-0.2724831382316994,-1.3837140667314696,0.00784313725490196,0.12294324191850349,1.0,59/301,14.24%,UBB;HMGB1;RPS27A;CALR;PSMA7;UBE3A;ELOB;PSMB5;PJA1;UBA52;KLHL9;PSMC3;RNF220;SEM1;NDUFA2;PSMC2;PSMA4;FBXL16;CANX;UBE2J1;PDIA3;PSMA5;RBX1;PSMD2;PSMD4;RNF6;PSMC5;UBE2N;ANAPC13;SEC61G;UBA3;UBA1;FBXW2;PSMB1;PSMA3;FBXO32;PSMD6;PSMA1;PSMB3;ASB13;FBXO9;UBE2S;RNF7;UBE2V1;PSMC1;SEC13;PSMD7;ITGAV;FBXO6;MKRN1;ASB5;PSMC4;PSME3;PJA2;STUB1;PSMA2;ANAPC11;UBE2Z;PSMC6
gsea,Oncogene Induced Senescence R-HSA-2559585,-0.4101287859982469,-1.3831217766750694,0.08300395256916997,0.12306368195507142,1.0,9/25,19.98%,UBB;RPS27A;UBA52;ETS2;CDK4;MAPK3;MAPK1;UBC;CDKN2D
gsea,Ion Transport By P-type ATPases R-HSA-936837,-0.38635865287083304,-1.3821829500112932,0.08,0.12353586182953354,1.0,10/37,14.70%,CALM1;ATP1B1;ATP1A3;ATP1B2;CUTC;ATP2B1;CAMK2B;FXYD1;SRI;ATP1A2
gsea,Activation Of GABAB Receptors R-HSA-991365,-0.39802388576983355,-1.3813882705993075,0.076,0.1238608997005334,1.0,11/30,15.66%,KCNJ3;GNB2;GNG2;KCNJ2;KCNJ4;GNAI1;GNG13;GNAI2;GNG10;GNG3;GNG7
gsea,Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,-0.4565621749953068,-1.3810263390111834,0.1,0.12388206453267299,1.0,6/17,11.48%,HSP90AA1;NRG3;NRG4;CDC37;HRAS;ERBIN
gsea,Glycolysis R-HSA-70171,-0.34723206743128926,-1.380962532538666,0.04590818363273453,0.12368157941269763,1.0,21/59,18.71%,PKM;ALDOC;PPP2R1A;TPI1;ENO2;PPP2CA;NUP50;PGK1;PGAM2;SEC13;NUP62;NUP37;PPP2R5D;PGP;PRKACB;PFKFB3;NUP205;PFKL;NUP35;ENO1;NUP107
gsea,Negative Regulation Of MET Activity R-HSA-6807004,-0.43658187870804743,-1.380693095627317,0.10153256704980843,0.12361331983307958,1.0,3/21,2.81%,UBB;RPS27A;UBA52
gsea,ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,-0.34406771003230324,-1.3785028051690653,0.04963235294117647,0.12494578714872395,1.0,18/60,18.28%,GNAS;GLP2R;GNB2;GNG2;RAMP2;GNAI1;GNG13;GNAI2;CHGA;GNG10;PRKAR1B;ADRB1;GNG3;PRKACB;GNG7;PTRH2;RAMP1;MC4R
gsea,Glucagon Signaling In Metabolic Regulation R-HSA-163359,-0.4233559240515939,-1.3779838525385888,0.08576998050682261,0.12502508941226112,1.0,9/24,15.66%,GNAS;GNB2;GNG2;GNG13;GNG10;PRKAR1B;GNG3;PRKACB;GNG7
gsea,Signaling By BRAF And RAF1 Fusions R-HSA-6802952,-0.35407793582631686,-1.3774283040351487,0.05436893203883495,0.12520593710140765,1.0,13/50,19.36%,CALM1;PEBP1;YWHAB;HRAS;FAM131B;CAMK2B;TRIM24;TLN1;MAPK3;CNKSR2;MAPK1;VCL;NRAS
gsea,Signaling By NTRK2 (TRKB) R-HSA-9006115,0.4416370855944167,1.3772489845833522,0.09645669291338582,0.2745589345029334,1.0,10/21,20.56%,DOCK3;NTF3;TIAM1;NTRK2;SOS1;FYN;GRIN2B;FRS2;PIK3CA;PLCG1
gsea,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,-0.37417098898430895,-1.375400705652847,0.0775347912524851,0.1264153889437167,1.0,22/39,34.20%,ELOB;POLR2G;POLR2F;POLR2I;TCEA1;POLR2E;POLR2C;NCBP2;POLR2L;ELOC;GTF2H5;SSRP1;ERCC3;POLR2J;GTF2H4;POLR2B;GTF2H3;ELOA;POLR2K;ELL;POLR2D;POLR2A
gsea,Unfolded Protein Response (UPR) R-HSA-381119,-0.33066543161058004,-1.3745682366583563,0.04809619238476954,0.12669082165203155,1.0,38/76,39.48%,CALR;NFYB;EIF2S2;PDIA6;EXOSC4;MYDGF;HDGF;CEBPB;DNAJB9;TLN1;EXOSC3;CXXC1;DCTN1;HSP90B1;CREB3L2;SSR1;EXOSC9;ACADVL;EXOSC7;EXOSC2;SRPRB;PPP2R5B;EXTL2;LMNA;DNAJB11;HSPA5;CUL7;DCP2;DDIT3;TSPYL2;HERPUD1;EDEM1;ATP6V0D1;CEBPG;EXOSC5;ATF4;TATDN2;SERP1
gsea,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,-0.36650784530345315,-1.3713351166710264,0.0854368932038835,0.1287683963467322,1.0,15/41,21.65%,ELOB;POLR2G;POLR2F;POLR2I;TCEA1;POLR2E;POLR2C;NCBP2;POLR2L;ELOC;GTF2H5;SSRP1;ERCC3;POLR2J;GTF2H4
gsea,CaM Pathway R-HSA-111997,0.40164957639104454,1.3670381437526145,0.08024691358024691,0.2861652035708451,1.0,8/29,5.22%,NBEA;PDE1A;ADCY8;ADCY2;CAMK2A;PRKCG;CAMK2G;ADCY9
gsea,Resolution Of Abasic Sites (AP Sites) R-HSA-73933,-0.3923574179786936,-1.3665462131749002,0.09450171821305842,0.13208742989147043,1.0,10/33,22.02%,PCNA;PARP1;RFC3;RPA3;APEX1;MPG;POLD4;ADPRS;TDG;POLD2
gsea,Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,-0.3498518662797836,-1.365913960421869,0.0686456400742115,0.13235869051421909,1.0,16/53,22.65%,UBB;RPS27A;UBA52;SNW1;PSENEN;RBX1;APH1A;TBL1XR1;JAG1;TBL1X;HEY1;UBC;MAMLD1;FBXW7;SKP1;MIB2
gsea,Signaling By EGFR R-HSA-177929,-0.35737979415772597,-1.3647654923677384,0.07909604519774012,0.13304694573426795,1.0,5/45,3.61%,UBB;RPS27A;UBA52;CDC42;SPRY2
gsea,Cleavage Of Damaged Purine R-HSA-110331,-0.47903365609832,-1.3626406035022998,0.12092130518234165,0.13428762369076797,1.0,6/15,17.09%,H2AZ1;H2BC4;H2AJ;TERF1;MPG;H2AX
gsea,FOXO-mediated Transcription R-HSA-9614085,-0.3543369579099112,-1.3603579614087355,0.07632093933463796,0.1357454141365408,1.0,13/50,17.14%,YWHAG;YWHAB;CITED2;PINK1;NFYB;YWHAZ;YWHAQ;AGRP;FBXO32;BTG1;CDKN1B;FOXO4;NPY
gsea,PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,-0.45601899613941993,-1.3591001075019369,0.08687943262411348,0.13656917419530148,1.0,9/18,34.71%,PCNA;RFC3;RPA3;APEX1;POLD4;POLD2;POLD3;POLG2;LRIG1
gsea,Regulation Of Beta-Cell Development R-HSA-186712,0.43220921803934986,1.358653247025472,0.10179640718562874,0.29559038881261596,1.0,6/21,12.04%,MAML2;FGF10;PAX6;ONECUT1;MAML3;AKT2
gsea,ISG15 Antiviral Mechanism R-HSA-1169408,-0.3351071704240868,-1.3570355471754743,0.07307692307692308,0.13788211932484587,1.0,24/58,27.04%,UBB;RPS27A;EIF4A1;UBA52;EIF4A2;UBE2N;NUP50;SEC13;MAPK3;NUP62;NUP37;EIF4G2;NUP205;NUP35;NUP107;UBC;JAK1;KPNA3;SEH1L;NUP85;KPNA2;EIF4A3;PDZD2;TPR
gsea,Signaling By FGFR2 In Disease R-HSA-5655253,-0.3844801789466956,-1.3561679147709922,0.09980430528375733,0.13830913372582787,1.0,13/30,21.26%,FGFR2;POLR2G;POLR2F;FGF13;POLR2I;HRAS;POLR2E;POLR2C;NCBP2;POLR2L;NRAS;FGF5;POLR2J
gsea,Mitotic Prometaphase R-HSA-68877,-0.28924949906895897,-1.3533310515249832,0.03461538461538462,0.140417216805343,1.0,35/142,20.36%,TUBA4A;DYNLL1;TUBA1A;DYNLL2;YWHAG;HSP90AA1;RPS27;NME7;YWHAE;CETN2;PPP2R1A;CSNK1E;TUBB4A;TUBB4B;SMC1A;PAFAH1B1;PPP2CA;CSNK2B;RAD21;DCTN3;SEC13;NUP37;ZWINT;PPP2R5D;PPP1CC;SSNA1;NEK6;HAUS2;CEP78;DCTN1;NUP107;B9D2;CENPP;ITGB3BP;RCC2
gsea,Serotonin Neurotransmitter Release Cycle R-HSA-181429,-0.4470064818287045,-1.353293844338533,0.11823647294589178,0.14015558287950286,1.0,5/18,11.97%,RAB3A;VAMP2;PPFIA2;SNAP25;SLC18A2
gsea,NCAM1 Interactions R-HSA-419037,0.42471225935335766,1.3517461583481953,0.11570247933884298,0.3028288066485451,1.0,8/20,21.48%,CACNA1C;CACNB2;COL4A1;CACNA1H;NCAN;GFRA2;COL4A2;CNTN2
gsea,HCMV Late Events R-HSA-9610379,-0.3309088624977577,-1.3515147849495694,0.047244094488188976,0.14130810670352037,1.0,21/60,22.20%,CEBPD;CHMP4B;H2BC4;H2AC25;VPS28;NUP50;TSG101;CHMP2A;SEC13;CHMP6;NUP62;HNRNPK;NUP37;NUP205;NUP35;VPS4A;CHMP7;NUP107;CHMP4C;SEH1L;UBAP1
gsea,Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,0.36422617657023454,1.3477985924481086,0.082,0.3051194071291215,1.0,16/43,12.71%,CACNB2;ATP2B4;PCLO;RIPOR2;CASK;EPB41L1;KCNMA1;PLS1;SPTAN1;CABP1;STX1A;MYH9;PCDH15;ESPN;EPS8;EPB41L3
gsea,DNA Strand Elongation R-HSA-69190,-0.4190886211699749,-1.3439541680676468,0.09265734265734266,0.14705055212005552,1.0,11/26,34.71%,GINS2;PCNA;RFC3;RPA3;POLD4;GINS4;POLD2;MCM6;POLD3;PRIM1;LRIG1
gsea,Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,0.45995870076715645,1.3416088915157451,0.115234375,0.3099778138769271,1.0,6/16,19.99%,ZMYM2;LRRFIP1;GAB2;CNTRL;PIK3CA;MYO18A
gsea,Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,-0.4184310137694428,-1.3400656896413834,0.1130952380952381,0.14989021584029005,1.0,8/22,15.66%,CALM1;NCALD;GNB2;GNG2;GNG13;GNG10;GNG3;GNG7
gsea,Signaling By RAF1 Mutants R-HSA-9656223,-0.38608058854636235,-1.3384869665861745,0.10789980732177264,0.15098503062826474,1.0,10/30,19.36%,CALM1;YWHAB;HRAS;CAMK2B;TLN1;MAPK3;CNKSR2;MAPK1;VCL;NRAS
gsea,Ca-dependent Events R-HSA-111996,0.3889468351162968,1.3380112047275912,0.08163265306122448,0.3115435256319446,1.0,8/30,5.22%,NBEA;PDE1A;ADCY8;ADCY2;CAMK2A;PRKCG;CAMK2G;ADCY9
gsea,Nuclear Signaling By ERBB4 R-HSA-1251985,-0.38811428549710986,-1.335175038282553,0.10707456978967496,0.1533910509861685,1.0,6/28,7.96%,APOE;PSENEN;NRG3;NRG4;STMN1;APH1A
gsea,Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,-0.45937153169685646,-1.3301264044982082,0.14711359404096835,0.15729308286654822,1.0,4/15,17.09%,H2AZ1;H2BC4;H2AJ;H2AX
gsea,Oncogenic MAPK Signaling R-HSA-6802957,-0.3251439137448914,-1.3246434858881837,0.08159392789373814,0.16163130000359932,1.0,19/63,23.88%,CALM1;PEBP1;YWHAB;DUSP7;HRAS;FAM131B;CAMK2B;TRIM24;TLN1;MAPK3;CNKSR2;PPP1CC;MAPK1;VCL;NRAS;DUSP8;MRAS;FAM114A2;MAP2K1
gsea,Nuclear Receptor Transcription Pathway R-HSA-383280,0.3593335180310736,1.324150866988703,0.10590631364562118,0.3302088002439513,1.0,7/33,8.10%,NR2F1;RARB;RORA;NR3C2;NR6A1;ESRRG;THRB
gsea,Circadian Clock R-HSA-400253,-0.3284901486840609,-1.319824427600636,0.09302325581395349,0.16564100379575486,1.0,18/57,27.07%,UBB;RPS27A;UBA52;MEF2C;CSNK1E;PPP1CA;TBL1XR1;NFIL3;PPP1CC;TBL1X;KLF15;UBC;SKP1;FBXL3;NRIP1;LIN9;CREB1;CRTC2
gsea,Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,-0.316606696439767,-1.3193429134344288,0.06357388316151202,0.16573462109598336,1.0,40/87,35.00%,PLPPR4;NPY1R;P2RY14;P2RY12;PROKR2;NPY5R;CX3CL1;CXCR6;CHGA;ADRA2C;SSTR2;ADRB1;PLPPR5;HEBP1;NPY;GPR37;MC4R;OPRM1;SSTR1;S1PR3;CXCL12;GPNMB;PDYN;TAC1;OPRL1;PLPPR3;HTR1F;S1PR1;ACKR4;GPR37L1;OPRD1;ADORA1;PTGER4;DHX34;PENK;NPFF;GPR39;DRD5;ACKR3;HTR1A
gsea,TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,-0.43529319199352445,-1.3162565302681986,0.13178294573643412,0.1682626210297598,1.0,4/19,11.66%,PLK2;BTG2;NPM1;CNOT8
gsea,Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,0.439353906915452,1.3161903320175636,0.1254980079681275,0.33958418500299337,1.0,8/16,23.35%,HLCS;ACACA;PCCB;ABCD4;AMN;MCCC2;MCCC1;CD320
gsea,Ion Channel Transport R-HSA-983712,-0.29742877147358915,-1.316022569030454,0.06319702602230483,0.16817485035791443,1.0,23/113,12.98%,CALM1;ATP1B1;UBB;ATP6V0C;ATP6V1D;RPS27A;ATP6V1A;ATP6V1G2;ATP6V0E2;UBA52;ATP1A3;ATP6V0B;ATP6V1F;ATP1B2;CUTC;ATP2B1;CAMK2B;CLCN4;ATP6V1C1;FXYD1;SRI;ATP6V1E1;ATP6V1B2
gsea,B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,-0.36558568401822383,-1.3156475918776336,0.11851851851851852,0.16817511858446102,1.0,10/35,18.00%,H2AZ1;DEK;POLR2F;H2BC4;H2AJ;POLR2E;POLR1G;GSK3B;H2AX;POLR2L
gsea,Regulation Of Insulin Secretion R-HSA-422356,-0.3257353816931428,-1.3154895504445265,0.08477842003853564,0.16799433134593583,1.0,18/59,15.66%,GNAS;VAMP2;ACSL3;GNB2;GNG2;SYT5;MARCKS;GNAI1;GNG13;SNAP25;GNA11;GNAI2;GNG10;ADRA2C;PRKAR1B;GNG3;PRKACB;GNG7
gsea,Cargo Concentration In ER R-HSA-5694530,-0.404666583340942,-1.315324516640138,0.118,0.1678142687055611,1.0,6/23,12.67%,CNIH2;CNIH1;TMED2;MCFD2;LMAN2;LMAN1
gsea,Sensory Processing Of Sound R-HSA-9659379,0.34489795721061356,1.3131083214743482,0.08739837398373984,0.3402520047277411,1.0,16/47,12.71%,CACNB2;ATP2B4;PCLO;RIPOR2;CASK;EPB41L1;KCNMA1;PLS1;SPTAN1;CABP1;STX1A;MYH9;PCDH15;ESPN;EPS8;EPB41L3
gsea,Meiosis R-HSA-1500620,-0.3447051935863942,-1.312513550390907,0.07889908256880734,0.17004533959216117,1.0,23/49,31.35%,H2AZ1;HSPA2;H2BC4;SMC1A;H2AJ;CDK4;RAD21;TERF1;RPA3;RAD50;H2AX;RAD51;SYCP3;SUN2;MLH1;SUN1;LMNA;SYNE2;TINF2;PSMC3IP;MLH3;SMC3;H2BC21
gsea,EPHB-mediated Forward Signaling R-HSA-3928662,-0.37292673249231906,-1.310261108242461,0.10297029702970296,0.17178458389140386,1.0,9/31,8.88%,ACTG1;CDC42;ARPC5;WASL;ARPC2;ARPC1A;HRAS;ARPC3;ACTR2
gsea,tRNA Processing In Nucleus R-HSA-6784531,-0.3367248472427949,-1.3094139079658533,0.11740890688259109,0.172202739820862,1.0,21/50,27.13%,RAN;POP5;NUP50;FAM98B;RPP21;SEC13;NUP62;NUP37;ZBTB8OS;RPP38;NUP205;NUP35;TSEN34;RTCB;NUP107;DDX1;SEH1L;TSEN2;NUP85;TPR;RTRAF
gsea,Smooth Muscle Contraction R-HSA-445355,-0.4051019655624839,-1.3075087757177006,0.14528301886792452,0.17371268642143764,1.0,8/25,18.98%,CALM1;MYL6;MYL12B;TPM1;TLN1;MYL9;VCL;MYL12A
gsea,Signaling By SCF-KIT R-HSA-1433557,0.3787556380876995,1.3072864018024597,0.1191919191919192,0.345719699418381,1.0,11/28,19.91%,CBL;GAB2;PIK3R3;JAK2;LCK;SOS1;FYN;FER;PIK3CA;KIT;SH2B3
gsea,Glycerophospholipid Biosynthesis R-HSA-1483206,0.29034458515254774,1.3070488476207767,0.05918367346938776,0.34134652677721167,1.0,22/92,15.99%,SLC44A5;MIGA2;PITPNM2;PLA2G4E;PCYT2;CSNK2A2;CHKA;OSBPL10;ETNK1;CHKB;MBOAT2;SLC44A2;ABHD4;CPNE1;PGS1;STARD10;TAFAZZIN;LPIN1;CHEK2;PLA2G3;MGLL;DGAT1
gsea,ECM Proteoglycans R-HSA-3000178,0.3697374645317799,1.306146549185247,0.1125,0.3383484119392526,1.0,9/29,17.90%,PTPRS;LAMB1;TNR;LAMC1;DMTF1;ITGA8;HAPLN1;NCAN;DCN
gsea,MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,-0.3859473095446754,-1.30526601515896,0.13360323886639677,0.17541044839710754,1.0,10/26,17.23%,JUN;MEF2C;DUSP3;DUSP7;PPP2R1A;PPP2CA;MAPK3;PPP2R5D;MAPK1;VRK3
gsea,Signaling By ERBB2 KD Mutants R-HSA-9664565,-0.4155586572152135,-1.3044808544327045,0.1483739837398374,0.17582786753837473,1.0,6/20,11.48%,HSP90AA1;NRG3;NRG4;CDC37;HRAS;ERBIN
gsea,Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,-0.3174407170407146,-1.3003979677552453,0.09125475285171103,0.17907688750107298,1.0,24/61,27.04%,UBB;RPS27A;EIF4A1;UBA52;EIF4A2;UBE2N;NUP50;SEC13;MAPK3;NUP62;NUP37;EIF4G2;NUP205;NUP35;NUP107;UBC;JAK1;KPNA3;SEH1L;NUP85;KPNA2;EIF4A3;PDZD2;TPR
gsea,Aquaporin-mediated Transport R-HSA-445717,-0.37399238997554995,-1.2997254767684276,0.12398373983739837,0.179352048079715,1.0,11/31,16.71%,GNAS;GNB2;GNG2;GNG13;RAB11A;GNG10;PRKAR1B;GNG3;PRKACB;GNG7;AQP11
gsea,Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,-0.2622134732255209,-1.2996625058609024,0.03792415169660679,0.1790611144807459,1.0,51/260,14.24%,UBB;RPS27A;PSMA7;UBE3A;ELOB;PSMB5;PJA1;UBA52;KLHL9;PSMC3;RNF220;SEM1;PSMC2;PSMA4;FBXL16;UBE2J1;PSMA5;RBX1;PSMD2;PSMD4;RNF6;PSMC5;UBE2N;ANAPC13;UBA3;UBA1;FBXW2;PSMB1;PSMA3;FBXO32;PSMD6;PSMA1;PSMB3;ASB13;FBXO9;UBE2S;RNF7;UBE2V1;PSMC1;PSMD7;FBXO6;MKRN1;ASB5;PSMC4;PSME3;PJA2;STUB1;PSMA2;ANAPC11;UBE2Z;PSMC6
gsea,Cristae Formation R-HSA-8949613,-0.44711100732710896,-1.299309358229879,0.16829745596868884,0.1790517982727845,1.0,7/15,21.12%,ATP5PB;IMMT;TMEM11;SAMM50;MICOS10;MTX2;HSPA9
gsea,RHO GTPases Activate CIT R-HSA-5625900,-0.4528697205825,-1.2974934785757275,0.1569767441860465,0.18050401801843927,1.0,7/15,20.26%,MYL6;MYL12B;MYL9;MYH14;CDKN1B;RHOB;MYH10
gsea,Class I Peroxisomal Membrane Protein Import R-HSA-9603798,-0.4081021973268488,-1.2952701895338952,0.1533980582524272,0.18230345054455177,1.0,7/19,32.34%,ATAD1;PEX12;PEX19;FIS1;PEX11B;SLC25A17;ABCD1
gsea,Activation Of HOX Genes During Differentiation R-HSA-5619507,-0.331437636074445,-1.2950403229101404,0.09497206703910614,0.1821322979837426,1.0,16/49,21.26%,JUN;H2AZ1;POLR2G;POLR2F;H2BC4;POLR2I;H2AJ;RBBP7;POLR2E;POLR2C;H2AX;POLR2L;CTCF;YY1;PBX1;POLR2J
gsea,Post NMDA Receptor Activation Events R-HSA-438064,0.3310070192804315,1.294406426790203,0.10537190082644628,0.3551380577137005,1.0,19/56,14.12%,GRIN2A;GRIA1;LRRC7;ADCY8;RPS6KA2;PRKAG2;ACTN2;NRG1;ERBB4;CAMK2A;MAPT;CAMK2G;RASGRF2;MPP3;RPS6KA6;ARHGEF7;RPS6KA1;CAMK2D;GRIN2B
gsea,Hemostasis R-HSA-109582,-0.25311946895773435,-1.2942479299789371,0.032490974729241874,0.18251252860408965,1.0,65/335,15.24%,CALM1;ATP1B1;PPIA;TMSB4X;TTR;TUBA4A;GNAS;TSPAN7;APLP2;RASGRP1;GNB2;BSG;CAPZA2;CDC42;FAM3C;GNG2;ORAI2;VEGFC;TIMP3;PPP2R1A;SOD1;P2RY12;MANF;PDGFA;ATP1B2;CD47;PPP2CA;PFN1;VTI1B;YWHAZ;ANGPT2;HRAS;C1QBP;GNAI1;GNG13;MAGED2;GNA11;VEGFB;ATP2B1;OLA1;SCCPDH;CLU;CD63;TAGLN2;GNAI2;GNG10;ADRA2C;SELPLG;ITGAV;TLN1;EHD3;PRKAR1B;MAPK3;SRI;LYN;ENDOD1;PTPN1;CHID1;PPP2R5D;SLC16A1;TEK;KIF15;GNG3;PRKACB;SLC8A2
gsea,Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,-0.4126153034696825,-1.2942470835603848,0.12835249042145594,0.1821574458636148,1.0,2/20,1.36%,TECR;ACSL3
gsea,RNA Polymerase I Promoter Escape R-HSA-73772,-0.35605282783864417,-1.2908067302880968,0.12045889101338432,0.18504851796516475,1.0,18/37,31.35%,H2AZ1;POLR2F;H2BC4;CBX3;H2AJ;POLR2E;POLR1G;H2AX;POLR2L;GTF2H5;ERCC3;GTF2H4;TAF1C;RRN3;GTF2H3;POLR1F;POLR2K;H2BC21
gsea,Signaling By ERBB2 In Cancer R-HSA-1227990,-0.4047827516657858,-1.2887916436773297,0.15682281059063136,0.18659163455194608,1.0,6/21,11.48%,HSP90AA1;NRG3;NRG4;CDC37;HRAS;ERBIN
gsea,"Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",-0.32133163693840555,-1.2885951602789882,0.10436432637571158,0.18642546958199477,1.0,11/60,10.60%,UBB;BEX3;RPS27A;UBA52;YWHAE;SQSTM1;MAGED1;PSENEN;APH1A;ARHGEF1;BAD
gsea,Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,-0.3697428249225885,-1.287629281124984,0.14056224899598393,0.1869852123045964,1.0,10/30,15.66%,GNAS;GNB2;GNG2;GNG13;RAB11A;GNG10;PRKAR1B;GNG3;PRKACB;GNG7
gsea,Death Receptor Signaling R-HSA-73887,-0.29221878094251147,-1.2872671499226167,0.06963249516441006,0.18699844876080748,1.0,16/111,9.27%,UBB;RACK1;BEX3;RPS27A;ARHGDIA;UBA52;YWHAE;SQSTM1;MAGED1;USP2;PSENEN;NSMAF;CLIP3;APH1A;RTN4;ARHGEF1
gsea,GPCR Downstream Signaling R-HSA-388396,0.25309927655504727,1.2856615874228652,0.034013605442176874,0.3668261960994014,1.0,65/279,14.48%,NBEA;DGKG;PDE2A;PLEKHG5;KALRN;PDE1A;TRIO;GABBR2;ADCY8;PRKCE;RPS6KA2;FGD4;ABR;PDE7B;ADCY2;ROCK1;PDE10A;ITSN1;RGS17;RGS8;DGKH;CHRM3;GRM8;CAMK2A;GPR45;PRKCG;PIK3R3;GNA12;RXFP1;CAMK2G;ADCY9;ADCYAP1R1;TIAM1;TRHR;DGKB;GRK3;RASGRF2;DGKQ;TRPC6;GPR68;GRM7;HTR2C;PDE4A;ARHGEF33;PRPF38B;FGD1;DGKI;RGS11;ARHGEF18;RGS7;ARHGEF17;SOS1;PDE11A;AKT2;ARHGEF7;RGS20;ADCY6;RPS6KA1;CHRM2;PREX1;CAMK2D;DGKA;ARHGEF2;ARHGEF4;ARHGEF3
gsea,IRE1alpha Activates Chaperones R-HSA-381070,-0.3413529802836579,-1.2854427674734679,0.12476007677543186,0.18843346834267052,1.0,21/45,39.48%,PDIA6;MYDGF;HDGF;DNAJB9;TLN1;CXXC1;DCTN1;SSR1;ACADVL;SRPRB;PPP2R5B;EXTL2;LMNA;DNAJB11;HSPA5;CUL7;TSPYL2;EDEM1;ATP6V0D1;TATDN2;SERP1
gsea,Ovarian Tumor Domain Proteases R-HSA-5689896,-0.3979087329418922,-1.2848490720009256,0.1515748031496063,0.18863712632697485,1.0,6/25,14.15%,UBB;RPS27A;UBA52;OTUB1;VCPIP1;VCP
gsea,Deadenylation-dependent mRNA Decay R-HSA-429914,-0.3223020266130671,-1.2824730716807757,0.11730769230769231,0.19060472933811307,1.0,20/54,27.16%,EIF4A1;EIF4A2;LSM2;PABPC1;LSM7;EXOSC4;LSM4;CNOT8;EXOSC3;LSM1;LSM3;SKIC8;CNOT11;EXOSC9;LSM5;EXOSC7;EIF4A3;XRN1;CNOT6L;EXOSC2
gsea,Signaling By TGFB Family Members R-HSA-9006936,-0.29233764269358753,-1.2808086215453507,0.08187134502923976,0.19186658894410719,1.0,16/94,13.38%,UBB;RPS27A;FKBP1A;UBA52;SNW1;SKIL;NEDD8;PPP1CA;YBX1;DRAP1;PARP1;INHBA;ITGAV;MAPK3;BAMBI;STUB1
gsea,Telomere Extension By Telomerase R-HSA-171319,-0.4304854809504374,-1.2807113051982668,0.178714859437751,0.1915893345644343,1.0,6/18,16.15%,NOP10;TERF1;RUVBL1;GAR1;ANKRD28;DKC1
gsea,HIV Transcription Initiation R-HSA-167161,-0.33453066787405766,-1.277964167681899,0.1218568665377176,0.19370608912803605,1.0,30/44,40.98%,POLR2G;POLR2F;POLR2I;GTF2B;POLR2E;POLR2C;TAF11;TAF10;POLR2L;GTF2H5;TAF5;ERCC3;POLR2J;GTF2H4;TAF7L;TAF12;TAF7;POLR2B;GTF2H3;POLR2K;GTF2A1;POLR2D;POLR2A;TBP;TAF13;CCNH;GTF2E1;TAF9B;GTF2F1;GTF2F2
gsea,TBC/RABGAPs R-HSA-8854214,-0.3533552491249083,-1.2755639894073816,0.12825278810408922,0.1957662271835507,1.0,14/38,27.88%,GABARAPL2;RAB6B;RAB6A;MAP1LC3B;GABARAP;RAB11A;TBC1D10B;TBC1D7;RAB5A;TBC1D20;RAB5C;RAB5B;ARF6;RAB35
gsea,RNA Polymerase II Transcription Termination R-HSA-73856,-0.3081319042384804,-1.2754611507261266,0.11623246492985972,0.19546033924324385,1.0,20/64,20.77%,SNRPG;CPSF2;SNRPF;MAGOH;RBM8A;SLBP;U2AF1;SRSF3;CDC40;CHTOP;SNRPE;U2AF1L4;U2AF2;DDX39B;NCBP2;SNRPB;MAGOHB;POLDIP3;SLU7;THOC7
gsea,Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,-0.3476989255351004,-1.2736243189071474,0.15841584158415842,0.1968803587573348,1.0,10/33,15.91%,SLC25A4;PSIP1;SLC25A5;BANF1;NUP50;SEC13;NUP62;NUP37;NUP205;NUP35
gsea,Signaling By FLT3 Fusion Proteins R-HSA-9703465,0.45054990102281334,1.2728608302314492,0.17034068136272545,0.3864042710045914,1.0,8/15,19.99%,ZMYM2;GAB2;TRIP11;SOS1;ETV6;PIK3CA;SPTBN1;MYO18A
gsea,P75 NTR Receptor-Mediated Signaling R-HSA-193704,-0.2987606451018765,-1.2696338471894084,0.09158878504672897,0.2005306718969274,1.0,13/80,10.60%,UBB;BEX3;RPS27A;ARHGDIA;UBA52;YWHAE;SQSTM1;MAGED1;PSENEN;APH1A;RTN4;ARHGEF1;BAD
gsea,Ion Homeostasis R-HSA-5578775,-0.34706458388582007,-1.269402395378179,0.14234234234234233,0.2003394472210235,1.0,11/39,15.24%,CALM1;ATP1B1;ORAI2;ATP1A3;ATP1B2;ATP2B1;CAMK2B;FXYD1;SRI;ATP1A2;SLC8A2
gsea,Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,-0.3595548044870963,-1.2693602498225218,0.1431297709923664,0.20000461073150774,1.0,9/33,15.66%,GNAS;GNB2;GNG2;GNG13;GNG10;PRKAR1B;GNG3;PRKACB;GNG7
gsea,Cell Junction Organization R-HSA-446728,0.31898407007575,1.2681933115559256,0.11850311850311851,0.3909242726140369,1.0,15/53,18.27%,DST;SDK2;CDH12;NECTIN1;LAMB3;PARVB;FLNA;CDH11;PATJ;CADM1;PARD6B;CDH10;PARVA;RSU1;CDH13
gsea,Transcription Of HIV Genome R-HSA-167172,-0.30891559446559463,-1.267131660939463,0.10424710424710425,0.20194775792030503,1.0,31/63,34.41%,ELOB;POLR2G;POLR2F;POLR2I;GTF2B;TCEA1;POLR2E;POLR2C;TAF11;TAF10;NCBP2;POLR2L;ELOC;GTF2H5;TAF5;SSRP1;ERCC3;POLR2J;GTF2H4;TAF7L;TAF12;TAF7;POLR2B;GTF2H3;ELOA;POLR2K;ELL;GTF2A1;POLR2D;POLR2A;RNMT
gsea,XBP1(S) Activates Chaperone Genes R-HSA-381038,-0.335756630673179,-1.2653319243768189,0.13851992409867173,0.20355092206624223,1.0,20/43,39.48%,PDIA6;MYDGF;HDGF;DNAJB9;TLN1;CXXC1;DCTN1;SSR1;ACADVL;SRPRB;PPP2R5B;EXTL2;LMNA;DNAJB11;CUL7;TSPYL2;EDEM1;ATP6V0D1;TATDN2;SERP1
gsea,RHOG GTPase Cycle R-HSA-9013408,0.306974537011549,1.2652509894737591,0.10756972111553785,0.3918099388443847,1.0,7/59,3.31%,KALRN;IQGAP2;TRIO;CYFIP1;DOCK3;DOCK4;ITSN1
gsea,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,-0.3134496235046442,-1.2650413695259946,0.1102803738317757,0.2034708536763345,1.0,17/62,20.65%,TMED9;ARF4;NAPG;RAB1B;ARF3;TMED2;ARF5;COPG2;TMED7;UBE2Z;KIF15;NSF;COPB2;COPG1;ARFGAP2;SURF4;COPE
gsea,Deadenylation Of mRNA R-HSA-429947,-0.37630998697865625,-1.2617611778817146,0.1708253358925144,0.20643872066329214,1.0,4/24,11.66%,EIF4A1;EIF4A2;PABPC1;CNOT8
gsea,"Base-Excision Repair, AP Site Formation R-HSA-73929",-0.41725863775207545,-1.2609063649011643,0.16633663366336635,0.20690588057145756,1.0,7/20,21.51%,H2AZ1;H2BC4;H2AJ;TERF1;MPG;H2AX;TDG
gsea,Nephrin Family Interactions R-HSA-373753,0.41295852985661596,1.2607427275136802,0.1781609195402299,0.39593725092915943,1.0,9/19,18.92%,ACTN2;CASK;ACTN4;NCK2;SPTAN1;FYN;PIK3CA;SPTBN1;IQGAP1
gsea,PLC Beta Mediated Events R-HSA-112043,0.3488200824225701,1.2605744059869959,0.144,0.39128158281716496,1.0,8/37,5.22%,NBEA;PDE1A;ADCY8;ADCY2;CAMK2A;PRKCG;CAMK2G;ADCY9
gsea,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,-0.37385057517713444,-1.2599691136392077,0.16535433070866143,0.20754480261775082,1.0,16/26,34.41%,POLR2G;POLR2F;POLR2I;POLR2E;POLR2C;POLR2L;GTF2H5;ERCC3;POLR2J;GTF2H4;POLR2B;GTF2H3;POLR2K;POLR2D;POLR2A;RNMT
gsea,NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,-0.3304509949270417,-1.25886311910622,0.15867158671586715,0.208374081548492,1.0,14/44,21.32%,UBB;RPS27A;UBA52;SNW1;TLE4;RBX1;TBL1XR1;TBL1X;HEY1;UBC;MAMLD1;TLE1;FBXW7;SKP1
gsea,RMTs Methylate Histone Arginines R-HSA-3214858,-0.35025630540821706,-1.256423127050751,0.16030534351145037,0.2105357526349664,1.0,12/36,22.37%,RPS2;H2AZ1;H2AC25;H2AJ;CDK4;RBBP7;PRMT7;H2AX;SMARCE1;SMARCB1;ACTL6B;COPRS
gsea,CD28 Dependent PI3K/Akt Signaling R-HSA-389357,0.41787856127841316,1.2547388693387302,0.17355371900826447,0.39771816833643153,1.0,6/17,12.06%,PIK3R3;LCK;MTOR;RICTOR;AKT2;FYN
gsea,G Alpha (Q) Signaling Events R-HSA-416476,0.2887416808125405,1.2529973256029592,0.07894736842105263,0.39620352266086717,1.0,16/85,8.55%,DGKG;KALRN;TRIO;PRKCE;RPS6KA2;RGS17;DGKH;CHRM3;PIK3R3;TRHR;DGKB;DGKQ;TRPC6;GPR68;HTR2C;DGKI
gsea,Extension Of Telomeres R-HSA-180786,-0.34062074110169865,-1.2528651963584114,0.14,0.21393892750857507,1.0,10/41,16.15%,NOP10;TERF1;RUVBL1;PCNA;RFC3;GAR1;ANKRD28;RPA3;POLD4;DKC1
gsea,DNA Repair R-HSA-73894,-0.2536992558055067,-1.2512735976572806,0.05913978494623656,0.21515178174926675,1.0,62/245,22.63%,UBB;RPS27A;H2AZ1;UBA52;CETN2;SUMO2;HMGN1;SEM1;POLR2G;POLR2F;H2BC4;RBX1;CENPX;EYA1;COPS6;ALKBH5;UBE2N;POLR2I;H2AJ;TCEA1;UBXN1;TERF1;POLR2E;POLR2C;PPP4C;RUVBL1;PCNA;PARP1;GPS1;RFC3;RNF168;COPS8;RPA3;APEX1;DDB2;MPG;SIRT6;POLD4;VCP;XRCC2;ACTR8;RAD50;H2AX;POLR2L;RAD51;GTF2H5;PRPF19;UBC;PPIE;YY1;BABAM2;ADPRS;UIMC1;ERCC3;POLL;POLR2J;TDG;GTF2H4;POLD2;FANCE;ASCC1;SUMO1
gsea,HCMV Early Events R-HSA-9609690,-0.3049833171420157,-1.2502902872766062,0.11530815109343936,0.21579454927778077,1.0,23/64,27.04%,DYNLL1;DYNLL2;H2BC4;H2AC25;PML;GPS2;NUP50;RBBP7;TBL1XR1;SEC13;NUP62;NUP37;NUP205;NUP35;TBL1X;NUP107;DUT;SEH1L;NUP85;CREB1;DAXX;RRM1;TPR
gsea,Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.27368231162674683,-1.249449029524874,0.07908611599297012,0.2162938069399288,1.0,42/125,31.15%,CALM1;TTR;APOE;HSP90AA1;C1D;PDXK;DHFR;MOCS2;GCH1;SLC25A16;CYB5R3;RBP4;PPCS;MMADHC;CYB5A;VKORC1;COQ3;ALDH1L1;NMNAT3;RFK;GPC1;PARP16;LRP10;MMACHC;NAXD;FASN;MTHFD2;PANK3;COQ9;PANK4;COQ7;RBP1;LDLR;SLC25A19;GSTO1;NAXE;AKT1;SLC19A2;SLC2A1;PDZD11;TPK1;PTGIS
gsea,Phospholipid Metabolism R-HSA-1483257,0.2604105137270172,1.249175754897509,0.0819327731092437,0.3988140969027395,1.0,42/160,18.00%,SLC44A5;MTMR12;MIGA2;PITPNM2;PLA2G4E;PCYT2;PIP5K1B;OCRL;PIK3R3;PLEKHA5;SYNJ1;CSNK2A2;CHKA;PIKFYVE;OSBPL10;MTMR1;ETNK1;MTMR7;CHKB;MBOAT2;SLC44A2;ABHD4;CPNE1;SBF2;PNPLA6;PGS1;PLEKHA6;STARD10;TAFAZZIN;SYNJ2;LPIN1;CHEK2;PLA2G3;MGLL;DGAT1;PI4KA;INPP5J;GDPD1;TNFAIP8L3;PLEKHA1;PIK3CA;ACP6
gsea,SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,0.317057135527732,1.2487864134482554,0.1322314049586777,0.3947186378673389,1.0,16/50,14.28%,PHC2;RANBP2;SATB1;NUP210;NUP188;PIAS2;HDAC1;NDC1;PIAS1;NUP160;PHC3;NUP98;SCMH1;NUP133;HDAC4;POM121
gsea,Notch-HLH Transcription Pathway R-HSA-350054,0.36299227683882274,1.248402497315635,0.1724137931034483,0.39093081553284387,1.0,12/26,23.58%,MAML2;NOTCH2;HDAC1;HDAC8;MAML3;HDAC4;HDAC7;HDAC6;HDAC9;RBPJ;NCOR2;HDAC3
gsea,RHOJ GTPase Cycle R-HSA-9013409,0.33825467195154296,1.2482022770583554,0.15833333333333333,0.38672778127244256,1.0,13/43,15.80%,TRIO;FNBP1;OCRL;CDC42BPA;CPNE8;SLC4A7;STEAP3;ARHGEF7;VANGL1;PREX1;WIPF2;ARHGAP32;GIT2
gsea,Signaling By GPCR R-HSA-372790,0.242609695384169,1.2464338736525806,0.045351473922902494,0.3856276338755299,1.0,51/303,8.95%,NBEA;DGKG;PDE2A;PLEKHG5;KALRN;PDE1A;TRIO;GABBR2;ADCY8;PRKCE;RPS6KA2;FGD4;ABR;PDE7B;ADCY2;ROCK1;PDE10A;ITSN1;RGS17;RGS8;DGKH;CHRM3;GRM8;CAMK2A;GPR45;PRKCG;PLPPR1;PIK3R3;GNA12;RXFP1;CAMK2G;ADCY9;ADCYAP1R1;TIAM1;TRHR;DGKB;GRK3;RASGRF2;DGKQ;TRPC6;GPR68;GRM7;HTR2C;ECE1;PDE4A;ARHGEF33;PRPF38B;FGD1;DGKI;RGS11;ARHGEF18
gsea,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,-0.39768919524427193,-1.2444070924030735,0.1743486973947896,0.22137683085311502,1.0,6/22,9.40%,H2AZ1;H2BC4;CBX3;CHD3;H2AJ;RBBP7
gsea,Arachidonic Acid Metabolism R-HSA-2142753,-0.40532877526649025,-1.2433945377566304,0.1871559633027523,0.22212044646955095,1.0,7/21,15.73%,PTGES3;GPX4;PON2;PTGDS;HPGDS;CBR1;PRXL2B
gsea,Voltage Gated Potassium Channels R-HSA-1296072,0.34719418069453345,1.2431825473995681,0.14314115308151093,0.3874774999223553,1.0,11/35,12.69%,KCNAB1;KCND3;KCNH1;KCNQ2;KCNQ3;KCNQ5;KCNG3;KCNG1;KCNC2;KCNAB2;KCNB2
gsea,Clathrin-mediated Endocytosis R-HSA-8856828,-0.279950187623852,-1.2404794380299953,0.12941176470588237,0.22503564888075472,1.0,20/110,10.90%,UBB;HSPA8;RPS27A;VAMP2;CLTA;NECAP1;UBA52;AP2M1;ARPC5;WASL;ARPC2;NEDD8;ARPC1A;COPS6;ARPC3;ACTR2;UBQLN2;PACSIN2;GPS1;HIP1R
gsea,Metabolism Of Carbohydrates R-HSA-71387,-0.2529260934236234,-1.237560915930394,0.07792207792207792,0.2280500828311652,1.0,48/216,20.49%,CALM1;UBB;RPS27A;NDST4;MDH2;PKM;MDH1;UBA52;ALDOC;DCXR;PPP2R1A;PHGDH;TPI1;B3GALT2;ENO2;PPP2CA;CHORDC1;NUP50;PGK1;GOT2;PGAM2;SEC13;NUP62;NUP37;GUSB;PPP2R5D;PHKG1;G6PC3;PGP;PRKACB;PFKFB3;NUP205;PFKL;HS3ST5;NUP35;CHSY3;CHST1;SLC35B3;ENO1;AKR1A1;HYAL2;NUP107;GPC1;UBC;B3GALT4;DSEL;LUM;OGN
gsea,RND3 GTPase Cycle R-HSA-9696264,0.345583177871916,1.2366110803849197,0.15808823529411764,0.39594445493109104,1.0,6/34,3.81%,PLEKHG5;DST;ROCK1;DLG5;PKP4;CCDC88A
gsea,Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,-0.32820468609806874,-1.2365118864763482,0.1534090909090909,0.2288076148103455,1.0,6/46,5.44%,HSPA8;HSP90AA1;CEBPD;NDN;IL18;FGF13
gsea,Signaling By Rho GTPases R-HSA-194315,0.23238234829427593,1.235560767315723,0.05625,0.39365810264611567,1.0,122/484,15.94%,PLEKHG5;DOCK9;KALRN;IQGAP2;TRIO;CYFIP1;DST;ARHGEF28;TAOK1;SHKBP1;FMNL2;DOCK3;DOCK11;DOCK10;RANBP2;WDR11;MAPK14;ARHGAP15;MYO9B;DLC1;FGD4;ABR;TJP2;MYO9A;ROCK1;SRGAP2;SH3PXD2A;DOCK7;FNBP1;DLG5;DOCK4;ITSN1;FMNL1;STK10;PKP4;RALGAPA1;CCDC88A;CLASP1;SCAI;OCRL;PIK3R3;CKAP5;MRTFA;PREX2;ABL2;TIAM1;MAD1L1;LCK;NCK2;CLIP1;RASGRF2;LIMK2;PPP1R12B;CDC42BPA;GMIP;PTK2;SPTAN1;CPSF7;LBR;FLNA;NCOA2;MTMR1;CPNE8;ARAP2;PRPF38B;FAM135A;ARHGAP18;SH3BP1;FGD1;SLC4A7;ARHGEF18;FAM169A;ITSN2;DHDDS;DYNC1I1;KANSL1;FARP2;MYH9;NUP160;ARHGEF17;SOS1;COPS4;MAPRE1;FARP1;NUP98;NCKIPSD;ANKRD26;LIMK1;PRAG1;STEAP3;DYNC1LI1;CLASP2;DAAM1;ARHGEF7;DYNC1I2;SENP1;SPATA13;NUP133;PARD6B;RNF20;VANGL1;H2AC4;TRA2B;PREX1;WDR81;ARHGEF2;SCFD1;WIPF2;ARHGEF4;ARHGEF3;SRGAP1;DVL3;ARFGAP3;FRS2;RND1;LEMD3;ARHGAP32;OBSCN;HGS;SRRM1;GIT2;KIF5A
gsea,Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,-0.41900755867382844,-1.2353291133148654,0.2147239263803681,0.22968830070815127,1.0,3/15,15.52%,PPP2R1A;PPP2CA;LCMT1
gsea,"Signaling By Rho GTPases, Miro GTPases And RHOBTB3 R-HSA-9716542",0.23161057913038957,1.2351168815865528,0.04149377593360996,0.39007602026184085,1.0,124/498,15.94%,PLEKHG5;DOCK9;KALRN;IQGAP2;TRIO;CYFIP1;DST;ARHGEF28;TAOK1;SHKBP1;FMNL2;DOCK3;DOCK11;DOCK10;RANBP2;WDR11;MAPK14;ARHGAP15;MYO9B;DLC1;FGD4;ABR;TJP2;MYO9A;ROCK1;SRGAP2;SH3PXD2A;DOCK7;FNBP1;DLG5;DOCK4;ITSN1;FMNL1;STK10;PKP4;RALGAPA1;CCDC88A;CLASP1;SCAI;OCRL;PIK3R3;CKAP5;MRTFA;PREX2;ABL2;TIAM1;MAD1L1;LCK;NCK2;CLIP1;RASGRF2;LIMK2;PPP1R12B;CDC42BPA;GMIP;PTK2;SPTAN1;RAP1GDS1;CPSF7;LBR;FLNA;NCOA2;MTMR1;CPNE8;ARAP2;PRPF38B;FAM135A;ARHGAP18;SH3BP1;FGD1;SLC4A7;ARHGEF18;FAM169A;ITSN2;DHDDS;DYNC1I1;KANSL1;TRAK2;FARP2;MYH9;NUP160;ARHGEF17;SOS1;COPS4;MAPRE1;FARP1;NUP98;NCKIPSD;ANKRD26;LIMK1;PRAG1;STEAP3;DYNC1LI1;CLASP2;DAAM1;ARHGEF7;DYNC1I2;SENP1;SPATA13;NUP133;PARD6B;RNF20;VANGL1;H2AC4;TRA2B;PREX1;WDR81;ARHGEF2;SCFD1;WIPF2;ARHGEF4;ARHGEF3;SRGAP1;DVL3;ARFGAP3;FRS2;RND1;LEMD3;ARHGAP32;OBSCN;HGS;SRRM1;GIT2;KIF5A
gsea,Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,-0.29358550024433744,-1.2330989704417454,0.12915851272015655,0.2318035048261509,1.0,29/75,29.12%,UBB;RPS27A;VAMP2;CLTA;NECAP1;UBA52;AP2M1;NEDD8;COPS6;UBQLN2;GPS1;COPS8;EPN1;AP2S1;AP2B1;VAMP3;UBC;STAM2;SH3GL2;M6PR;CLTB;AP2A2;LDLR;STAM;UBQLN1;TOR1A;COPS7A;EPS15;ARRB1
gsea,Metabolism Of Non-Coding RNA R-HSA-194441,-0.31706846592966764,-1.2317545025634653,0.15768463073852296,0.23294010656034858,1.0,22/47,27.38%,SNRPD2;SNRPG;SNRPF;NUP50;DDX20;SEC13;NUP62;NUP37;SNRPE;NUP205;NUP35;NCBP2;SNRPB;GEMIN6;NUP107;GEMIN7;CLNS1A;SEH1L;NUP85;LIN9;TPR;PRMT5
gsea,GABA Receptor Activation R-HSA-977443,-0.32286800095263807,-1.2309608964601495,0.1643835616438356,0.2334328318688528,1.0,12/42,15.66%,KCNJ3;GNB2;GABRG2;GNG2;KCNJ2;KCNJ4;GNAI1;GNG13;GNAI2;GNG10;GNG3;GNG7
gsea,G Alpha (Z) Signaling Events R-HSA-418597,-0.34976246904548836,-1.2302549963356006,0.1592741935483871,0.23376888035726295,1.0,11/32,15.66%,GNAS;GNB2;GNG2;RGS4;GNAI1;GNG13;GNAI2;GNG10;ADRA2C;GNG3;GNG7
gsea,RHOU GTPase Cycle R-HSA-9013420,0.3464361192423954,1.2275498567221568,0.18700787401574803,0.4004008256109902,1.0,13/36,19.68%,DST;SRGAP2;DLG5;NCK2;SPTAN1;ITSN2;ARHGEF7;VANGL1;HGS;GIT2;SPTBN1;IQGAP1;WDR6
gsea,Reproduction R-HSA-1474165,-0.3110112587152472,-1.2258009565784282,0.14361702127659576,0.23837597828300056,1.0,29/59,35.37%,H2AZ1;HSPA2;H2BC4;SMC1A;H2AJ;CDK4;RAD21;TERF1;RPA3;RAD50;H2AX;RAD51;SYCP3;ADAM21;SUN2;OVGP1;MLH1;SUN1;LMNA;SYNE2;TINF2;PSMC3IP;MLH3;SMC3;H2BC21;CD9;H2AZ2;SYCP2;SYCE2
gsea,Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,-0.39494142012296096,-1.2240790293756045,0.195357833655706,0.23989057205004563,1.0,12/21,34.20%,POLR2G;POLR2F;POLR2I;POLR2E;POLR2C;NCBP2;POLR2L;POLR2J;POLR2B;POLR2K;POLR2D;POLR2A
gsea,Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,0.3546874757256184,1.223627741312541,0.18237704918032788,0.40329456500750116,1.0,8/28,17.90%,GPC5;ST3GAL3;HEXA;HEXB;GPC3;EXT1;NCAN;DCN
gsea,Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,0.3868630585270934,1.2211175929900107,0.23952095808383234,0.40374112606074053,1.0,7/20,7.87%,GRIN2A;LRRC7;ACTN2;PPM1E;CAMK2A;CAMK2G;MPP3
gsea,mRNA Capping R-HSA-72086,-0.35521036816172036,-1.2210223060597514,0.1952662721893491,0.2431024755411345,1.0,17/28,34.41%,POLR2G;POLR2F;POLR2I;POLR2E;POLR2C;NCBP2;POLR2L;GTF2H5;ERCC3;POLR2J;GTF2H4;POLR2B;GTF2H3;POLR2K;POLR2D;POLR2A;RNMT
gsea,Integration Of Energy Metabolism R-HSA-163685,-0.2864426521387179,-1.220417920469536,0.15547024952015356,0.24332432270584942,1.0,22/80,15.66%,GNAS;VAMP2;ACSL3;GNB2;GNG2;SYT5;MARCKS;PPP2R1A;PPP2CA;GNAI1;GNG13;SNAP25;GNA11;GNAI2;GNG10;ACLY;ADRA2C;PRKAR1B;PPP2R5D;GNG3;PRKACB;GNG7
gsea,Defective Pyroptosis R-HSA-9710421,-0.39660269402411996,-1.218186105216434,0.20463320463320464,0.2453793777955693,1.0,6/20,17.09%,H2AZ1;H2BC4;H2AJ;RBBP7;GSDME;H2AX
gsea,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,0.34702945800616203,1.2150141588178691,0.19875776397515527,0.41159907031068604,1.0,12/36,15.91%,TNRC6C;MOV10;KMT2A;HDAC1;KMT2B;KMT2C;TNRC6B;AGO1;DPY30;H2AC4;AGO4;KMT2E
gsea,DNA Double-Strand Break Repair R-HSA-5693532,-0.27614963815523985,-1.2143860664755382,0.12695652173913044,0.24941372302592774,1.0,27/107,22.63%,UBB;RPS27A;UBA52;SUMO2;SEM1;H2BC4;EYA1;UBE2N;UBXN1;PPP4C;PCNA;PARP1;RFC3;RNF168;RPA3;SIRT6;POLD4;XRCC2;RAD50;H2AX;RAD51;UBC;BABAM2;UIMC1;POLL;POLD2;SUMO1
gsea,Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,-0.3238641466390462,-1.211776080171587,0.18329938900203666,0.25220194041364646,1.0,14/41,24.25%,RAB6B;NAPG;STX16;RAB6A;NAA38;SCOC;NSF;ARFRP1;VAMP3;TMF1;VPS52;STX6;M6PR;SYS1
gsea,TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,-0.3097989096018394,-1.2115120096392042,0.1695906432748538,0.2520523971311828,1.0,16/51,21.65%,JUN;ELOB;POLR2G;POLR2F;POLR2I;TCEA1;POLR2E;POLR2C;DDB2;POLR2L;ELOC;GTF2H5;SSRP1;ERCC3;POLR2J;GTF2H4
gsea,FGFR2 Alternative Splicing R-HSA-6803529,-0.36666594064030705,-1.2112513244029528,0.19675456389452334,0.25190873390103835,1.0,10/24,21.26%,POLR2G;POLR2F;POLR2I;HNRNPA1;POLR2E;POLR2C;HNRNPF;NCBP2;POLR2L;POLR2J
gsea,Signaling By NTRK3 (TRKC) R-HSA-9034015,0.41305998325801996,1.2085789694356144,0.2222222222222222,0.4199024664676262,1.0,3/16,4.00%,PTPRS;NTRK3;NTF3
gsea,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,-0.41342601966637027,-1.2083623448464917,0.22718446601941747,0.2549312349864244,1.0,9/15,36.09%,H2AZ1;H2BC4;H2AJ;H2AX;TAF1C;H2BC21;SUV39H1;H2AZ2;TBP
gsea,Transcriptional Regulation By MECP2 R-HSA-8986944,0.3109295222812329,1.2069185181572857,0.16632443531827515,0.41898672517518637,1.0,14/55,14.51%,RBFOX1;TNRC6C;GRIN2A;MOV10;CAMK2A;CAMK2G;HDAC1;LBR;TNRC6B;AGO1;CAMK2D;DGCR8;GRIN2B;AGO4
gsea,Cleavage Of Damaged Pyrimidine R-HSA-110329,-0.41001596347598557,-1.2055928163697964,0.20428015564202334,0.2578684133024689,1.0,6/18,21.51%,H2AZ1;H2BC4;H2AJ;TERF1;H2AX;TDG
gsea,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,-0.31332191012966637,-1.2040540020786428,0.19615384615384615,0.25934031837437155,1.0,13/49,18.00%,H2AZ1;DEK;POLR2F;H2BC4;CBX3;CHD3;H2AJ;RBBP7;POLR2E;POLR1G;GSK3B;H2AX;POLR2L
gsea,Organelle Biogenesis And Maintenance R-HSA-1852241,-0.2416339934170141,-1.2035137267354503,0.1038961038961039,0.25954587939279594,1.0,55/237,23.19%,CALM1;TUBA4A;DYNLL1;TUBA1A;DYNLL2;YWHAG;HSP90AA1;ATP5PB;YWHAE;MEF2C;CETN2;ARF4;CCT2;PPP2R1A;CSNK1E;TUBB4A;TUBB4B;CYCS;BBIP1;PAFAH1B1;DYNLRB1;DCTN3;TBL1XR1;BBS2;IMMT;RAB11A;CCT5;TMEM11;TMEM216;IFT20;SAMM50;TFAM;SSNA1;IDH2;CCT8;ESRRA;NUDT19;TBL1X;HAUS2;CEP78;DCTN1;TRAF3IP1;TCTN1;B9D2;TFB2M;TTBK2;CCT3;MICOS10;MTX2;HSPA9;BBS10;SIRT5;IFT52;B9D1;IFT46
gsea,Rab Regulation Of Trafficking R-HSA-9007101,-0.2760079329012965,-1.202632045903445,0.14311926605504588,0.26013766719282144,1.0,27/101,22.10%,RAB3A;TRAPPC6B;YWHAE;GABARAPL2;RAB32;RAB6B;RAB1B;RAB6A;MAP1LC3B;RAB14;GABARAP;TRAPPC2L;TRAPPC2;RAB11A;RAB18;TRAPPC1;RAB31;SBF1;TBC1D10B;TBC1D7;TRAPPC6A;RAB5A;TRAPPC4;DENND5B;TBC1D20;TRAPPC10;RAB39B
gsea,Interferon Signaling R-HSA-913531,-0.2701284707805417,-1.2021580529148446,0.14147286821705427,0.26025114719168874,1.0,37/101,27.04%,UBB;RPS27A;EIF4A1;UBA52;EIF4A2;TRIM35;EGR1;PML;IFNGR2;UBE2N;NUP50;CAMK2B;SEC13;SAMHD1;MAPK3;NUP62;NUP37;PTPN1;EIF4G2;NUP205;NUP35;TRIM45;NUP107;UBC;JAK1;KPNA3;SEH1L;NCAM1;SUMO1;SMAD7;IFI27;NUP85;KPNA2;EIF4A3;PDZD2;B2M;TPR
gsea,Lysosome Vesicle Biogenesis R-HSA-432720,-0.34934821893441115,-1.202050861695753,0.21124031007751937,0.25989148226254827,1.0,3/30,1.63%,HSPA8;VAMP2;CLTA
gsea,Ca2+ Pathway R-HSA-4086398,-0.3290300400914105,-1.1989605749507157,0.19047619047619047,0.26331632192362725,1.0,7/39,8.40%,CALM1;PPP3CA;GNB2;GNG2;PPP3R1;PPP3CB;GNG13
gsea,Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,-0.36135992731719035,-1.1981845668514528,0.24308300395256918,0.2637920893199762,1.0,7/25,19.49%,TTR;APOE;C1D;RBP4;VKORC1;GPC1;LRP10
gsea,RHOV GTPase Cycle R-HSA-9013424,0.3464150541992497,1.1979763571368343,0.218568665377176,0.43272593561287087,1.0,12/32,19.68%,DST;MYO9A;DLG5;NCK2;SPTAN1;ARHGEF7;PARD6B;VANGL1;GIT2;SPTBN1;IQGAP1;WDR6
gsea,Peptide Hormone Metabolism R-HSA-2980736,-0.3132843934655002,-1.1954569899246803,0.1976284584980237,0.26663066221020026,1.0,10/45,15.49%,VAMP2;SPCS2;CPE;GNG13;ATP6AP2;INHBA;CHGA;SPCS1;PLA2G7;SLC30A6
gsea,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,-0.3301042291197414,-1.1934194073651252,0.1793372319688109,0.26868041430236866,1.0,6/38,7.96%,EPHA5;EPHA7;CLTA;AP2M1;PSENEN;APH1A
gsea,RORA Activates Gene Expression R-HSA-1368082,0.4022375850496711,1.1908336895554024,0.238,0.4428061792261248,1.0,4/15,8.46%,RORA;NCOA2;NCOA1;NCOA6
gsea,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,0.3054752594012697,1.1897591476398095,0.18661257606490872,0.44075412563314176,1.0,14/46,14.04%,CNTN5;NTM;CNTN4;GPLD1;NTNG2;NEGR1;MDGA1;MDGA2;RTN4RL1;PIGT;PIGO;PIGS;RECK;PIGQ
gsea,TRAF6 Mediated NF-kB Activation R-HSA-933542,-0.4010924273350007,-1.1895150076113772,0.2188679245283019,0.27310543518773744,1.0,4/16,16.20%,HMGB1;NFKB2;NFKBIB;NKIRAS1
gsea,Meiotic Synapsis R-HSA-1221632,-0.3399753045630949,-1.1893071550556378,0.21428571428571427,0.2729074981707784,1.0,19/31,35.37%,H2AZ1;HSPA2;H2BC4;SMC1A;H2AJ;RAD21;TERF1;H2AX;SYCP3;SUN2;SUN1;LMNA;SYNE2;TINF2;SMC3;H2BC21;H2AZ2;SYCP2;SYCE2
gsea,Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,-0.4077567810124145,-1.1879703398500472,0.22095238095238096,0.27424169823213596,1.0,13/16,40.92%,YWHAB;EXOSC4;EXOSC3;EXOSC9;EXOSC7;XRN1;EXOSC2;AKT1;DCP1A;DCP2;ZFP36L1;EXOSC5;EXOSC1
gsea,Metabolism Of Porphyrins R-HSA-189445,-0.3920247109487517,-1.1874844241343365,0.22264875239923224,0.2743888661540756,1.0,4/18,17.36%,HMOX2;ALAD;GUSB;FECH
gsea,Cilium Assembly R-HSA-5617833,-0.2501153229463636,-1.186935425782033,0.14149139579349904,0.27456152400395323,1.0,34/170,19.82%,TUBA4A;DYNLL1;TUBA1A;DYNLL2;YWHAG;HSP90AA1;YWHAE;CETN2;ARF4;CCT2;PPP2R1A;CSNK1E;TUBB4A;TUBB4B;BBIP1;PAFAH1B1;DYNLRB1;DCTN3;BBS2;RAB11A;CCT5;TMEM216;IFT20;SSNA1;CCT8;NUDT19;HAUS2;CEP78;DCTN1;TRAF3IP1;TCTN1;B9D2;TTBK2;CCT3
gsea,RET Signaling R-HSA-8853659,0.34711397607166095,1.1856110509263194,0.24031007751937986,0.4448336326881652,1.0,12/30,20.56%,GAB2;DOK5;PIK3R3;SHANK3;DOK6;SOS1;FRS2;MAPK7;PIK3CA;GFRA2;SHC3;PLCG1
gsea,Beta-catenin Phosphorylation Cascade R-HSA-196299,-0.3985198852751083,-1.1784094523017878,0.2504970178926441,0.28489727208168547,1.0,4/16,14.20%,PPP2R1A;PPP2CA;PPP2R5D;GSK3B
gsea,DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,-0.3492203604395054,-1.1760578523915515,0.2411764705882353,0.28759812117890166,1.0,13/26,33.87%,H2AZ1;H2BC4;H2AJ;TERF1;RAD50;CDKN1B;H2AX;ASF1A;HMGA1;TINF2;H2BC21;KAT5;H2AZ2
gsea,Regulation Of PTEN Gene Transcription R-HSA-8943724,-0.29790156149751346,-1.175359416725828,0.22851153039832284,0.2879799363422982,1.0,18/52,23.71%,JUN;LAMTOR2;RHEB;RRAGA;LAMTOR3;EGR1;CHD3;RBBP7;RRAGD;MAPK3;CBX6;RING1;MAPK1;CBX4;RRAGC;MAF1;LAMTOR1;LAMTOR5
gsea,TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,-0.3674221503188905,-1.1751990834395858,0.25287356321839083,0.28770976355386,1.0,5/23,12.75%,BNIP3L;BAX;TRIAP1;PRELID3A;PRELID1
gsea,NOD1/2 Signaling Pathway R-HSA-168638,0.3648751730187715,1.1731785204277283,0.23353293413173654,0.4662631685177078,1.0,4/22,9.95%,CHUK;MAPK14;IKBKB;MAP3K7
gsea,Retinoid Metabolism And Transport R-HSA-975634,-0.3662587832332001,-1.1709715858726333,0.25748502994011974,0.2929385772538481,1.0,6/22,19.49%,TTR;APOE;C1D;RBP4;GPC1;LRP10
gsea,Potassium Channels R-HSA-1296071,-0.2780617672345643,-1.169535851593247,0.20436507936507936,0.2942459328539354,1.0,14/72,11.73%,KCNJ3;KCNA1;GNB2;GNG2;KCNK2;KCND2;KCNK1;KCNJ2;KCNA2;KCNJ4;GNG13;KCNN1;KCNA4;GNG10
gsea,Signaling By VEGF R-HSA-194138,-0.2747999613320836,-1.1694249678152755,0.1669902912621359,0.29385340700465695,1.0,10/74,9.22%,CALM1;HSP90AA1;CDC42;BRK1;VEGFC;AXL;ABI1;NCK1;HRAS;VEGFB
gsea,Signaling By NOTCH1 R-HSA-1980143,-0.281717646109323,-1.1665573669030298,0.2058287795992714,0.2973088541596687,1.0,18/68,22.65%,UBB;RPS27A;UBA52;SNW1;TLE4;PSENEN;RBX1;APH1A;TBL1XR1;JAG1;TBL1X;HEY1;UBC;MAMLD1;TLE1;FBXW7;SKP1;MIB2
gsea,G-protein Mediated Events R-HSA-112040,0.317330247822606,1.165508463258165,0.24346076458752516,0.4781209093561268,1.0,8/41,5.22%,NBEA;PDE1A;ADCY8;ADCY2;CAMK2A;PRKCG;CAMK2G;ADCY9
gsea,VEGFA-VEGFR2 Pathway R-HSA-4420097,-0.2781191848864882,-1.1649824754193092,0.18497109826589594,0.2989502503888982,1.0,8/69,7.58%,CALM1;HSP90AA1;CDC42;BRK1;AXL;ABI1;NCK1;HRAS
gsea,RAC3 GTPase Cycle R-HSA-9013423,0.2743281577397142,1.1633264223575974,0.19560878243512975,0.4781503977952443,1.0,17/71,16.12%,TRIO;CYFIP1;DOCK10;ARHGAP15;ABR;SRGAP2;OCRL;ABL2;TIAM1;LBR;ARAP2;VANGL1;PREX1;LEMD3;ARHGAP32;GIT2;ARHGAP42
gsea,FLT3 Signaling In Disease R-HSA-9682385,-0.36196290670430625,-1.1615000700876283,0.26011560693641617,0.30339222190015924,1.0,4/23,7.58%,UBB;RPS27A;UBA52;HRAS
gsea,mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,-0.39568632631026646,-1.158478203275321,0.2573099415204678,0.30695930177933806,1.0,7/15,26.73%,LSM2;LSM7;LSM4;LSM1;LSM3;LSM5;XRN1
gsea,Gene Silencing By RNA R-HSA-211000,-0.2768572553045442,-1.1567927194855276,0.21083172147001933,0.308639671142759,1.0,21/71,18.71%,HSP90AA1;RAN;H2AZ1;POLR2G;POLR2F;H2BC4;POLR2I;H2AJ;NUP50;POLR2E;POLR2C;SEC13;NUP62;NUP37;MOV10L1;NUP205;NUP35;H2AX;POLR2L;IPO8;NUP107
gsea,MicroRNA (miRNA) Biogenesis R-HSA-203927,-0.35471819052788045,-1.1561957641258174,0.2529182879377432,0.30900230705264464,1.0,6/24,9.79%,RAN;POLR2G;POLR2F;POLR2I;POLR2E;POLR2C
gsea,Sulfur Amino Acid Metabolism R-HSA-1614635,-0.40882892758809036,-1.1550262978281465,0.27703984819734345,0.31009986296211006,1.0,7/15,33.09%,GOT2;ETHE1;ADO;MTAP;TXN2;MTRR;APIP
gsea,Signaling By FGFR In Disease R-HSA-1226099,-0.29565983415773806,-1.1535745423884636,0.24509803921568626,0.3115662373316176,1.0,16/46,21.26%,FGFR2;POLR2G;POLR2F;FGF13;POLR2I;HRAS;POLR2E;POLR2C;FGFR1;TRIM24;BAG4;NCBP2;POLR2L;NRAS;FGF5;POLR2J
gsea,Formation Of Early Elongation Complex R-HSA-113418,-0.33034796244113196,-1.1535624331116003,0.24031007751937986,0.31105689435381234,1.0,11/31,21.65%,POLR2G;POLR2F;POLR2I;POLR2E;POLR2C;NCBP2;POLR2L;GTF2H5;ERCC3;POLR2J;GTF2H4
gsea,GAG Synthesis Requires Tetrasaccharide Linker Sequence R-HSA-1971475,0.3697907567322568,1.1505166234178092,0.28210526315789475,0.5019788751173271,1.0,6/21,17.90%,GPC5;GPC3;XYLT2;XYLT1;NCAN;DCN
gsea,"Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",-0.3496483754592966,-1.144692278489687,0.2709551656920078,0.32277079978527473,1.0,9/22,15.66%,GNB2;GNG2;GNAI1;GNG13;GNAI2;GNG10;ADRA2C;GNG3;GNG7
gsea,RNA Polymerase III Chain Elongation R-HSA-73780,-0.3884362105535097,-1.144172101988741,0.2746615087040619,0.3229553998002869,1.0,8/17,30.73%,POLR2F;POLR2E;POLR3D;POLR3H;POLR2L;POLR3A;POLR3E;POLR2K
gsea,"Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",-0.39227064076677914,-1.1430717697795292,0.30177514792899407,0.323975082346535,1.0,7/15,27.16%,YWHAB;EXOSC4;EXOSC3;EXOSC9;EXOSC7;XRN1;EXOSC2
gsea,FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,-0.39982914163598177,-1.13894342682387,0.29558541266794625,0.3295046347653737,1.0,3/15,6.47%,CITED2;PINK1;NFYB
gsea,Metabolism Of Nucleotides R-HSA-15869,-0.27223817386935184,-1.1378767442573878,0.2363013698630137,0.33043471607183234,1.0,22/71,22.96%,NME2;DTYMK;PAICS;APRT;ATIC;SCO2;ITPA;UCKL1;NME4;TK2;SAMHD1;IMPDH2;GMPS;NUDT5;NUDT1;RRM2B;TXNRD1;DUT;NUDT18;GSR;DCTPP1;ADK
gsea,SUMOylation Of Intracellular Receptors R-HSA-4090294,0.36542951604062357,1.1363935625770571,0.3012295081967213,0.5289546116595326,1.0,8/19,19.36%,RORA;NR3C2;PIAS2;THRB;PIAS1;HDAC4;PGR;PPARG
gsea,RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,-0.27435499978406075,-1.12869393579674,0.2618110236220472,0.34311070861979537,1.0,14/73,13.44%,RAB3A;TRAPPC6B;YWHAE;RAB32;RAB6B;RAB1B;RAB6A;RAB14;TRAPPC2L;TRAPPC2;RAB18;TRAPPC1;RAB31;SBF1
gsea,Transport Of Mature Transcript To Cytoplasm R-HSA-72202,-0.26106625104687786,-1.1276112523090673,0.2396694214876033,0.3441175729074857,1.0,24/77,22.12%,CPSF2;MAGOH;RBM8A;NUP50;SLBP;U2AF1;SRSF3;SEC13;CDC40;CHTOP;NUP62;NUP37;U2AF1L4;U2AF2;NUP205;DDX39B;NUP35;NCBP2;MAGOHB;POLDIP3;NUP107;SLU7;THOC7;SEH1L
gsea,Integrin Cell Surface Interactions R-HSA-216083,-0.3317625659473645,-1.1273205693618107,0.2801418439716312,0.34400526175836144,1.0,9/31,20.34%,ICAM5;BSG;CD47;VTN;ITGAV;ITGA9;CXXC1;JAM2;LUM
gsea,Role Of Phospholipids In Phagocytosis R-HSA-2029485,0.3743290880988262,1.126688699033535,0.30327868852459017,0.5472022795392445,1.0,3/17,5.73%,PRKCE;PLPP4;PLCG2
gsea,Sensory Perception R-HSA-9709957,-0.25559239707803766,-1.1266055204477081,0.24615384615384617,0.34460108663801664,1.0,24/108,19.49%,CALM1;TTR;RAB3A;APOE;VAMP2;CAPZA2;SYP;C1D;KCNJ2;GNG13;SNAP25;ATP2B1;SCN1B;METAP2;RNF7;TWF1;RBP4;EZR;RDX;OR4A47;REEP1;GPC1;SCN2B;LRP10
gsea,Signaling By WNT In Cancer R-HSA-4791275,-0.3495764630087615,-1.12599669797933,0.3048780487804878,0.34488891470588007,1.0,8/22,29.90%,PPP2R1A;PPP2CA;PPP2R5D;GSK3B;KREMEN1;CSNK1A1;PPP2R5B;FZD8
gsea,Processing Of Intronless Pre-mRNAs R-HSA-77595,0.36489195581500244,1.1242832693157983,0.321011673151751,0.5476611922291705,1.0,8/19,20.16%,PABPN1;CPSF7;NCBP1;PAPOLA;CSTF2;SYMPK;FIP1L1;CSTF3
gsea,Oxidative Stress Induced Senescence R-HSA-2559580,-0.278879585548537,-1.1241037507424534,0.29218106995884774,0.3470933517646438,1.0,18/61,21.23%,UBB;RPS27A;JUN;H2AZ1;UBA52;H2BC4;H2AJ;CDK4;RBBP7;MAPK3;CBX6;RING1;MAPK1;H2AX;MAPKAPK5;UBC;CDKN2D;CBX4
gsea,"Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",-0.33100172998723,-1.1228998085387691,0.28378378378378377,0.34826636108371867,1.0,4/29,11.01%,EEF2;DOHH;ARSA;ARSJ
gsea,Non-integrin membrane-ECM Interactions R-HSA-3000171,-0.3364386005936467,-1.1227557170559959,0.27566539923954375,0.3479525596635101,1.0,5/25,11.95%,TTR;FGF13;PDGFA;VTN;ITGAV
gsea,Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,-0.26743736121965533,-1.1196263728181042,0.2513863216266174,0.3517056228608037,1.0,20/66,27.39%,UBB;RPS27A;UBA52;CSNK2B;CDK5R1;TAF11;TAF10;RFC3;RPA3;RAD50;MAPKAPK5;HIPK1;UBC;TAF5;SSRP1;TAF7L;TAF12;TAF7;PDZD2;RAD9B
gsea,Semaphorin Interactions R-HSA-373755,-0.2941189694747925,-1.1192261078199106,0.3037475345167653,0.3516734429606143,1.0,12/54,16.34%,HSP90AB1;HSP90AA1;MYL6;SEMA5A;MYL12B;DPYSL2;CDK5R1;TLN1;GSK3B;SEMA7A;MYL9;MYH14
gsea,Fatty acyl-CoA Biosynthesis R-HSA-75105,-0.32967076838348297,-1.1183899093907261,0.2896281800391389,0.35233361963189785,1.0,5/29,12.07%,TECR;ACSL3;HSD17B8;ACLY;HACD4
gsea,PRC2 Methylates Histones And DNA R-HSA-212300,-0.35979550164551216,-1.116380456925799,0.2857142857142857,0.3546616324084207,1.0,4/19,9.40%,H2AZ1;H2BC4;H2AJ;RBBP7
gsea,Viral Messenger RNA Synthesis R-HSA-168325,-0.29002485787766646,-1.1146292800127315,0.2788844621513944,0.35674140063488535,1.0,18/43,27.04%,POLR2G;POLR2F;POLR2I;NUP50;POLR2E;POLR2C;SEC13;NUP62;NUP37;NUP205;NUP35;POLR2L;NUP107;POLR2J;SEH1L;NUP85;POLR2B;TPR
gsea,Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,-0.3636950480627864,-1.1139070554061434,0.3301158301158301,0.3572822142553803,1.0,2/19,0.66%,CALM1;NEFL
gsea,Platelet Calcium Homeostasis R-HSA-418360,-0.3728553929142243,-1.112365357030771,0.2826510721247563,0.3590817173769377,1.0,5/16,15.24%,CALM1;ORAI2;ATP2B1;SRI;SLC8A2
gsea,Lagging Strand Synthesis R-HSA-69186,-0.373114980280259,-1.110216865005219,0.3155080213903743,0.36161330492509414,1.0,8/19,34.71%,PCNA;RFC3;RPA3;POLD4;POLD2;POLD3;PRIM1;LRIG1
gsea,E2F Mediated Regulation Of DNA Replication R-HSA-113510,-0.37117623992822607,-1.1099720610985022,0.3157894736842105,0.3614361116353251,1.0,2/17,6.26%,PPP2R1A;PPP2CA
gsea,Interleukin-2 Family Signaling R-HSA-451927,0.34660067356437974,1.1075648921549968,0.2909441233140655,0.58273540116816,1.0,7/21,17.78%,GAB2;PIK3R3;JAK2;LCK;SOS1;CSF2RA;PIK3CA
gsea,Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.28307786623558157,-1.10722310906522,0.29563492063492064,0.3648300495726903,1.0,17/49,29.74%,UBB;RPS27A;UBA52;CANX;DAD1;DDOST;GSK3B;STT3A;PARP16;UBC;SUMO1;CSNK1A1;PRMT1;ZDHHC8;ST6GAL1;MOGS;TUSC3
gsea,tRNA Processing R-HSA-72306,-0.2522431593551283,-1.1044570536688743,0.2749003984063745,0.3683491755417723,1.0,31/95,27.60%,RAN;TRMT112;POP5;NUP50;FAM98B;RPP21;LAGE3;SEC13;NUP62;TRMT12;NUP37;ZBTB8OS;RPP38;NUP205;NUP35;TSEN34;RTCB;NUP107;TRDMT1;DDX1;SEH1L;TSEN2;QTRT2;WDR4;URM1;NUP85;OSGEP;LCMT2;TPR;RTRAF;HSD17B10
gsea,RHO GTPases Activate Formins R-HSA-5663220,-0.2575249442787485,-1.1027325312054372,0.2730844793713163,0.3703226195255893,1.0,27/82,25.34%,DYNLL1;PFN2;DYNLL2;ACTG1;RPS27;CDC42;PPP2R1A;PAFAH1B1;PPP2CA;PFN1;SEC13;NUP37;ZWINT;PPP2R5D;PPP1CC;RHOB;NUP107;B9D2;CENPP;ITGB3BP;RCC2;SEH1L;BUB3;NUDC;NUP85;MIS12;EVL
gsea,Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,-0.3039065705562332,-1.0997324883652424,0.2813102119460501,0.3742990216361123,1.0,12/34,22.07%,CCT2;CCT6A;FBXW2;CCT5;CCT7;FBXO6;CCT8;AP3M1;CCT3;FBXW7;DCAF7;FBXL3
gsea,Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,0.30752855463579715,1.0971427879467466,0.30612244897959184,0.6035462688018277,1.0,10/30,16.32%,RANBP2;NEK7;NUP210;NUP188;NDC1;NUP160;NUP98;NUP133;POM121;AAAS
gsea,BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,-0.3416143384256677,-1.0943212477216882,0.30377358490566037,0.38212960082179953,1.0,7/22,22.09%,CCT2;BBIP1;BBS2;CCT5;CCT8;CCT3;BBS10
gsea,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,-0.28880523512074413,-1.0931882302024656,0.304,0.38338522782766293,1.0,14/45,27.07%,CALM1;MEF2C;CYCS;TBL1XR1;TFAM;IDH2;ESRRA;TBL1X;TFB2M;SIRT5;HCFC1;LIN9;CREB1;CRTC2
gsea,Defective B3GAT3 Causes JDSSDHD R-HSA-3560801,0.3779582663927908,1.09198431586091,0.3389473684210526,0.6111720650734064,1.0,4/15,17.90%,GPC5;GPC3;NCAN;DCN
gsea,Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,0.29193750121662027,1.0898498177062332,0.31610337972166996,0.6108419750414315,1.0,11/40,19.05%,CHST11;GPC5;HEXA;HEXB;GPC3;XYLT2;XYLT1;UST;NCAN;DCN;CHST9
gsea,Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.2687731249649336,-1.0882662772014713,0.29239766081871343,0.3904283265887625,1.0,21/60,25.06%,DYNLL1;DYNLL2;RPS27;PPP2R1A;PAFAH1B1;PPP2CA;SEC13;NUP37;ZWINT;PPP2R5D;PPP1CC;NUP107;B9D2;CENPP;ITGB3BP;RCC2;SEH1L;BUB3;NUDC;NUP85;MIS12
gsea,Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,-0.32480373270212004,-1.088135603246921,0.33398821218074654,0.390002525372746,1.0,10/26,24.94%,RAN;SEC13;NUP62;NUP37;NUP205;NUP35;NUP107;SEH1L;SUMO1;NUP85
gsea,Recycling Pathway Of L1 R-HSA-437239,0.3276808823611804,1.0871324524857782,0.34291581108829566,0.6123269947192895,1.0,8/24,12.91%,RPS6KA2;SHTN1;DNM3;DNM1;DNM2;L1CAM;RPS6KA6;RPS6KA1
gsea,"Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",-0.30335126593108974,-1.0860135477310389,0.36278195488721804,0.39278075054524175,1.0,4/35,11.29%,HSP90AB1;NFKB2;UBE2N;UBE2V1
gsea,Signaling By NTRKs R-HSA-166520,-0.24651567973772953,-1.08492356557306,0.298,0.39388651056780494,1.0,30/110,20.10%,CLTA;YWHAB;CDK5R2;MEF2C;AP2M1;DUSP3;JUND;DUSP7;BAX;PPP2R1A;EGR1;IRS2;PPP2CA;HRAS;DNAL4;CDK5R1;RALA;MAPK3;PPP2R5D;VGF;AP2S1;EGR3;MAPK1;EGR4;ASCL1;VRK3;AP2B1;NRAS;ID4;PIK3R2
gsea,Resolution Of Sister Chromatid Cohesion R-HSA-2500257,-0.2603332870213538,-1.0805834263911864,0.31274900398406374,0.40007940375521284,1.0,23/70,25.06%,DYNLL1;DYNLL2;RPS27;PPP2R1A;SMC1A;PAFAH1B1;PPP2CA;RAD21;SEC13;NUP37;ZWINT;PPP2R5D;PPP1CC;NUP107;B9D2;CENPP;ITGB3BP;RCC2;SEH1L;BUB3;NUDC;NUP85;MIS12
gsea,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,0.3659721882938246,1.0728727182587705,0.36923076923076925,0.6435224165459473,1.0,2/16,1.68%,MAML2;NOTCH2
gsea,Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,-0.2527759721241788,-1.0704093351177197,0.3210633946830266,0.41578834569927386,1.0,22/68,22.12%,MAGOH;RBM8A;NUP50;U2AF1;SRSF3;SEC13;CDC40;CHTOP;NUP62;NUP37;U2AF1L4;U2AF2;NUP205;DDX39B;NUP35;NCBP2;MAGOHB;POLDIP3;NUP107;SLU7;THOC7;SEH1L
gsea,FLT3 Signaling R-HSA-9607240,-0.30377250816069334,-1.0703078208484116,0.3574074074074074,0.41529933100369976,1.0,3/32,2.81%,UBB;RPS27A;UBA52
gsea,Pre-NOTCH Transcription And Translation R-HSA-1912408,0.2993257789995658,1.06878140332143,0.33399602385685884,0.6481689505944411,1.0,9/34,14.51%,TNRC6C;MAML2;NOTCH2;MOV10;TNRC6B;AGO1;MAML3;H2AC4;AGO4
gsea,Mitochondrial Biogenesis R-HSA-1592230,-0.2575294795495241,-1.065311074515684,0.3359073359073359,0.4227001210267282,1.0,22/67,27.95%,CALM1;ATP5PB;MEF2C;CYCS;TBL1XR1;IMMT;TMEM11;SAMM50;TFAM;IDH2;ESRRA;TBL1X;TFB2M;MICOS10;MTX2;HSPA9;SIRT5;HCFC1;LIN9;CREB1;CRTC2;MTX1
gsea,Regulation Of MECP2 Expression And Activity R-HSA-9022692,0.31847305011527505,1.0649541518447947,0.3538767395626243,0.6525527731210372,1.0,10/29,14.51%,TNRC6C;MOV10;CAMK2A;CAMK2G;HDAC1;LBR;TNRC6B;AGO1;CAMK2D;AGO4
gsea,RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,-0.3229994674420256,-1.0645704923342445,0.3709677419354839,0.423271013845083,1.0,11/26,30.73%,POLR2F;SNAPC5;POLR2E;POLR3D;POLR3H;POLR2L;SNAPC1;POLR3A;SNAPC2;POLR3E;POLR2K
gsea,ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,-0.32748396775784033,-1.0632945551090534,0.3412698412698413,0.424655675573489,1.0,14/22,40.92%,NFYB;EXOSC4;CEBPB;EXOSC3;EXOSC9;EXOSC7;EXOSC2;DCP2;DDIT3;HERPUD1;CEBPG;EXOSC5;ATF4;EXOSC1
gsea,SHC1 Events In ERBB2 Signaling R-HSA-1250196,0.35769880173442054,1.0591548961235784,0.38247011952191234,0.6622770618136243,1.0,5/16,12.62%,PRKCE;NRG1;ERBB4;SOS1;NRG2
gsea,Signal Transduction By L1 R-HSA-445144,-0.370096969381435,-1.0573403401321184,0.3697813121272366,0.4340435145744694,1.0,8/15,23.88%,CSNK2B;FGFR1;ITGAV;ITGA9;MAPK3;MAPK1;NCAM1;MAP2K1
gsea,PERK Regulates Gene Expression R-HSA-381042,-0.31537740310637935,-1.0568267261499198,0.3453815261044177,0.4341932385255538,1.0,15/26,38.95%,NFYB;EIF2S2;EXOSC4;CEBPB;EXOSC3;EXOSC9;EXOSC7;EXOSC2;HSPA5;DCP2;DDIT3;HERPUD1;CEBPG;EXOSC5;ATF4
gsea,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,-0.3248359291228301,-1.0532360531621858,0.36617100371747213,0.4394826107201385,1.0,13/24,32.88%,NME2;DTYMK;NME4;RRM2B;TXNRD1;DUT;GSR;DCTPP1;RRM1;GUK1;CMPK1;TXN2;AK1
gsea,Signaling By KIT In Disease R-HSA-9669938,0.3390854873411976,1.0494768429709662,0.3691683569979716,0.6817911978604537,1.0,7/18,19.34%,PIK3R3;JAK2;LCK;SOS1;FYN;PIK3CA;KIT
gsea,Synthesis Of Bile Acids And Bile Salts R-HSA-192105,0.3328391746287421,1.048997390533914,0.3877551020408163,0.6772459173054722,1.0,7/19,23.06%,NCOA2;NCOA1;OSBPL2;OSBPL1A;OSBP;SLC27A2;OSBPL7
gsea,SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,0.2818459176282026,1.0469159150138023,0.36023622047244097,0.6771623367942604,1.0,11/35,16.32%,RANBP2;NUP210;NUP188;PIAS2;NDC1;PIAS1;NUP160;NUP98;NUP133;POM121;AAAS
gsea,Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,-0.32831636680850657,-1.0467541548498247,0.38823529411764707,0.44977160951628653,1.0,7/21,27.85%,PPP2R1A;PPP2CA;PPP2R5D;GSK3B;CSNK1A1;CSNK1G2;PPP2R5B
gsea,Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,-0.3068672775925819,-1.04491250991409,0.37924151696606784,0.45231166343044205,1.0,6/28,13.22%,LAMTOR2;RHEB;RRAGA;LAMTOR3;RRAGD;CAB39
gsea,RNA Polymerase I Promoter Clearance R-HSA-73854,-0.2697475953734721,-1.0436100756238809,0.3847695390781563,0.45317244597650574,1.0,16/54,23.28%,H2AZ1;POLR2F;H2BC4;CBX3;CHD3;H2AJ;RBBP7;POLR2E;POLR1G;MAPK3;H2AX;POLR2L;GTF2H5;ERCC3;GTF2H4;TAF1C
gsea,RNA Polymerase I Transcription R-HSA-73864,-0.2697475953734721,-1.0436100756238809,0.3847695390781563,0.45317244597650574,1.0,16/54,23.28%,H2AZ1;POLR2F;H2BC4;CBX3;CHD3;H2AJ;RBBP7;POLR2E;POLR1G;MAPK3;H2AX;POLR2L;GTF2H5;ERCC3;GTF2H4;TAF1C
gsea,Bile Acid And Bile Salt Metabolism R-HSA-194068,0.32571476567009455,1.043266217214795,0.39835728952772076,0.6813346979155503,1.0,7/20,23.06%,NCOA2;NCOA1;OSBPL2;OSBPL1A;OSBP;SLC27A2;OSBPL7
gsea,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,-0.24553017144499292,-1.0430468252769396,0.3856858846918489,0.4534904614830971,1.0,18/72,22.12%,HSP90AB1;HSP90AA1;CNBP;UBE2N;NUP50;G3BP2;MASP2;UBE2V1;SEC13;NUP62;NUP37;NUP205;NUP35;NUP107;TBK1;G3BP1;JAK1;SEH1L
gsea,Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,-0.3318242924783807,-1.0395027456090327,0.38011695906432746,0.45896044514633577,1.0,1/21,0.03%,CALM1
gsea,Cellular Senescence R-HSA-2559583,-0.2266906303094056,-1.0352912825383902,0.36904761904761907,0.465658659008474,1.0,26/110,19.98%,UBB;RPS27A;JUN;H2AZ1;UBA52;ETS2;IGFBP7;H2BC4;H2AJ;CDK4;RBBP7;TERF1;UBE2S;CEBPB;MAPK3;ANAPC11;CBX6;RING1;RAD50;MAPK1;CDKN1B;H2AX;MAPKAPK5;UBC;ASF1A;CDKN2D
gsea,Growth Hormone Receptor Signaling R-HSA-982772,-0.3648477238749569,-1.0336847012892287,0.39766081871345027,0.4678768633285008,1.0,5/15,16.37%,IRS2;MAPK3;LYN;PTPN1;MAPK1
gsea,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,-0.3237847347120289,-1.0333479756914459,0.38247011952191234,0.46776171427338376,1.0,6/22,18.14%,DLAT;GOT2;LDHD;NDUFAB1;DBT;GRHPR
gsea,Processing Of Capped Intronless Pre-mRNA R-HSA-75067,-0.30625951002307494,-1.0302221634106163,0.39520958083832336,0.4724068000206804,1.0,7/27,16.41%,SNRPG;CPSF2;SNRPF;SLBP;SNRPE;NCBP2;SNRPB
gsea,RND2 GTPase Cycle R-HSA-9696270,0.28315325045074086,1.030165466913777,0.3782178217821782,0.710417091277358,1.0,9/35,15.13%,DST;FNBP1;DLG5;PKP4;ANKRD26;PRAG1;VANGL1;FRS2;LEMD3
gsea,Regulation Of TP53 Activity R-HSA-5633007,-0.22554912956367257,-1.0299560667048597,0.3879472693032015,0.4721477469836511,1.0,27/120,21.15%,UBB;RPS27A;UBA52;USP2;PPP2R1A;PML;PPP2CA;CHD3;CSNK2B;RBBP7;CDK5R1;TAF11;PIP4K2A;TAF10;RFC3;PHF20;RPA3;PIP4P1;BRD7;RAD50;MAPKAPK5;HIPK1;UBC;TAF5;KMT5A;SSRP1;KAT6A
gsea,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,0.33557533878122847,1.028708425748271,0.396078431372549,0.7084224106355854,1.0,3/18,5.92%,LAMB1;SMARCA4;LAMC1
gsea,Signaling By Erythropoietin R-HSA-9006335,-0.33262677761107284,-1.0281943908259714,0.3991769547325103,0.4744235005995312,1.0,7/19,23.24%,CLSTN1;IRS2;HRAS;EPOR;LYN;NRAS;PIK3CB
gsea,Sialic Acid Metabolism R-HSA-4085001,0.30142090886622747,1.0270773589588322,0.40169133192389006,0.7071840232907031,1.0,8/26,22.08%,ST6GALNAC3;ST6GALNAC5;ST3GAL3;NPL;SLC17A5;ST3GAL4;ST3GAL2;ST3GAL5
gsea,CD28 Co-Stimulation R-HSA-389356,0.3037597923920086,1.0258966865707908,0.424,0.7049671583262779,1.0,7/25,12.55%,PIK3R3;LCK;MTOR;RICTOR;AKT2;FYN;ARHGEF7
gsea,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,-0.2978195436487609,-1.0251508528824718,0.42585551330798477,0.4792107303481748,1.0,8/31,19.91%,H2AZ1;TLE4;H2BC4;H2AJ;RUVBL1;H2AX;CDC73;TLE1
gsea,CTLA4 Inhibitory Signaling R-HSA-389513,-0.3283459262663142,-1.024586386459481,0.4137254901960784,0.47949347710553003,1.0,8/18,29.06%,PPP2R1A;PPP2CA;LYN;PPP2R5D;AKT3;PPP2R5B;PTPN11;AKT1
gsea,"Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",-0.32534337227690135,-1.0231158578944675,0.4028056112224449,0.4812804172173333,1.0,4/21,11.74%,CALR;CANX;PDIA3;SEC13
gsea,Polymerase Switching On C-strand Of Telomere R-HSA-174411,-0.33580027786482225,-1.0205991702676545,0.4416058394160584,0.4850678444306267,1.0,8/20,32.62%,TERF1;PCNA;RFC3;POLD4;POLD2;TINF2;POLD3;PRIM1
gsea,Signaling By Hippo R-HSA-2028269,-0.33086718165246054,-1.0198272665415435,0.39768339768339767,0.4857321285912201,1.0,2/18,2.82%,YWHAB;YWHAE
gsea,NS1 Mediated Effects On Host Pathways R-HSA-168276,0.2847183517822808,1.0196135811008558,0.4196242171189979,0.7159416732742342,1.0,10/34,16.32%,RANBP2;PABPN1;NUP210;NUP188;NDC1;NUP160;NUP98;NUP133;POM121;AAAS
gsea,G Alpha (S) Signaling Events R-HSA-418555,0.2349835226306377,1.0194967385393037,0.40869565217391307,0.7106197750859324,1.0,12/79,7.76%,PDE2A;PDE1A;ADCY8;PDE7B;ADCY2;PDE10A;GPR45;RXFP1;ADCY9;ADCYAP1R1;GRK3;PDE4A
gsea,RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,0.2846801976549785,1.0187528781287367,0.42045454545454547,0.707089794720972,1.0,7/33,12.89%,PHC2;SMARCA4;ARID2;CSNK2A2;SMARCA2;PHC3;SCMH1
gsea,HDACs Deacetylate Histones R-HSA-3214815,-0.28740259011938984,-1.0186852463998857,0.4148296593186373,0.48690296634342806,1.0,7/34,9.67%,H2BC4;H2AC25;SAP18;GPS2;CHD3;RBBP7;TBL1XR1
gsea,HATs Acetylate Histones R-HSA-3214847,-0.23754904563508347,-1.0180056778492252,0.40556660039761433,0.48740156810405394,1.0,12/76,12.39%,MORF4L1;MORF4L2;H2BC4;H2AC25;USP22;RBBP7;RUVBL1;TAF10;TADA3;PHF20;MRGBP;TADA2B
gsea,Transport Of SLBP Independent Mature mRNA R-HSA-159227,0.2842778036201019,1.0146583044727826,0.4110429447852761,0.7123776881715788,1.0,10/31,16.32%,RANBP2;NUP210;NUP188;NDC1;NCBP1;NUP160;NUP98;NUP133;POM121;AAAS
gsea,Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,-0.25886858744984204,-1.0142083893355516,0.40159045725646125,0.4933796751119656,1.0,13/51,21.32%,RPS6;EEF1G;SQSTM1;RBX1;NPM1;ATIC;CEBPB;MAPK3;MAPK1;DCTN1;VCL;PRKAR1A;SKP1
gsea,Interactions Of Rev With Host Cellular Proteins R-HSA-177243,-0.28326995125413407,-1.0119318398540258,0.43478260869565216,0.4968082447231651,1.0,10/33,18.71%,RAN;RANBP1;NUP50;NPM1;SEC13;NUP62;NUP37;NUP205;NUP35;NUP107
gsea,EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,-0.2453738849117167,-1.0092023398110994,0.42105263157894735,0.501020067916166,1.0,22/64,25.06%,DYNLL1;DYNLL2;RPS27;PPP2R1A;PAFAH1B1;PPP2CA;SEC13;NUP37;ZWINT;PPP2R5D;PPP1CC;NEK6;NUP107;B9D2;CENPP;ITGB3BP;RCC2;SEH1L;BUB3;NUDC;NUP85;MIS12
gsea,TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,-0.319662951330926,-1.0088084949312224,0.44466800804828976,0.5010397045688313,1.0,2/21,3.63%,RACK1;USP2
gsea,Intra-Golgi Traffic R-HSA-6811438,0.28256651474901734,1.007276664976795,0.4375,0.7268927409651976,1.0,9/34,12.60%,MAN2A1;MAN1C1;MAN2A2;VPS45;TRIP11;MAN1A2;COG4;VTI1A;COG3
gsea,CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,0.30028458878216924,1.0072330390832454,0.42714570858283435,0.7214669668714557,1.0,11/26,14.12%,LRRC7;RPS6KA2;ACTN2;CAMK2A;CAMK2G;RASGRF2;MPP3;RPS6KA6;RPS6KA1;CAMK2D;GRIN2B
gsea,NoRC Negatively Regulates rRNA Expression R-HSA-427413,-0.2641427703369676,-1.0072280358604815,0.4499054820415879,0.503059149599861,1.0,20/50,31.35%,H2AZ1;POLR2F;H2BC4;SAP18;SIN3B;H2AJ;POLR2E;POLR1G;H2AX;POLR2L;GTF2H5;ERCC3;GTF2H4;TAF1C;GTF2H3;SMARCA5;POLR1F;SIN3A;POLR2K;H2BC21
gsea,RHO GTPases Activate ROCKs R-HSA-5627117,-0.337155936545778,-0.9976473412209985,0.4695817490494297,0.5200681127473405,1.0,6/17,20.26%,MYL6;MYL12B;MYL9;MYH14;RHOB;MYH10
gsea,Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,0.2747519807338183,0.9972430650970693,0.4495967741935484,0.7430886108084094,1.0,9/31,16.32%,RANBP2;NUP210;NUP188;NDC1;NUP160;NUP98;NUP133;POM121;AAAS
gsea,Mitochondrial Calcium Ion Transport R-HSA-8949215,-0.3232429755861501,-0.9971102705407969,0.449901768172888,0.5202907353152408,1.0,12/19,39.27%,VDAC1;SMDT1;VDAC2;PHB2;PMPCA;SPG7;MICU2;PMPCB;STOML2;LETM1;PARL;AFG3L2
gsea,Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,-0.34702767357716213,-0.9952448719299587,0.46055045871559636,0.5227940526432173,1.0,4/16,18.07%,SEM1;XRCC2;RAD50;RAD51
gsea,Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,0.28252310872346476,0.9946381178257303,0.4348697394789579,0.744360008796109,1.0,9/28,16.32%,RANBP2;NUP210;NUP188;NDC1;NUP160;NUP98;NUP133;POM121;AAAS
gsea,RAC2 GTPase Cycle R-HSA-9013404,0.24152293953389087,0.9941535246723259,0.4787018255578093,0.7400833939123065,1.0,9/66,7.36%,TRIO;CYFIP1;DOCK3;DOCK10;ABR;DOCK4;PIK3R3;TIAM1;LBR
gsea,Mitotic Spindle Checkpoint R-HSA-69618,-0.2345378575687412,-0.9938462713553564,0.44466800804828976,0.5246506391493639,1.0,27/76,28.29%,DYNLL1;DYNLL2;RPS27;PPP2R1A;PAFAH1B1;PPP2CA;UBE2S;SEC13;NUP37;ZWINT;PPP2R5D;ANAPC11;PPP1CC;NUP107;B9D2;CENPP;ITGB3BP;RCC2;SEH1L;BUB3;NUDC;NUP85;MIS12;CDC26;ANAPC16;PPP2R5B;CDC16
gsea,RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,0.2629988926485677,0.9919119711715294,0.4631782945736434,0.7405293771706439,1.0,11/38,18.10%,NFIA;GTF3C2;BDP1;NFIB;GTF3C1;POLR2H;BRF1;SNAPC4;POLR3G;GTF3C4;POLR3B
gsea,Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,-0.35235416301925304,-0.9915185281594843,0.4581818181818182,0.5281265966584935,1.0,4/15,18.07%,SEM1;XRCC2;RAD50;RAD51
gsea,Downstream Signal Transduction R-HSA-186763,-0.2987910381456894,-0.9890808690238311,0.4713114754098361,0.5318474549125142,1.0,14/23,38.03%,PDGFA;NCK1;HRAS;PDGFB;NRAS;PIK3R2;PIK3CB;PTPN11;PIK3R1;BCAR1;RAPGEF1;STAT1;GRB2;STAT3
gsea,MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,0.34082231747169867,0.9890455002970444,0.4634146341463415,0.7429257853491202,1.0,4/16,16.80%,GRIN2A;HDAC1;GRIN2B;MECP2
gsea,SUMOylation Of DNA Methylation Proteins R-HSA-4655427,0.3386926588475373,0.9862749898642117,0.5211267605633803,0.7449040473906651,1.0,5/15,18.70%,PHC2;PHC3;SCMH1;DNMT1;DNMT3A
gsea,Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.29650511259520773,-0.9850051999580727,0.4780114722753346,0.538901099783294,1.0,15/27,40.24%,MCEE;DBI;ACOT13;NDUFAB1;ACADVL;ACBD6;DECR1;ACOT9;THEM4;MMUT;ACOT2;MCAT;ACOT12;ACOT1;ACAA2
gsea,"Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.295240329805473,-0.9849323693781896,0.4688715953307393,0.538255368152709,1.0,5/27,17.20%,SLC25A4;SLC25A5;SLC35A1;ARL2BP;SLC35B3
gsea,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,-0.25487209404143263,-0.9849261966279372,0.47418738049713194,0.5374653440386099,1.0,22/53,33.87%,H2AZ1;POLR2F;H2BC4;SAP18;SIN3B;H2AJ;POLR2E;POLR1G;H2AX;POLR2L;GTF2H5;ERCC3;GTF2H4;TAF1C;GTF2H3;SMARCA5;POLR1F;SIN3A;POLR2K;H2BC21;SUV39H1;H2AZ2
gsea,PKA-mediated Phosphorylation Of CREB R-HSA-111931,0.3367851365564348,0.980430541307716,0.47024952015355087,0.7546281855136184,1.0,4/16,5.22%,NBEA;ADCY8;ADCY2;ADCY9
gsea,Signaling By NODAL R-HSA-1181150,-0.33820322380970114,-0.9794037114160247,0.4798464491362764,0.5471475238305905,1.0,7/15,32.94%,DRAP1;MAPK3;MAPK1;SMAD4;ACVR1C;SMAD2;FOXO3
gsea,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,0.26060678965483186,0.9787084141362917,0.4790794979079498,0.7538535634662361,1.0,12/42,18.26%,GPC5;HS3ST4;GPC3;HS6ST3;HS2ST1;EXT1;XYLT2;XYLT1;HS3ST2;NCAN;DCN;NAGLU
gsea,SUMOylation Of Transcription Cofactors R-HSA-3899300,-0.25787636408499853,-0.9780106568999115,0.48073022312373226,0.5490649961532574,1.0,3/40,3.49%,DDX5;PARK7;SUMO2
gsea,"Defective B4GALT7 Causes EDS, Progeroid Type R-HSA-3560783",0.3398128912578996,0.9755435569800197,0.47291666666666665,0.7568132096651325,1.0,4/15,17.90%,GPC5;GPC3;NCAN;DCN
gsea,tRNA Aminoacylation R-HSA-379724,-0.2940711579416499,-0.9713387902485937,0.47654784240150094,0.5609159645322729,1.0,12/26,29.72%,WARS2;AIMP1;MARS1;FARS2;AIMP2;WARS1;PARS2;DTD1;PPA2;EEF1E1;YARS2;PPA1
gsea,Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,0.3315481257259115,0.9709561121355876,0.48697394789579157,0.762967204889143,1.0,3/16,9.95%,MAPK14;MAPKAPK2;MAP3K7
gsea,Diseases Of Metabolism R-HSA-5668914,0.19876012890099531,0.9700920049531331,0.5522727272727272,0.7597895200623104,1.0,41/156,20.79%,ADAMTS17;HLCS;SEMA5B;NOTCH2;ADAMTS20;SPON1;ADAMTS18;GPC5;ADAMTS3;LARGE1;ABCA3;ST3GAL3;HEXA;HEXB;ACACA;ALG8;CFP;GALNS;DHDDS;ALG12;GPC3;PCCB;EXT1;GALE;THSD1;ABCD4;CYP2R1;AMN;CSF2RA;CYP2U1;NCAN;DCN;NAGLU;POMGNT1;ADAMTS1;POMT2;GALNT12;MCCC2;MCCC1;FDXR;GBE1
gsea,FCERI Mediated MAPK Activation R-HSA-2871796,-0.30856489081996163,-0.9684480848550118,0.46680497925311204,0.5656003016425092,1.0,6/21,19.36%,JUN;HRAS;MAPK3;LYN;MAPK1;NRAS
gsea,Removal Of Flap Intermediate From C-strand R-HSA-174437,-0.33390962290340565,-0.9661250468920254,0.5083179297597042,0.569221248201112,1.0,7/15,31.63%,TERF1;PCNA;RPA3;POLD4;POLD2;TINF2;POLD3
gsea,Fatty Acid Metabolism R-HSA-8978868,-0.21955673048576607,-0.9659930428900462,0.4900900900900901,0.5686152736516378,1.0,35/109,33.26%,TECR;ACSL3;HSD17B8;PTGES3;GPX4;MCEE;PON2;PTGDS;DBI;ACOT13;ACLY;HACD4;HPGDS;CBR1;NDUFAB1;PRXL2B;NUDT19;THRSP;HSD17B12;CROT;ACSBG1;FASN;ACOX1;PTGR1;ACADVL;ACBD6;MID1IP1;ALOX5AP;SLC25A17;DECR1;ACOT9;PTGIS;ABCD1;THEM4;MMUT
gsea,Defective B3GALT6 Causes EDSP2 And SEMDJL1 R-HSA-4420332,0.3313361406386621,0.9653571006589114,0.484472049689441,0.7670505897412007,1.0,4/15,17.90%,GPC5;GPC3;NCAN;DCN
gsea,Cholesterol Biosynthesis R-HSA-191273,-0.2971131606640698,-0.9628214996867034,0.49800796812749004,0.5741200573886999,1.0,4/23,10.49%,SQLE;MSMO1;HMGCS1;FDPS
gsea,"PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",-0.23617880640249925,-0.9625338108996142,0.5327102803738317,0.5737931735516079,1.0,13/64,13.65%,PPP2R1A;FGFR2;NRG3;NRG4;FGF13;CLSTN1;PDGFA;IRS2;PPP2CA;PIP4K2A;FGFR1;MAPK3;PPP2R5D
gsea,HS-GAG Biosynthesis R-HSA-2022928,0.30211811459008675,0.96227310971663,0.5059055118110236,0.7696477140881356,1.0,6/22,12.67%,GPC5;HS3ST4;GPC3;HS6ST3;HS2ST1;EXT1
gsea,N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,0.3020158773437188,0.961771450835599,0.5132382892057027,0.7656672131827673,1.0,6/20,19.73%,MAN2A1;MAN2A2;MGAT5;MGAT4C;ST3GAL4;CHST10
gsea,mRNA 3-End Processing R-HSA-72187,-0.23531353519156495,-0.958790911781952,0.5318275154004107,0.5799621603500895,1.0,15/56,20.77%,CPSF2;MAGOH;RBM8A;U2AF1;SRSF3;CDC40;CHTOP;U2AF1L4;U2AF2;DDX39B;NCBP2;MAGOHB;POLDIP3;SLU7;THOC7
gsea,PI Metabolism R-HSA-1483255,0.23066202257001206,0.9583302180698485,0.5338645418326693,0.7689667823022073,1.0,19/69,17.78%,MTMR12;PIP5K1B;OCRL;PIK3R3;PLEKHA5;SYNJ1;PIKFYVE;MTMR1;MTMR7;SBF2;PNPLA6;PLEKHA6;SYNJ2;PI4KA;INPP5J;GDPD1;TNFAIP8L3;PLEKHA1;PIK3CA
gsea,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,-0.23100988947509085,-0.956800983582794,0.5094339622641509,0.5830276545982207,1.0,15/64,19.51%,CEBPD;NR2F2;MED4;MED19;CEBPA;MED10;CDK4;TBL1XR1;CEBPB;MED7;MED9;MED31;TBL1X;MED21;CCND3
gsea,PI3K/AKT Signaling In Cancer R-HSA-2219528,0.23039705203845096,0.9496514507312449,0.569620253164557,0.7863737625525679,1.0,15/66,12.62%,FGF10;CHUK;NRG1;ERBB4;GAB2;PIK3R3;LCK;FLT3;MTOR;RICTOR;KL;SOS1;AKT2;FYN;NRG2
gsea,Nuclear Import Of Rev Protein R-HSA-180746,-0.2714489479979878,-0.949137598233611,0.5177865612648221,0.5965768211438185,1.0,9/30,18.71%,RAN;NUP50;NPM1;SEC13;NUP62;NUP37;NUP205;NUP35;NUP107
gsea,Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,-0.3292502121368897,-0.9482297977085046,0.514018691588785,0.5975050139208052,1.0,2/16,4.01%,MAGED1;NDUFA2
gsea,Pre-NOTCH Expression And Processing R-HSA-1912422,0.24706875083171229,0.9446345625196392,0.5623721881390593,0.7940810557895357,1.0,10/46,14.51%,TNRC6C;MAML2;NOTCH2;MOV10;ST3GAL3;TNRC6B;AGO1;MAML3;H2AC4;AGO4
gsea,SUMOylation Of RNA Binding Proteins R-HSA-4570464,0.24526592226429927,0.9445232760942387,0.5291828793774319,0.7890823234517916,1.0,12/42,16.32%,PHC2;RANBP2;NUP210;NUP188;NDC1;NUP160;PHC3;NUP98;SCMH1;NUP133;POM121;AAAS
gsea,FCGR3A-mediated IL10 Synthesis R-HSA-9664323,-0.2880187175493095,-0.9426762475753098,0.5413223140495868,0.6074999496455166,1.0,5/26,15.26%,CALM1;PRKAR1B;LYN;PRKACB;HCK
gsea,VxPx Cargo-Targeting To Cilium R-HSA-5620916,0.3008207075703824,0.9386814422855976,0.5470941883767535,0.7987900123286247,1.0,3/17,8.48%,PKD1;RAB3IP;RAB11FIP3
gsea,Downstream Signaling Of Activated FGFR1 R-HSA-5654687,-0.29881633774487415,-0.9381584954385308,0.5158102766798419,0.6154494199449684,1.0,5/21,11.37%,FLRT2;FGF13;HRAS;FLRT3;FGFR1
gsea,Transport Of SLBP Dependant Mature mRNA R-HSA-159230,0.26100040102035316,0.9376298078884016,0.5297741273100616,0.7962628124786968,1.0,10/32,16.32%,RANBP2;NUP210;NUP188;NDC1;NCBP1;NUP160;NUP98;NUP133;POM121;AAAS
gsea,Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,0.2544242897601619,0.9357829710439596,0.567741935483871,0.7957622013904687,1.0,11/41,12.62%,FGF10;NRG1;ERBB4;GAB2;PIK3R3;LCK;FLT3;KL;SOS1;FYN;NRG2
gsea,Insulin Receptor Signaling Cascade R-HSA-74751,-0.2582852308333706,-0.935546084533105,0.5657142857142857,0.6198134532190904,1.0,14/33,29.59%,FGFR2;FGF13;IRS2;HRAS;FGFR1;MAPK3;MAPK1;NRAS;PIK3R2;FGF5;PIK3CB;GRB10;PTPN11;PIK3R1
gsea,Inositol Phosphate Metabolism R-HSA-1483249,0.24721474436335836,0.9343858614104334,0.5610766045548654,0.7941876927530812,1.0,10/41,10.15%,IPPK;INPP5A;OCRL;SYNJ1;PLCG2;ITPKB;PLCH1;PPIP5K1;MTMR7;PLCE1
gsea,SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,-0.1985738356483435,-0.9305775262081193,0.6050583657587548,0.6286729804196324,1.0,37/133,26.08%,DDX5;PARK7;CETN2;SUMO2;SMC1A;PML;NFKB2;CHD3;NUP50;NPM1;RAD21;PCNA;PARP1;NSMCE3;SEC13;RNF168;NUP62;HNRNPK;NUP37;NR4A2;NUP205;NUP35;RING1;CBX5;THRA;NUP107;NR1H2;CBX4;TDG;SEH1L;NFKBIA;SUMO1;HNRNPC;NRIP1;NUP85;NSMCE4A;DAXX
gsea,Signaling By ALK R-HSA-201556,0.30236366209438903,0.9281997431077194,0.5734406438631791,0.8049017809278046,1.0,9/20,28.45%,PTPRZ1;HDAC1;FRS2;PIK3CA;PLCG1;ALK;HDAC3;IRS1;EP300
gsea,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",0.25515581732929493,0.9259158149583417,0.5708154506437768,0.8055345127222495,1.0,8/40,14.23%,SLC44A5;SLC6A1;SLC22A4;SLC44A2;SLC6A7;SLC5A3;SLC39A14;SLC40A1
gsea,Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,-0.3143523736761741,-0.9250433474856343,0.5475728155339806,0.6387483298813013,1.0,6/17,20.26%,MYL6;MYL12B;MYL9;MYH14;RHOB;MYH10
gsea,Interferon Alpha/Beta Signaling R-HSA-909733,-0.2973121151890252,-0.9239340007452317,0.5731958762886598,0.6400888617936041,1.0,9/20,37.08%,EGR1;SAMHD1;PTPN1;JAK1;IFI27;PTPN11;IRF1;IRF3;STAT1
gsea,SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,-0.21732455675224877,-0.9211616014817684,0.6314741035856574,0.6446672343746771,1.0,20/67,22.63%,CETN2;SUMO2;SMC1A;PML;NUP50;RAD21;PARP1;NSMCE3;SEC13;RNF168;NUP62;NUP37;NUP205;NUP35;RING1;NUP107;CBX4;TDG;SEH1L;SUMO1
gsea,SUMOylation R-HSA-2990846,-0.1945867799756122,-0.920492299344851,0.6335282651072125,0.6449992566714599,1.0,33/139,22.63%,DDX5;PARK7;CETN2;SUMO2;SMC1A;PML;NFKB2;CHD3;NUP50;NPM1;RAD21;PCNA;PARP1;NSMCE3;SEC13;RNF168;NUP62;HNRNPK;NUP37;NR4A2;UBA2;NUP205;NUP35;RING1;CBX5;THRA;NUP107;NR1H2;CBX4;TDG;SEH1L;NFKBIA;SUMO1
gsea,Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,-0.2588220664641484,-0.9187823643968343,0.5826771653543307,0.6473390728905926,1.0,9/31,18.71%,RAN;RANBP1;NUP50;SEC13;NUP62;NUP37;NUP205;NUP35;NUP107
gsea,Glycosaminoglycan Metabolism R-HSA-1630316,0.2072721648173071,0.9178699342927917,0.6244813278008299,0.8207199162704711,1.0,24/90,20.32%,CHST11;GPC5;ABCC5;ST3GAL3;HS3ST4;HEXA;HEXB;SLC9A1;GPC3;HS6ST3;HS2ST1;EXT1;XYLT2;PAPSS1;XYLT1;HS3ST2;UST;NCAN;DCN;NAGLU;CEMIP;CHST9;ST3GAL4;ST3GAL2
gsea,Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,0.24280749490307985,0.9157694482306065,0.5816733067729084,0.8207364420843672,1.0,12/38,18.30%,RANBP2;NUP210;NUP188;NDC1;NCBP1;NUP160;NUP98;NUP133;POM121;SYMPK;AAAS;FIP1L1
gsea,Intraflagellar Transport R-HSA-5620924,0.24910316765776414,0.9152295373880847,0.586864406779661,0.816873763870643,1.0,7/37,10.66%,DYNC2H1;IFT140;IFT88;TRIP11;DYNLT2B;KIF3C;TTC21B
gsea,Cell-cell Junction Organization R-HSA-421270,0.2543819881913391,0.9129236861865614,0.6040816326530613,0.8172762735771985,1.0,9/34,18.27%,SDK2;CDH12;NECTIN1;CDH11;PATJ;CADM1;PARD6B;CDH10;CDH13
gsea,Insulin Processing R-HSA-264876,0.2729669512046407,0.9119403526804255,0.568,0.8144936537290377,1.0,10/24,23.08%,RAB27A;MYRIP;STX1A;KIF5A;MYO5A;ERO1A;ERO1B;EXOC2;EXOC1;EXOC6
gsea,Epigenetic Regulation Of Gene Expression R-HSA-212165,-0.21396077410926218,-0.907913189259774,0.6152263374485597,0.668031809155384,1.0,12/86,10.40%,H2AZ1;DEK;POLR2F;H2BC4;SAP18;CBX3;CHD3;SIN3B;H2AJ;RBBP7;POLR2E;POLR1G
gsea,Chromatin Modifying Enzymes R-HSA-3247509,0.1853270757209099,0.9078816368442592,0.693069306930693,0.8191674086629555,1.0,52/195,21.07%,YEATS2;PHF21A;BRWD1;KAT6B;EHMT1;KMT2A;MTA2;KDM2B;SMARCA4;ATXN7;HDAC1;ARID2;JAK2;KMT2B;KMT2C;NSD1;BRD1;HDAC8;NCOA2;SETDB1;NCOA1;MTA3;SMARCA2;KANSL1;KDM2A;KDM4B;NSD3;CHD4;DPY30;KDM5B;H2AC4;EHMT2;ZZZ3;KMT2E;EZH2;BRPF3;WDR77;TRRAP;SETD2;KDM7A;GATAD2A;KMT5B;DNMT3A;ARID4B;SUZ12;ELP2;SMARCC2;REST;KDM3A;EPC1;NFKB1;AEBP2
gsea,Platelet Aggregation (Plug Formation) R-HSA-76009,-0.2797225217707548,-0.8998914346068575,0.6171428571428571,0.6829581124295281,1.0,11/21,37.48%,RASGRP1;ADRA2C;TLN1;PTPN1;RAP1A;AKT1;FN1;BCAR1;PDPK1;RAP1B;GRB2
gsea,Vpr-mediated Nuclear Import Of PICs R-HSA-180910,-0.2505861115286043,-0.8994531137996609,0.6152304609218436,0.6828463359981873,1.0,13/31,27.04%,PSIP1;BANF1;NUP50;SEC13;NUP62;NUP37;NUP205;NUP35;NUP107;SEH1L;HMGA1;NUP85;TPR
gsea,Other Interleukin Signaling R-HSA-449836,-0.3068439071179746,-0.8977051401616976,0.5909980430528375,0.6852438047975666,1.0,5/16,23.11%,VAMP2;SNAP25;CSF1R;JAK1;IL10RB
gsea,HDMs Demethylate Histones R-HSA-3214842,0.2873237892451252,0.8952464149299693,0.6204081632653061,0.8449905128454807,1.0,7/19,23.62%,KDM2B;KDM2A;KDM4B;KDM5B;KDM7A;KDM3A;KDM4A
gsea,Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,-0.2619500848875599,-0.8943634127437996,0.6151202749140894,0.6887481123844422,1.0,6/29,18.07%,SEM1;RFC3;RPA3;XRCC2;RAD50;RAD51
gsea,Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,-0.2619500848875599,-0.8943634127437996,0.6151202749140894,0.6887481123844422,1.0,6/29,18.07%,SEM1;RFC3;RPA3;XRCC2;RAD50;RAD51
gsea,Homologous DNA Pairing And Strand Exchange R-HSA-5693579,-0.2619500848875599,-0.8943634127437996,0.6151202749140894,0.6887481123844422,1.0,6/29,18.07%,SEM1;RFC3;RPA3;XRCC2;RAD50;RAD51
gsea,Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,0.21271836708451858,0.8913824134283352,0.6703296703296703,0.8492672765458419,1.0,20/66,18.81%,SLC8A1;SLC9A7;SLC24A3;SLC7A8;SLC4A7;SLC9A1;SLC9A5;SLC24A4;SLC26A4;SLC1A1;SLC25A10;SLC12A2;SLC25A22;SLC1A4;SLC17A5;SLC15A4;AHCYL2;SLC26A11;SLC7A6;SLC6A15
gsea,"Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",0.26532435423796574,0.8900836856360922,0.6282306163021869,0.847208198698448,1.0,8/27,17.78%,CBL;GAB2;PIK3R3;JAK2;SOS1;FYN;CSF2RA;PIK3CA
gsea,SLC-mediated Transmembrane Transport R-HSA-425407,0.19058437983733084,0.887975917743064,0.7120181405895691,0.847138737312972,1.0,36/138,18.81%,SLC44A5;SLC8A1;SLCO3A1;SLC6A1;SLC9A7;SLC24A3;SLC7A8;SLC4A7;SLC9A1;SLC9A5;SLC22A4;SLC24A4;SLC26A4;SLC44A2;SLC1A1;SLC6A7;SLC25A10;SLC12A2;SLC25A22;SLC5A3;SLC39A14;SLC16A2;SLC29A4;SLC1A4;SLC17A5;SLC40A1;SLC15A4;AHCYL2;SLC29A2;SLC5A6;SLCO2A1;SLC26A11;SLC7A6;SLC2A6;SLC35A2;SLC6A15
gsea,Sema4D In Semaphorin Signaling R-HSA-400685,-0.29477516544995624,-0.8872542062161008,0.5957854406130269,0.7016167425980436,1.0,6/19,20.26%,MYL6;MYL12B;MYL9;MYH14;RHOB;MYH10
gsea,Processive Synthesis On C-strand Of Telomere R-HSA-174414,-0.2982240155794633,-0.8857663299019463,0.6275992438563327,0.7034448287371307,1.0,8/17,34.71%,TERF1;PCNA;RPA3;POLD4;POLD2;TINF2;POLD3;LRIG1
gsea,FGFR1 Mutant Receptor Activation R-HSA-1839124,0.2771212120791038,0.8848011816207205,0.6237623762376238,0.84945566321254,1.0,3/22,4.49%,ZMYM2;LRRFIP1;GAB2
gsea,Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,-0.24148691711067968,-0.8841546736664515,0.6473988439306358,0.705545016107691,1.0,11/36,27.70%,SQLE;NFYB;HMGCS1;TBL1XR1;FDPS;TBL1X;HMGCR;FASN;FDFT1;LIN9;SREBF2
gsea,SLC Transporter Disorders R-HSA-5619102,0.21633112019029843,0.8782442876944248,0.676595744680851,0.859641707627924,1.0,16/59,16.86%,RANBP2;NUP210;NUP188;SLC9A7;SLC24A4;SLC26A4;NDC1;SLC1A1;NUP160;NUP98;NUP133;SLC17A5;SLC40A1;POM121;AAAS;SLCO2A1
gsea,Heme Signaling R-HSA-9707616,0.24326862775035346,0.874684115344511,0.6607843137254902,0.8625911826638175,1.0,5/31,8.46%,RORA;CRTC3;NCOA2;NCOA1;NCOA6
gsea,RHOH GTPase Cycle R-HSA-9013407,-0.25893427664525936,-0.874657457670948,0.6827309236947792,0.722905010574342,1.0,9/28,23.06%,ARHGDIA;TMEM59;NIPSNAP2;VCP;TUBA1B;DBT;VAMP3;NSFL1C;LAMTOR1
gsea,Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,0.2988778837826931,0.8741597868764047,0.6639676113360324,0.8587377094985079,1.0,2/15,6.71%,MTMR12;PIKFYVE
gsea,Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,-0.2618052576648315,-0.8719633333384433,0.6750902527075813,0.7270637212381563,1.0,5/28,14.02%,TERF1;PCNA;RFC3;RPA3;POLD4
gsea,Nuclear Envelope Breakdown R-HSA-2980766,0.22143209939766212,0.8704139890606074,0.678,0.8621372295631857,1.0,12/45,16.32%,RANBP2;NEK7;NUP210;NUP188;NDC1;NUP160;NUP98;NUP133;POM121;LPIN1;LEMD3;AAAS
gsea,Peroxisomal Lipid Metabolism R-HSA-390918,-0.2731386308759617,-0.8699843864017702,0.6544401544401545,0.7299133367718152,1.0,10/23,42.46%,NUDT19;CROT;ACOX1;SLC25A17;ABCD1;SYCP2;CRAT;ACOT6;ACOT8;ACOT4
gsea,Downstream Signaling Of Activated FGFR3 R-HSA-5654708,-0.301662461274941,-0.8670670842547591,0.65625,0.7345119742621221,1.0,6/15,29.59%,FGF13;HRAS;NRAS;FGF5;PTPN11;PIK3R1
gsea,Negative Regulation Of PI3K/AKT Network R-HSA-199418,-0.21013255214977544,-0.8655713644064931,0.7265774378585086,0.7364570595073384,1.0,13/70,13.65%,PPP2R1A;FGFR2;NRG3;NRG4;FGF13;CLSTN1;PDGFA;IRS2;PPP2CA;PIP4K2A;FGFR1;MAPK3;PPP2R5D
gsea,Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,-0.2739709987690151,-0.8648987240299422,0.6647727272727273,0.7366082460132527,1.0,12/20,36.77%,AP2M1;AP2S1;HCK;AP2B1;CD247;AP2A2;B2M;AP1S1;AP1M1;AP1S2;PKN2;AP2A1
gsea,Myogenesis R-HSA-525793,-0.27252487166311645,-0.8580350304653702,0.6639344262295082,0.7485170762397139,1.0,2/21,3.03%,MEF2C;CDC42
gsea,Signaling By MET R-HSA-6806834,-0.21674332310165914,-0.8546404104711216,0.7241379310344828,0.7538094442232508,1.0,3/53,2.81%,UBB;RPS27A;UBA52
gsea,Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,0.22634245322757032,0.8507439834790785,0.7281746031746031,0.900880220197072,1.0,12/44,17.78%,PIP5K1B;OCRL;PIK3R3;PLEKHA5;SYNJ1;MTMR1;SBF2;PLEKHA6;SYNJ2;INPP5J;PLEKHA1;PIK3CA
gsea,Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,0.22393543930062906,0.8501765493197954,0.6972111553784861,0.8968017426574906,1.0,12/39,18.30%,RANBP2;NUP210;NUP188;NDC1;NCBP1;NUP160;NUP98;NUP133;POM121;SYMPK;AAAS;FIP1L1
gsea,NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,0.2408515913348606,0.8496061224217057,0.6979591836734694,0.8928422798931801,1.0,5/30,9.61%,TNRC6C;MOV10;TNRC6B;NCOA1;AGO1
gsea,Signaling By FGFR1 In Disease R-HSA-5655302,0.24787101299392336,0.8493591276535133,0.66796875,0.8882005790919433,1.0,9/28,20.56%,ZMYM2;LRRFIP1;GAB2;SOS1;CNTRL;FRS2;PIK3CA;MYO18A;PLCG1
gsea,RHOBTB1 GTPase Cycle R-HSA-9013422,0.26342708316647223,0.8461647452002589,0.6770186335403726,0.8901295036084039,1.0,11/22,26.05%,ROCK1;CPSF7;COPS4;RNF20;TRA2B;SRRM1;CUL3;COPS2;MYO6;DBN1;RBMX
gsea,RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,0.24059052461623964,0.8449868712845422,0.7069306930693069,0.8875809698968202,1.0,8/27,18.10%,GTF3C2;BDP1;GTF3C1;POLR2H;BRF1;POLR3G;GTF3C4;POLR3B
gsea,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,-0.22192894045247563,-0.8445886394131081,0.7509881422924901,0.7709581737204547,1.0,10/45,22.09%,ARF4;CCT2;BBIP1;BBS2;RAB11A;CCT5;CCT8;NUDT19;CCT3;BBS10
gsea,RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,0.204523562125489,0.8427524091443378,0.7637795275590551,0.8873037320461413,1.0,16/69,14.70%,INTS11;POU2F2;INTS2;NABP1;RPRD2;ELL2;POLR2H;NCBP1;INTS6;INTS1;TAF6;ICE2;RPRD1A;CDK9;SNAPC4;ICE1
gsea,RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,-0.29228749206989263,-0.8413162376180611,0.6934579439252336,0.7757694558444911,1.0,4/15,17.58%,MAPK3;MAPK1;CBFB;HEY1
gsea,Interferon Gamma Signaling R-HSA-877300,0.23573672982841393,0.8407734583777366,0.7233606557377049,0.8865148177985486,1.0,10/34,14.65%,CAMK2A;CAMK2G;TRIM46;JAK2;PTPN2;PIAS1;TRIM17;MID1;CAMK2D;IRF2
gsea,Integrin Signaling R-HSA-354192,-0.26868130337894736,-0.8401844659661366,0.6716981132075471,0.7767277610126183,1.0,10/19,37.48%,RASGRP1;TLN1;PTPN1;RAP1A;AKT1;FN1;BCAR1;PDPK1;RAP1B;GRB2
gsea,RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,0.24429875446511984,0.8399863765573539,0.7195121951219512,0.8832162997745299,1.0,8/26,18.10%,GTF3C2;BDP1;GTF3C1;POLR2H;BRF1;POLR3G;GTF3C4;POLR3B
gsea,SUMOylation Of DNA Replication Proteins R-HSA-4615885,-0.22281436294065138,-0.8387134971779665,0.7211538461538461,0.7782899663874644,1.0,13/37,27.04%,SUMO2;NUP50;PCNA;SEC13;NUP62;NUP37;NUP205;NUP35;NUP107;SEH1L;SUMO1;NUP85;TPR
gsea,SUMOylation Of SUMOylation Proteins R-HSA-4085377,-0.23037924507976731,-0.8384916689007937,0.7137254901960784,0.7776063200517049,1.0,12/31,27.04%,SUMO2;NUP50;SEC13;NUP62;NUP37;NUP205;NUP35;NUP107;SEH1L;SUMO1;NUP85;TPR
gsea,Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,-0.2879142299805045,-0.834297854418036,0.6933333333333334,0.7839894199289392,1.0,8/15,33.07%,AP2M1;AP2S1;AP2B1;AP2A2;B2M;AP1S1;AP1M1;AP1S2
gsea,RNA Polymerase I Transcription Termination R-HSA-73863,-0.23795078656845783,-0.8341326369558053,0.7262357414448669,0.7831860526723013,1.0,11/29,30.73%,POLR2F;POLR2E;POLR1G;POLR2L;GTF2H5;ERCC3;GTF2H4;TAF1C;GTF2H3;POLR1F;POLR2K
gsea,Adherens Junctions Interactions R-HSA-418990,-0.2539578609190375,-0.8301708373601688,0.7068965517241379,0.7893270136284815,1.0,3/22,12.66%,CADM2;CDH18;CDH9
gsea,RNA Polymerase I Transcription Initiation R-HSA-73762,0.2141279380654229,0.8297991539461432,0.7595190380761523,0.8991379865226842,1.0,9/45,13.55%,TAF1B;MTA2;HDAC1;GTF2H2;ERCC2;POLR2H;MTA3;CHD4;EHMT2
gsea,Signaling To ERKs R-HSA-187687,-0.24128010712765974,-0.8268913918635996,0.7314285714285714,0.7940320222364792,1.0,14/28,39.09%,YWHAB;HRAS;RALA;MAPK3;MAPK1;NRAS;MAP2K1;RAP1A;BCL11B;RAPGEF1;SHC2;MAP2K2;GRB2;RIT2
gsea,Amine Ligand-Binding Receptors R-HSA-375280,0.267263275220352,0.8264909230071483,0.6940133037694013,0.900759372048481,1.0,6/19,20.71%,CHRM3;HTR2C;CHRM2;HTR4;HRH2;HTR7
gsea,NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,-0.22859707462339818,-0.821538120062754,0.7614314115308151,0.8023770388032881,1.0,11/31,27.04%,RAN;NUP50;SEC13;NUP62;NUP37;NUP205;NUP35;NUP107;SEH1L;NUP85;TPR
gsea,Chondroitin Sulfate Biosynthesis R-HSA-2022870,0.2681869319559337,0.820922984505908,0.6986899563318777,0.9068233951037747,1.0,9/17,28.96%,CHST11;NCAN;DCN;CHST9;CHSY1;CHPF;CSGALNACT1;CSPG4;VCAN
gsea,"FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",0.2552930010848098,0.8181036964171766,0.7448559670781894,0.9072049606054622,1.0,2/21,5.18%,PLXNA4;HDAC1
gsea,IRS-related Events Triggered By IGF1R R-HSA-2428928,0.2356207973448429,0.8155917104099212,0.7610441767068273,0.9071119018049907,1.0,8/29,14.96%,FGF10;GAB2;FLT3;IGF1R;KL;SOS1;AKT2;FRS2
gsea,Downstream Signaling Of Activated FGFR2 R-HSA-5654696,-0.2743437084373057,-0.8131024224050808,0.7420634920634921,0.8154791503677888,1.0,3/17,7.58%,FGFR2;FGF13;HRAS
gsea,IGF1R Signaling Cascade R-HSA-2428924,0.23353914985519347,0.8102862465900743,0.7718940936863544,0.907342215884616,1.0,8/30,14.96%,FGF10;GAB2;FLT3;IGF1R;KL;SOS1;AKT2;FRS2
gsea,Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,0.23353914985519347,0.8102862465900743,0.7718940936863544,0.907342215884616,1.0,8/30,14.96%,FGF10;GAB2;FLT3;IGF1R;KL;SOS1;AKT2;FRS2
gsea,Metal Ion SLC Transporters R-HSA-425410,-0.2630944099937868,-0.8101722677374613,0.7523629489603024,0.8194321653942006,1.0,9/20,37.40%,SLC39A3;SLC41A1;SLC30A6;CP;SLC39A7;SLC39A1;SLC31A1;SLC30A1;SLC39A6
gsea,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,-0.26102194710630267,-0.809129868987506,0.74609375,0.820116151260279,1.0,5/18,20.12%,SNW1;FABP7;HEY1;MAMLD1;PBX1
gsea,Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,-0.20756962697109166,-0.8078378725110295,0.7681451612903226,0.8210650250735512,1.0,14/49,28.66%,RAN;SQLE;NFYB;HMGCS1;TBL1XR1;FDPS;INSIG2;TBL1X;HMGCR;FASN;FDFT1;LIN9;SREBF2;INSIG1
gsea,Impaired BRCA2 Binding To RAD51 R-HSA-9709570,-0.24734808333997743,-0.8068468647182109,0.7546468401486989,0.8215721006914218,1.0,5/25,18.07%,SEM1;RFC3;RPA3;RAD50;RAD51
gsea,Diseases Of Mitotic Cell Cycle R-HSA-9675126,0.221275660636589,0.8060095492174513,0.7816593886462883,0.9104756453464307,1.0,3/32,5.13%,CDC27;ATRX;CCND2
gsea,Nonhomologous End-Joining (NHEJ) R-HSA-5693571,0.22357952119144126,0.7936832272507068,0.7959183673469388,0.9276812072381447,1.0,10/32,20.70%,PRKDC;HERC2;BRCC3;DCLRE1C;TDP1;PAXIP1;LRIF1;ATM;XRCC5;MDC1
gsea,Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,-0.2203636099108606,-0.7909945887335209,0.8024439918533605,0.845728960884615,1.0,8/32,18.71%,RAN;NUP50;SEC13;NUP62;NUP37;NUP205;NUP35;NUP107
gsea,KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,0.2689772210492358,0.7903868201292918,0.7615230460921844,0.9284909117358652,1.0,3/16,8.39%,MAPK14;KHSRP;EXOSC8
gsea,Resolution Of D-Loop Structures R-HSA-5693537,-0.26131035207671194,-0.7897153140078411,0.7813688212927756,0.8467070216671826,1.0,4/20,18.07%,SEM1;XRCC2;RAD50;RAD51
gsea,IRS-mediated Signaling R-HSA-112399,-0.2299012370169835,-0.7890932682837405,0.7855750487329435,0.8463786179473384,1.0,9/28,23.24%,FGFR2;FGF13;IRS2;HRAS;FGFR1;NRAS;PIK3R2;FGF5;PIK3CB
gsea,Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,-0.2650454544709799,-0.7874059572632066,0.767175572519084,0.8477815599491189,1.0,4/19,18.07%,SEM1;XRCC2;RAD50;RAD51
gsea,HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,0.23102630885251,0.7871855509299435,0.7876712328767124,0.9288655554487127,1.0,12/27,28.69%,WRN;TOPBP1;ERCC4;HUS1;ATM;ABL1;RMI1;RAD17;RAD52;RFC4;BLM;POLR1B
gsea,Miscellaneous Transport And Binding Events R-HSA-5223345,-0.26100129539897715,-0.7821707432581644,0.7595959595959596,0.8544991835432302,1.0,6/18,34.12%,ADD2;NIPAL3;NIPA1;TUSC3;CTNS;SLC66A1
gsea,PPARA Activates Gene Expression R-HSA-1989781,0.17539077876382875,0.7765871607810987,0.8803418803418803,0.9408781281270189,1.0,15/89,13.24%,MED13;RORA;PPARGC1B;CDK8;TNFRSF21;NCOA2;NCOA1;NCOA6;GRHL1;MED13L;MED14;ACADM;NRF1;FAM120B;MED23
gsea,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,-0.22829611860241028,-0.7731560610190459,0.8016194331983806,0.8666024774234741,1.0,6/27,15.38%,PML;CHD3;RBBP7;PIP4K2A;PIP4P1;BRD7
gsea,Synthesis Of PA R-HSA-1483166,-0.24277445778045476,-0.7715946113162135,0.814,0.8677616425662135,1.0,5/22,22.17%,GPD2;GPD1;GPD1L;AGPAT5;AGPAT1
gsea,mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,0.26322436619608164,0.7703907413817038,0.7916666666666666,0.9455515914571048,1.0,3/15,8.39%,SKIC2;SKIC3;EXOSC8
gsea,Signaling By PDGFR In Disease R-HSA-9671555,0.25176904420725027,0.7662916028525465,0.7871485943775101,0.9467362469339097,1.0,7/17,19.61%,SOS1;KANK1;GOLGA4;ETV6;PIK3CA;FIP1L1;STRN
gsea,Nucleotide Salvage R-HSA-8956321,-0.2578112748823117,-0.7652489332158917,0.796875,0.8754473956150483,1.0,4/17,12.01%,APRT;SCO2;UCKL1;TK2
gsea,RNA Polymerase III Transcription Termination R-HSA-73980,-0.24383999474217422,-0.7649506504723083,0.7855750487329435,0.8746815001327215,1.0,9/21,30.73%,POLR2F;POLR2E;POLR3D;POLR3H;POLR2L;POLR3A;SSB;POLR3E;POLR2K
gsea,ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,-0.2614938828289074,-0.761617746498541,0.7938931297709924,0.8779948343082039,1.0,5/15,22.50%,NFKB2;NFKBIB;NKIRAS1;TBK1;NFKBIA
gsea,DAP12 Signaling R-HSA-2424491,0.2510464382324766,0.7604913746096529,0.8032128514056225,0.9455908122990695,1.0,6/18,20.56%,PLCG2;LCK;SOS1;FYN;PIK3CA;PLCG1
gsea,DAP12 Interactions R-HSA-2172127,0.2510464382324766,0.7604913746096529,0.8032128514056225,0.9455908122990695,1.0,6/18,20.56%,PLCG2;LCK;SOS1;FYN;PIK3CA;PLCG1
gsea,Signaling By PDGF R-HSA-186797,0.21117288804827697,0.7594253223050836,0.8492871690427699,0.9423098725698559,1.0,6/32,12.02%,SYNGAP1;THBS3;PLAT;NCK2;SOS1;COL4A1
gsea,Elastic Fibre Formation R-HSA-1566948,0.25542949812688276,0.7575679048300659,0.8089171974522293,0.9400930328228239,1.0,4/17,15.72%,FBN2;LTBP4;ITGA8;ITGB8
gsea,Keratan Sulfate/Keratin Metabolism R-HSA-1638074,0.22957587301238908,0.7543455122345376,0.839835728952772,0.9397916151848686,1.0,3/23,6.77%,ST3GAL3;HEXA;HEXB
gsea,Glycosphingolipid Metabolism R-HSA-1660662,0.21004619127219015,0.747357392334603,0.8778947368421053,0.9442135890748545,1.0,4/31,8.62%,HEXA;ESYT2;HEXB;ESYT3
gsea,"BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",0.23792022323790732,0.7440112479978379,0.8466257668711656,0.9437886754898028,1.0,10/20,31.69%,NCOA2;NCOA1;NCOA6;CHD9;BHLHE40;CLOCK;CARM1;NPAS2;NAMPT;CREBBP
gsea,NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,-0.2075950884734349,-0.7430038458370138,0.8929961089494164,0.9011383169357288,1.0,11/35,25.76%,APOE;GPS2;KDM1B;TBL1XR1;TBL1X;ANGPTL3;NR1H2;PLTP;FASN;NRIP1;ARL4C
gsea,Sphingolipid Metabolism R-HSA-428157,0.17479797981942646,0.7425880256762286,0.9518828451882845,0.9408778042854663,1.0,8/66,9.91%,SGMS1;SPNS2;CERS4;HEXA;ESYT2;HEXB;ESYT3;CERS6
gsea,RNA Polymerase III Transcription Initiation R-HSA-76046,0.20095855426255554,0.7417465009157892,0.8895463510848126,0.9372047538517945,1.0,9/34,18.10%,GTF3C2;BDP1;GTF3C1;POLR2H;BRF1;SNAPC4;POLR3G;GTF3C4;POLR3B
gsea,Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,-0.22548165977705098,-0.7384740805544967,0.8323699421965318,0.9053995406931771,1.0,11/24,32.94%,BAD;AKT1S1;GSK3B;CDKN1B;FOXO4;NR4A1;CREB1;AKT3;AKT1;TSC2;FOXO3
gsea,Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,-0.18877958637094652,-0.7384143629541984,0.9118773946360154,0.9042515315333056,1.0,24/52,37.02%,PMM1;DPM3;CMAS;SLC35A1;NANP;DPM2;EGFL7;GFPT2;GNPNAT1;AMDHD2;GNE;SRD5A3;DPM1;ST6GAL1;UAP1;ALG5;ST6GALNAC6;ST3GAL1;FPGT;GFUS;PGM3;ST8SIA4;FUOM;ST6GAL2
gsea,Nucleotide Catabolism R-HSA-8956319,-0.22929790484620866,-0.735657661223901,0.8411214953271028,0.906214233892942,1.0,10/23,33.60%,SCO2;ITPA;SAMHD1;NUDT5;NUDT1;NUDT18;ENTPD6;NT5C;NUDT15;NT5C1A
gsea,Sphingolipid De Novo Biosynthesis R-HSA-1660661,0.200233504255859,0.7316274340871124,0.8846918489065606,0.944909435572308,1.0,8/35,18.95%,SGMS1;SPNS2;CERS4;CERS6;OSBP;SPTLC1;SGPL1;PPM1L
gsea,PI3K Cascade R-HSA-109704,0.21806400018596328,0.7305913948908501,0.8502024291497976,0.9414738371322564,1.0,7/25,17.78%,FGF10;GAB2;FLT3;KL;AKT2;FRS2;PIK3CA
gsea,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,-0.1672545404186612,-0.730076687066738,0.9455909943714822,0.9112811024799549,1.0,19/91,19.13%,NFYB;GPS2;MED4;SIN3B;MED19;HMGCS1;MED10;TBL1XR1;ARNT2;MED7;MED9;MED31;ESRRA;TBL1X;MED21;MIA3;HMGCR;NR1H2;TXNRD1
gsea,GPVI-mediated Activation Cascade R-HSA-114604,-0.23304765654594153,-0.7275039649381411,0.8517034068136272,0.9129316684129373,1.0,8/19,29.59%,CDC42;LYN;RHOB;PIK3R2;PIK3CB;PTPN11;VAV3;PIK3R1
gsea,Costimulation By CD28 Family R-HSA-388841,-0.1966437548510097,-0.7264439955252385,0.8996062992125984,0.912906235971824,1.0,18/38,37.48%,CDC42;PPP2R1A;PPP2CA;LYN;PPP2R5D;PIK3R2;CD247;MAP3K8;AKT3;PPP2R5B;PTPN11;AKT1;PIK3R1;THEM4;PKN2;PPP2R5A;PDPK1;GRB2
gsea,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,-0.24414618017151452,-0.7257945423600487,0.8674463937621832,0.9124097393896639,1.0,9/18,35.14%,MAPK3;MAPK1;CDKN1B;CREB1;AKT3;AKT1;CCND1;FOXO3;XPO1
gsea,Amino Acid Transport Across Plasma Membrane R-HSA-352230,-0.23458241313772066,-0.7131956299448645,0.8389513108614233,0.9244942955018706,1.0,4/19,17.94%,SLC38A2;SLC3A1;SLC38A5;SLC25A29
gsea,Metabolism Of Steroid Hormones R-HSA-196071,-0.24911484706921264,-0.7125752856674695,0.8697318007662835,0.9238458013956241,1.0,4/16,23.51%,CHGA;FDX2;HSD17B12;SRD5A3
gsea,Signaling By BMP R-HSA-201451,0.2219560008712701,0.7046627445236119,0.8650793650793651,0.9645474691902126,1.0,20/20,77.84%,ZFYVE16;SMURF2;NOG;SMAD1;FSTL1;SKI;SMURF1;ACVR2A;GREM2;UBE2D3;UBE2D1;CHRDL1;BMPR1B;ACVR2B;BMPR1A;SMAD5;SMAD4;SMAD9;SMAD7;BMPR2
gsea,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,0.23690756666281376,0.6969480812835308,0.8556910569105691,0.9669286697703824,1.0,3/16,16.74%,MAPK10;MAP3K7;MAP2K4
gsea,Keratinization R-HSA-6805567,-0.23754559685007748,-0.6852855050908716,0.8740601503759399,0.9478862451239585,1.0,3/16,15.81%,KRT10;TCHH;RCAN1
gsea,Branched-chain Amino Acid Catabolism R-HSA-70895,-0.21488246983671833,-0.6852369424334338,0.8888888888888888,0.9466586604969662,1.0,5/21,18.20%,ACAD8;ALDH6A1;LDHD;DBT;IVD
gsea,Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,-0.2332571673885914,-0.6831870785000814,0.906934306569343,0.9471630398102658,1.0,9/17,36.98%,VDAC2;FDX2;ARNT2;MIA3;CYP46A1;AHR;PTGIS;CYP7B1;FDX1
gsea,Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,-0.22460077883410928,-0.6824022622792305,0.9034090909090909,0.9465259096572118,1.0,7/17,35.36%,PIGF;DPM2;PIGH;PIGP;PIGB;PIGM;PIGN
gsea,Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,-0.19160201854910763,-0.6784970158623427,0.9328358208955224,0.9483488015852571,1.0,10/30,31.50%,CDK4;UBE2S;ANAPC11;CDKN1B;CCND3;CDC26;ANAPC16;CDC16;CCND1;UBE2E1
gsea,RUNX2 Regulates Bone Development R-HSA-8941326,-0.2203189734054816,-0.673227211980451,0.9143897996357013,0.9511572692697391,1.0,6/18,28.40%,MAPK3;MAPK1;CBFB;HEY1;MAF;SMAD4
gsea,Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,-0.1669187767985033,-0.6718226775071484,0.9768339768339769,0.9509286587454405,1.0,29/66,37.93%,PMM1;DPM3;CMAS;SLC35A1;NANP;ALG13;DPM2;EGFL7;ALG14;GFPT2;GNPNAT1;AMDHD2;GNE;SRD5A3;DPM1;ST6GAL1;UAP1;ALG5;ST6GALNAC6;ST3GAL1;FPGT;ALG6;GFUS;PGM3;ST8SIA4;FUOM;ST6GAL2;ALG11;ALG3
gsea,Metabolism Of Steroids R-HSA-8957322,-0.15130532215412212,-0.6701705175573687,0.9887640449438202,0.9508869990251889,1.0,20/95,26.14%,RAN;SUMO2;SQLE;NFYB;MSMO1;HMGCS1;TBL1XR1;FDPS;CHGA;FDX2;INSIG2;TBL1X;HMGCR;HSD17B12;FASN;SRD5A3;FDFT1;LIN9;OSBPL3;CYP46A1
gsea,Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,-0.21755813283291497,-0.6690430578960777,0.8732394366197183,0.9504292421334921,1.0,7/17,31.50%,UBE2S;ANAPC11;BUB3;CDC26;ANAPC16;CDC16;UBE2E1
gsea,tRNA Modification In Nucleus And Cytosol R-HSA-6782315,0.1752859291412811,0.6587146388423635,0.9593147751605996,0.9929797663739613,1.0,12/39,24.01%,QTRT1;THADA;ALKBH8;TRMT13;CTU2;PUS7;NSUN2;TRMT11;DUS2;TRMU;TYW5;ADAT1
gsea,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,-0.15159735351727813,-0.6488195518742815,0.980701754385965,0.9624283537387652,1.0,26/85,31.15%,PDXK;DHFR;MOCS2;SLC25A16;CYB5R3;PPCS;MMADHC;CYB5A;ALDH1L1;NMNAT3;RFK;PARP16;MMACHC;NAXD;FASN;MTHFD2;PANK3;PANK4;SLC25A19;GSTO1;NAXE;SLC19A2;SLC2A1;PDZD11;TPK1;PTGIS
gsea,Regulation Of Signaling By CBL R-HSA-912631,-0.21872066863732148,-0.6352703948525734,0.9132231404958677,0.9687976964806976,1.0,5/16,23.24%,CLSTN1;LYN;HCK;PIK3R2;PIK3CB
gsea,Signaling By Retinoic Acid R-HSA-5362517,0.20352206946794366,0.631152903021064,0.9355509355509356,1.0,1.0,4/19,17.42%,RARB;PPARD;RDH13;RARG
gsea,Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,0.20520321475858608,0.6272452165183915,0.9214145383104125,1.0,1.0,1/17,1.57%,CDC27
gsea,Phosphorylation Of APC/C R-HSA-176412,0.20902079167753146,0.62208248529511,0.92,0.9991118863361633,1.0,1/16,1.57%,CDC27
gsea,Diseases Of DNA Repair R-HSA-9675135,-0.1754425930861898,-0.621166023101703,0.9647887323943662,0.9743947826266558,1.0,6/37,18.07%,SEM1;RFC3;RPA3;XRCC2;RAD50;RAD51
gsea,Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,0.19580678979674204,0.6149327314095373,0.9564356435643564,0.9974996397434086,1.0,1/19,1.57%,CDC27
gsea,Transcriptional Regulation By E2F6 R-HSA-8953750,0.17494451991284463,0.6095883528670666,0.9613152804642167,0.994966465524272,1.0,13/28,31.12%,EHMT1;MGA;PHC3;EHMT2;EZH2;SUZ12;EPC1;PCGF6;APAF1;RBBP4;E2F6;PHC1;L3MBTL2
gsea,HS-GAG Degradation R-HSA-2024096,0.21319525981681353,0.6070588062989944,0.9333333333333333,0.9912659166282596,1.0,3/15,18.26%,GPC5;GPC3;NAGLU
gsea,G1/S-Specific Transcription R-HSA-69205,-0.19391411715556944,-0.6044482330734371,0.9628180039138943,0.980158168384344,1.0,4/20,25.80%,DHFR;PCNA;E2F4;LIN9
gsea,G0 And Early G1 R-HSA-1538133,0.18618211178198513,0.5832138780194086,0.976,0.994926537028006,1.0,4/19,20.24%,HDAC1;MYBL2;LIN52;LIN54
gsea,RHOD GTPase Cycle R-HSA-9013405,0.14825416346082568,0.5721353747199497,0.9899193548387096,0.9933380519943943,1.0,13/44,26.36%,LBR;CPNE8;SLC4A7;STEAP3;VANGL1;LEMD3;ARHGAP32;FILIP1;MOSPD2;TMPO;DBN1;ANKFY1;PLXNB1
gsea,Nicotinate Metabolism R-HSA-196807,0.1860526399684226,0.5647514347009942,0.9746835443037974,0.9904702784420711,1.0,8/18,31.07%,NUDT12;RNLS;NMNAT2;PTGS2;NMRK1;NT5E;PARP6;NAMPT
gsea,Keratan Sulfate Biosynthesis R-HSA-2022854,-0.18412193474174893,-0.55713653830829,0.9825918762088974,0.992646823045507,1.0,9/18,40.03%,CHST1;LUM;OGN;CHST2;B4GALT6;ST3GAL1;B4GALT2;B4GALT5;B4GAT1
gsea,Mitochondrial tRNA Aminoacylation R-HSA-379726,-0.18000372411966356,-0.5378626243680206,0.9906367041198502,0.9951708242593362,1.0,6/18,28.96%,WARS2;FARS2;PARS2;DTD1;PPA2;YARS2
gsea,Activation Of ATR In Response To Replication Stress R-HSA-176187,-0.16630600488540456,-0.5311955400183133,0.987012987012987,0.9948828976887194,1.0,6/24,37.19%,RFC3;RPA3;RAD9B;MCM6;ORC4;CDC7
gsea,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,-0.16621215244718446,-0.5077814752226648,0.9945155393053017,0.9963954676835878,1.0,9/19,41.83%,ALG13;EGFL7;ALG14;MOGS;ALG6;ALG11;ALG3;GLB1;ALG2
gsea,Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,0.15124133828448696,0.4384643863223455,0.9958677685950413,0.9991045301860328,1.0,3/15,20.24%,HDAC1;LIN52;LIN54
gsea,Activation Of Pre-Replicative Complex R-HSA-68962,-0.14156094568740368,-0.4328455802736462,0.998109640831758,0.9992150101139126,1.0,5/20,37.19%,RPA3;MCM6;PRIM1;ORC4;CDC7
